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Carer: A person who self-defines as a family member or friend who acts as an unpaid carer 
for the patient (Froggatt et al., 2018).   
Chief Investigator: The individual who takes primary overall responsibility for the design, 
conduct and reporting of a trial (National Institute for Health Research, 2019b).   
Clinical recruitment centre: A clinical setting such as a hospital or hospice where 
recruitment activity takes place, also referred to as trial or research site in the literature 
(Bruhn et al., 2019).  
Health care professional or clinician: A generic term for medical, nursing and allied health 
care professionals working in the clinical recruitment centres.  
Medical staff or doctor: Medically trained clinicians whose role is to recruit participants to a 
palliative care trial.  
Nurse or nursing staff: A generic term for nurses responsible for recruiting participants to a 
palliative care trial and includes both research nurses and specialist nurses.  
Principal Investigator: The person responsible for the conduct of a trial in a clinical 
recruitment centre (National Institute for Health Research, 2019b). In the case of a single-
centre trial, the Chief investigator and the Principal Investigator will normally be the same 
person (Health Research Authority, 2018). 
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Randomised controlled trial or trial: In this thesis, both terms have been used to indicate a 
randomised controlled trial. Where this is not the case, this has been clearly indicated in the 
text. An in-depth definition of a randomised controlled trial is provided in chapter one.  
Recruiting staff: Health care professionals, both medical and nursing staff, directly involved 
in recruiting participants to a palliative care trial.   
Research nurses: Research nurses work in clinical recruitment centres and their role 
typically involves; screening and recruitment of participants, ensuring informed consent, 
operationalising randomisation procedures, collecting and recording data and following 
participants up during the trial (Spilsbury et al., 2008). 
Specialist nurses: Specialist nurses are dedicated to a particular area of nursing such as 
cancer, palliative care, heart failure or dementia. They provide direct patient care and can 
play a vital role in educating patients on how best to manage their symptoms, as well as 
offering support following diagnosis (Liljeroos & Strömberg, 2019; Wallace et al., 2019).  
Study Coordinating Centre: Responsible for general oversight of the conduct of the trial and 
overall data management, monitoring and communication among all of the clinical 
recruitment centres (John Hopkins Medicine, 2016).   
Study coordinating centre staff: A generic term for researchers who work in the trial’s study 






Introduction: Trial recruitment is an interactional process between health care 
professionals, patients and carers. There is limited understanding of how health care 
professionals carry out this role in palliative care trials as well as the reasons why they do or 
do not recruit eligible participants. The ‘6 Ps’ of the ‘Social Marketing Mix Framework’ may 
help guide recruitment planning, but most evidence is anecdotal. The ‘6 Ps’ are; identifying 
participants, product, price, place, promotion and working with partners.  
Aims: To explore how health care professionals undertake recruitment to palliative care 
randomised controlled trials and the factors that influence the strategies they use and the 
decisions they make during the recruitment process.      
Method: A narrative synthesis of palliative care trial recruitment barriers and facilitators 
identified in existing trial literature informed the study design. A qualitative multiple case 
study, using Yin’s approach, was conducted. Cases were diverse UK palliative care trials 
across a variety of settings. Participants included study investigators and research staff 
involved in the recruitment process from trial coordinating centres and clinical recruitment 
sites. Data collection included interviews and study documentation. Analysis was informed 
by developing and refining theoretical propositions, guided by the ‘6Ps’ as an initial 
analytical framework. Framework Analysis guided within and then cross-case analysis. 
Results Three cases were included in the study (n = 3, 9, 7 participants). Cross-case analysis 
suggests the ‘6 Ps’ are a useful framework for understanding recruitment processes but 
wider contextual issues also need to be incorporated. These include the ‘emotional labour’ 
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of diagnosing dying and communicating palliative and end-of-life care to potential 
participants and how the recruitment process is influenced by the power relationships and 
hierarchies that exist among professional groups. These factors can lead to and support 
paternalistic practices. 
Discussion/conclusion Those planning trials need to ensure that trial recruiters, depending 
on their experience and trial characteristics, have access to training and support to address 
the ‘emotional labour’ of recruitment. Consideration also needs to be given to who is 















Chapter one: Background and Introduction 
1.1 Introduction  
 
Fewer than 50% of randomised controlled trials achieve their recruitment targets (Treweek 
et al., 2018) with reports of palliative care trials only reaching their recruitment targets in 
37% of cases (Bouça-Machado et al., 2017). Health care professionals play a key role in the 
recruitment process (Preston et al., 2016), but why they do or do not recruit potentially 
eligible patients and family carers to palliative care randomised controlled trials is poorly 
understood. In this study, how health care professionals involved in the recruitment process 
recruit patients and family carers to palliative care randomised controlled trials, is identified. 
Why they choose to implement particular recruitment strategies, and the factors that 
influence their choices, when recruiting to a palliative care trial is also explored.  
In this chapter, why palliative care research and more specifically recruitment issues in 
palliative care randomised controlled trials has been chosen as the focus of this study is 
discussed. The factors that influence the definition of a palliative care randomised 
controlled trial are presented as well as the key issues and challenges found in palliative 
care research. The role of randomised controlled trials in palliative care, their key features 
and the challenges associated with this study design is examined. How recruitment is 
defined and why it is challenging to achieve recruitment targets in palliative care trials is 
explored. Finally, the type of theoretical frameworks that can inform the recruitment 
process are discussed and why the ‘Social Marketing Mix’ was chosen as the theoretical 




1.2  My background as a researcher 
 
I am a registered nurse and the majority of my career has been spent in the speciality of 
palliative care. I have previous experience of working as a specialist palliative care nurse in a 
hospital and community setting. This role involved managing the complex physical and 
psychosocial needs of palliative care patients and their carers and working closely with 
members of the wider multi-disciplinary team. I also have previous experience of working as 
a palliative care research nurse in a hospice setting. This role involved recruiting patients 
and carers to palliative care research studies including randomised controlled trials. For 
example, I was involved in setting up and recruiting to a multi-centre randomised double 
blind placebo controlled trial of Ketamine for neuropathic pain. The trial was challenging to 
set up and recruit to and only one patient was recruited from the hospice (Dunleavy et al., 
2011).  
These experiences strongly influenced the topic and focus of my research as I had some 
insight into the challenges of palliative care research and more specifically recruiting 
patients and carers to palliative care trials. During my PhD, I was no longer involved in direct 
patient care but was working as a research associate on a number of palliative care trials of 
complex interventions. The issue of reflexivity and how it has been addressed in this study is 
explored in more detail in chapter four. It is also important to note that my supervisors are 
also registered nurses who currently work in palliative care research including as senior 
investigators on palliative care trials. Professor Catherine Walshe has previously worked as a 
community specialist palliative care nurse and Professor Nancy Preston’s background 
includes experience as an oncology research nurse in a specialist cancer hospital. The issue 
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of reflexivity, how it has influenced decision making during this study and how it has been 
addressed is explored across the following chapters.  
 
1.3  What is a palliative care randomised controlled trial?  
 
There is a lack of clarity and consensus surrounding the definition of a palliative care 
randomised controlled trial in the literature (Bausewein & Higginson, 2012; Gaertner et al., 
2016; Sigurdardottir et al., 2014; Van Mechelen et al., 2013; Zafar et al., 2012). This is 
unsurprising as there is a lack of clarity and consensus surrounding the definition of 
palliative care outside the field of research. Despite this lack of clarity and consensus, 
overall, palliative care is associated with providing care with a non-curative intent. A 
palliative care randomised controlled trial, therefore, typically aims to test the effectiveness 
of an intervention with a non-curative intent. 
The modern hospice movement began in 1967 with the opening of St Christopher’s Hospice 
in London (Radbruch & Payne, 2009) and the term palliative care was first introduced in the 
mid-1970s with the speciality of palliative medicine being introduced in the UK in 1987 
(Pastrana et al., 2008). Terms such as supportive care, hospice care, terminal care and end-
of-life care are also used interchangeably in clinical practice, government policy and 
legislation (Cramp & Bennett, 2013). For example, in the UK the National Institute for Health 
and Care Excellence has developed quality standards for end-of-life care which they define 
as those patients who are likely to die within 12 months (National Institute for Health and 
Care Excellence, 2017). Definitions can also vary between countries, for example, in the 
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United States hospice care focuses on those patients with a prognosis of 6 months or less 
(Hui et al., 2013).  
This lack of clarity and consensus over terminology can act as a barrier to communication 
both in clinical practice and in research (Cramp & Bennett, 2013; Hui et al., 2013). Terminal 
care, end-of-life care and palliative care can be viewed as synonymous terms by patients 
(Chosich et al., 2020) and the wider public (McIlfatrick et al., 2014). It has been suggested 
that the term supportive care is less likely to provoke anxiety among patients, carers and 
clinicians as terms such as hospice care and palliative care are often associated with death 
and dying (Hui et al., 2013; Siouta et al., 2018; Zimmermann et al., 2016). This use of 
multiple terms with their associated meanings has implications for the trial recruitment 
process. It has the potential to influence the acceptability of a palliative care trial to 
patients, carers and health care professionals and how it is introduced.  
 
1.3.1 Factors that influence the definition of a palliative care randomised controlled trial 
 
There are a number of complex, interlinked factors that need to be considered when 
attempting to define a palliative care trial. These factors are; who is a palliative care patient; 
what are palliative care needs; where do palliative care patients receive care and from 
whom; what is a palliative care intervention and what outcome measures are used in a 




1.3.2 Who is a palliative care patient? 
 
Palliative care populations are heterogeneous as patients can have different diagnoses and 
comorbidities (Eule et al., 2018; Visser et al., 2015) and as a result, palliative care trial 
populations can vary widely (Currow et al., 2011). Family carers are also included in a 
palliative care population and therefore may also be included in a trial population (Hui et al., 
2011). The World Health Organisation (2002) recommends that the palliative care approach 
be introduced as early as possible in the course of any life-threatening illness and not just 
when the patient is not responding to curative therapy. The World Health Organisation 
definition also recognises the needs of carers, including those who are bereaved (Sepúlveda 
et al., 2002);  
‘Palliative care is an approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual.’ (Sepúlveda et al., 2002) (p.94) 
The International Association for Hospice and Palliative Care has recently developed an even 
broader definition. They found it challenging to achieve agreement between those who 
believe palliative care should be aimed at the relief of all suffering and those who believe it 
involves the care of those with a very limited remaining life span. This difference of opinion 
is reflected in their definition;  
‘Palliative care is the active holistic care of individuals across all ages with serious 
health-related suffering due to severe illness and especially of those near the end of 
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life. It aims to improve the quality of life of patients, their families and their 
caregivers.’ (Radbruch et al., 2020) (p. 761)  
The definition of a palliative care patient chosen for this study reflects an earlier World 
Health Organisation definition of palliative care (World Health Organization, 1990). This 
definition is based on the idea that palliative care is aimed at those patients who are not 
responding to curative therapy, and their family carers. Unlike the original World Health 
Organisation definition that focused on cancer patients with advanced disease, the palliative 
care population in this study also includes those patients living with progressive, life 
threatening non-malignant disease. This decision was influenced by the definition of a 
palliative care patient proposed in a review of palliative care randomised controlled trials 
(Van Mechelen et al., 2013). Van Mechelen et al (2013) proposed that the palliative care 
patient be defined as those living with ‘a progressive, life-threatening disease with no 
possibility of obtaining remission or stabilisation, or modifying the course of the illness’ 
(p.197). It was also informed by the definition of a palliative care patient used in Cochrane 
systematic reviews of palliative care interventions. This example is taken from a Cochrane 
review of pharmacological treatments for fatigue associated with palliative care; 
 ‘Palliative care patients with fatigue, i.e. patients with an incurable disease (terminal 
illness) such as advanced cancer, HIV/AIDS, multiple sclerosis, amyotrophic lateral 
sclerosis, or cardiac, lung or kidney failure.’ (Muecke et al., 2015) (p.4) 
A number of strategies are used to operationalise this definition of a palliative care patient 
in the context of palliative care trials. A trial’s eligibility criteria may include disease staging 
criteria to help recruiting staff determine that the patient has advanced disease with a 
limited life expectancy. For example, a Functional Assessment Staging score of 6 or 7 for 
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those living with advanced dementia (Froggatt et al., 2020), stage iii or iv of the TNM 
(Tumour, Node, Metastases) classification and staging system for non-small cell lung cancer 
patients (Rietjens et al., 2016) or a Hoehn and Yahr score of ≥4 for those living with 
Parkinson’s disease (Veronese et al., 2017). These type of scores would indicate that the 
patient has advanced disease with a limited life expectancy.  
Symptom assessment scales may also be used as part of a trial’s eligibility to define a 
palliative care patient with advanced disease. For example, a modified Medical Research 
Council Scale score of 3 or 4, despite optimal management of underlying cause, for patients 
living with chronic breathlessness with a range of aetiologies (Currow et al., 2019; Ferreira 
et al., 2020). This may also be achieved by clinicians assessing a patient’s prognosis as part 
of a trial’s eligibility assessment (Ferreira et al., 2020; Vanbutsele et al., 2018). In one review 
of palliative care trials, the estimated prognosis of patients varied between ‘less than one 
week’ and 24 months with the most common being 6 months (Bouça-Machado et al., 2017). 
Validated performance status scales such as the Eastern Cooperative Oncology Group 
(ECOG) or the Karnofsky scale may be used to estimate survival, both the original or 
palliative care versions (Abernethy et al., 2005; Chow et al., 2020; Ferreira et al., 2020). 
Disease specific clinical indicators may be used to inform prognostication as illustrated in a 
trial of specialist palliative care for those living with advanced neurodegenerative disorders 






1.3.3 What are palliative care needs? 
 
Patients living with advanced progressive disease can have a variety of complex physical 
needs that may affect their quality of life. For example, they may need help managing 
symptoms such as pain, fatigue, nausea and vomiting, dyspnoea, insomnia, appetite loss 
and constipation (Carvajalino et al., 2018; Verkissen et al., 2019). They may also have 
psychological, social and spiritual needs that may affect their quality of life. For example, 
psychological distress is common in advanced progressive disease (Boakye et al., 2019) with 
higher rates of distress seen in patients with increased symptom burden (Fitzgerald et al., 
2015). Those living with advanced cancer or end stage non-malignant disease may 
experience different symptoms and illness trajectories (Currow et al., 2011). For example, 
those living with heart failure, chronic obstructive disease and end stage renal failure were 
found to have less functionality in their activities of daily living compared to cancer patients 
on referral to specialist palliative care (Bostwick et al., 2017). Family carers may also have 
psychosocial and spiritual needs that need to be addressed (Dunleavy et al., 2020; Grande et 
al., 2017). This holistic focus of care is reflected in the 2002 World Health Organisation 
definition of palliative care outlined above.  
 
1.3.4 Where does the palliative care patient receive care and from whom? 
 
Patients living with advanced progressive disease are cared for in a variety of clinical settings 
that includes hospitals, hospices, nursing homes and primary care. Patients may also be 
cared for in different areas within these settings such as inpatients, outpatients, day care or 
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home care. The number of patients who will require palliative care is predicted to increase 
over the coming years because of the ageing population and the number of people living 
and dying with chronic and complex conditions (Etkind  et al., 2017). It has been estimated 
that end-of-life care provision in care homes and the community needs to double by 2040 to 
meet this need (Bone et al., 2018). 
Palliative care is also provided by generalist or specialist palliative care services. Generalist 
palliative care is provided by the patient’s usual care team and specialist palliative care is 
provided by professionals specifically trained in palliative care who work full time in this 
area (Bausewein & Higginson, 2012). How this type of care is provided may differ slightly 
between countries but generally inpatient specialist palliative care is provided in dedicated 
palliative care units or hospices (Bausewein & Higginson, 2012). Specialist palliative care 
teams provide advice and support either in the hospital and/or in the community setting 
(Bajwah et al., 2020; Bausewein & Higginson, 2012). Specialist palliative care provision may 
also be the intervention in a palliative care trial as illustrated in a recent Cochrane review of 
hospital based specialist palliative care (Bajwah et al., 2020).  
 
1.3.5 What is a palliative care intervention? 
 
Defining a palliative care trial intervention can be challenging as terms such as palliative care 
or best supportive care can also be used to define a control group in an oncology treatment 
trial (Bausewein & Higginson, 2012; Zafar et al., 2012).  Palliative care interventions are 
interventions that have a non-curative intent. They can be heterogeneous but a typical 
palliative care intervention would be a complex intervention that reflects a holistic and 
28 
 
multi-disciplinary approach to care or the administration of medication for symptom control 
(Van Mechelen et al., 2013).  Trials may also test non-pharmacological single interventions 
such as aromatherapy to improve quality of sleep (Kawabata et al., 2020). 
Trial interventions may be taken from other patient populations and applied to those living 
with advanced progressive disease. For example, the use of physiotherapy for fatigue in 
advanced cancer (Pyszora et al., 2017) or mindfulness to reduce stress in advanced cancer 
or non-malignant disease (Warth et al., 2020). Interventions may also be developed 
specifically to meet the needs of those living with advanced progressive disease. For 
example, the development of the Gold Standard Framework intervention for use in care 
homes to prevent unnecessary hospital admissions (Kinley et al., 2014) or the 
implementation of early palliative care telehealth in advanced heart failure (Bakitas et al., 
2020). Palliative care interventions, like those in the general trial literature, can be poorly 
reported, especially in non-pharmaceutical trials (Bausewein & Higginson, 2012). The TIDieR 
12 item checklist has been developed to improve the reporting of interventions in trials and 
therefore potentially their replicability (Hoffmann et al., 2014).  
 
1.3.6 What is a palliative care trial outcome measure? 
 
The main goals of palliative care are to relieve and prevent suffering and improve quality of 
life as illustrated in the definitions outlined above (Pastrana et al., 2008; Radbruch et al., 
2020).  In a palliative care trial, the primary outcome is usually quality of life and/or 
symptom control (Gaertner et al., 2016; Van Mechelen et al., 2013; Vinches et al., 2020) 
rather than survival or tumour/disease response (Hui et al., 2011). A recent review of 
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palliative care studies for advanced cancer listed on the clinicaltrials.gov database found the 
most applied primary outcome measures were efficacy/symptom control (61%), quality of 
life (14%) and feasibility (12%) (Vinches et al., 2020). Temel et al (2010) showed an 
improvement in overall survival as well as quality of life in lung cancer patients who received 
early palliative care and standard oncology care compared with those who received 
standard oncology care alone (Temel et al., 2010). As a result, it was suggested that it may 
be possible for a trial testing a palliative care intervention to use survival as its primary 
endpoint (Radbruch, 2014). Follow up trials of early palliative care have, however, continued 
to use quality of life as their primary outcome (Johnsen et al., 2019; Vanbutsele et al., 2018). 
 
1.3.7 The working definition of a palliative care randomised controlled trial used in this 
study 
 
The working definition of a palliative care randomised controlled trial used in this study is: 
A trial aimed at; adult patients with incurable cancer and/or advanced, progressive non-
malignant disease and their family carers; that aims to address physical, psychosocial and/or 
spiritual needs; with an intervention with a non-curative intent; in any setting; by specialist 
or generalist professionals; and where the primary endpoint is usually symptom control 
and/or quality of life. 
This definition informed the development of the randomised controlled trial definition for 
the systematic review in chapter two. Both these definitions then subsequently influenced 
the definition of a randomised controlled trial used in the case study.  
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Table 1: More detailed explanation of the working definition of a palliative care 
randomised controlled trial used in this study.  
Trial population 
 
Adult patients with incurable cancer and/or advanced, progressive 
non-malignant disease and their family carers.  
Needs of the trial 
population 




Hospital, hospice, nursing home and/or primary care. Areas within 
these settings such as inpatients, outpatients, day care or home care. 




Interventions that have a non-curative intent. Typically, a complex 
intervention that reflects a holistic and multi-disciplinary approach to 
care or the administration of medication for symptom control. Trials 
may also test non-pharmacological single interventions.  
Trial outcome 
measure  
Primary endpoint symptom control and/or quality of life. Trials that 
test an intervention that is clearly a palliative care intervention and 
the study primary endpoint is survival.  
 
 
1.4 Palliative care research  
 
There is a call to improve the evidence base in palliative care through the conduct, 
publication and implementation of high quality research (Higginson, 2016; LeBlanc et al., 
2010; Vinches et al., 2020; Visser et al., 2015). Visser et al (2015) warned that ‘despite the 
growth in published literature, palliative care is not an evidence-based discipline, or at least 
it is not informed by the level of evidence which most would require to label it such’ (p.198). 
The majority of treatments, interventions and guidelines commonly used in palliative care 
have little supporting trial evidence (Higginson et al., 2013; LeBlanc et al., 2010; Watts et al., 
2019). For example, the use of benzodiazepines for the relief of breathlessness in advanced 
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cancer or chronic obstructive pulmonary disease (Simon et al., 2016) or the use of 
haloperidol for nausea and vomiting in palliative care (Murray‐Brown & Dorman, 2015) has 
little supporting trial evidence.  
 
1.4.1 Palliative care research funding and infrastructure 
 
Palliative care research is historically underfunded in comparison to research into the 
prevention and cure of life-limiting illnesses (Higginson, 2016). A recent search of the 
clinicaltrials.gov database found over 69,000 cancer studies, out of those only 514 studies 
(0.8%) were palliative care studies (Vinches et al., 2020). A bibliometric analysis of European 
cancer research papers from 2002 to 2013 found only 1.2% of papers focused on palliative 
care research (Begum et al., 2018). In the United States, fewer than 1% of all grants 
awarded by large national funders were awarded to investigators performing palliative care 
research (Brown et al., 2018) and funding for palliative care research was 0.03% of overall 
heart failure funding by the National Institutes of Health (Xie et al., 2017). 
Non hospital settings, where palliative care patients are largely cared for, often lack or have 
limited research infrastructure. This includes; limited access to research funding, staff with 
the relevant expertise, protected time for clinicians and the necessary governance 
structures to facilitate research activity (Dunleavy et al., 2011; Edwards et al., 2019; Moore 
et al., 2019; Oliver et al., 2020). These contextual factors can make it challenging to carry 




1.4.2: The issue of vulnerability in palliative care research 
 
Palliative care patients are viewed as vulnerable and usually present with at least one or 
several characteristics of vulnerability (see table 2) (Pereira & Hernández-Marrero, 2019).       
Patients can be frail and have a high symptom burden (LeBlanc et al., 2013) as illustrated in 
a recent feasibility trial, where 63% of those taking part required help to complete study 
questionnaires (Lovell et al., 2020). Patients can have a limited life expectancy, be living with 
prognostic uncertainty and be dealing with many competing demands (LeBlanc et al., 2013). 
Patients can deteriorate rapidly or die before they are recruited or be too cognitively 
impaired to consent to a study (Kaiser et al., 2020; Stone et al., 2013). There may need to be 
the involvement of a consultee or proxy if the patient lacks capacity which can add 
additional complexity to the research process (Hickman et al., 2012; Kaiser et al., 2020).  
 
Table 2: Characteristics of vulnerability taken from Pereira and Hernandez-Marrero (2019) 
(p.1) 
Cognitive Does the person have the capacity to understand and make a 
decision? 
Situational Is the person in a situation in which medical exigency prevents the 
education and deliberation needed to decide? 
Medical  Has the person a serious health-related condition with limited 
prognosis? 
Allocational Is the person lacking in important social goods that can influence his 
or her decision? 
Social  Does the person belong to a group whose rights and interests have 
been socially disvalued? 
Deferential  Is the person’s deferential behaviour masking an underlying 




Palliative care patients are viewed as particularly vulnerable as they near the end of life 
(Bloomer, Hutchinson, et al., 2018; LeBlanc et al., 2013). Concerns about vulnerability leads 
to a preconception that palliative care patients require extra protection from potential 
exploitation (Abernethy et al., 2014). They can be excluded from taking part in research 





Fear of potential patient burden and concerns about vulnerability can lead health care 
professionals (Kaiser et al., 2020; Snowden & Young, 2017), research ethics committees 
(Gardiner et al., 2010), family carers (Bull et al., 2019; Gysels et al., 2008), management 
within organisations (Kars et al., 2016) and even study researchers (Coyle et al., 2016; 
Hickman et al., 2012) to act as gatekeepers. Gatekeeping is when a gatekeeper prevents a 
potential participant from receiving information about a research study for which they are 
eligible (Agar et al., 2013; Kars et al., 2016). Assumptions are made that the research is too 
intrusive or burdensome, that it may be upsetting, give false hope or yield no benefit for the 
patient (LeBlanc et al., 2013). Clinicians may feel reticent towards research, feel they lack 
the relevant expertise and worry that the research may over burden the patient’s family 
carers (Kars et al., 2016).   
Gatekeeping is not unique to palliative care research (Williams, 2020) but is seen as a 
particularly challenging issue in this population (Kars et al., 2016; Snowden & Young, 2017; 
White et al., 2008). Current evidence suggests that patients can value participation in 
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research and are willing to engage in research even when they are close to death (Bloomer, 
Hutchinson, et al., 2018; Coyle et al., 2016; Gysels et al., 2013; White et al., 2019).  Family 
carers (Aoun et al., 2017), including those who are bereaved (Barclay et al., 2019), can also 
value participating in research despite the stress of caring for or losing a close relative. The 
reasons why gatekeeping occurs in palliative care research, especially health care 
professional gatekeeping, requires further exploration and research.  
 
1.5 Randomised controlled trials in palliative care research 
 
The concept of randomisation was introduced in agricultural research by Fischer in the 
1920s. The first randomised controlled trial in health care that used random number 
allocation was the Medical Research Council’s 1946 streptomycin trial (Friedman et al., 
2010; Medical Research Council Streptomycin in Tuberculosis Trials Committee, 1948). In a 
randomised controlled trial; 
‘Two or more groups are formed through random allocation; one or more of the 
groups is exposed to an intervention (experimental group), while the other group(s) 
receive(s) an alternative treatment or no treatment (comparison or control group). 
The effects of the intervention are observed by comparing the outcomes of both 
groups.’ (Torgerson, 2008) (p.2)  
The role of randomised controlled trials in improving the evidence base in palliative care has 
been debated in the literature (LeBlanc et al., 2010; Visser et al., 2015). They only make up a 
small part of the evidence base in palliative care (Eule et al., 2018; Hui et al., 2012; Hui et al., 
2011; Rinck et al., 1997; Tieman et al., 2008). In 2005, only 7.22% of published palliative care 
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and hospice papers were clinical trials (Tieman et al., 2008) while a search of the supportive 
and palliative oncology literature in the first 6 months of 2004 and 2009, found that 
randomised controlled trials comprised only 6% of the studies identified (Hui et al., 2011). 
Even though the minority of studies in palliative care are randomised controlled trials, their 
numbers are increasing. Of the 107 trials included in a review of therapeutic interventions 
searched in Medline until February 2015, 13 were published between 1989 and 1999, 49 
between 2000 and 2009 and 44 between 2010 and 2015. The majority of these trials 
focused on oncology and 43% evaluated pharmacological interventions (Bouça-Machado et 
al., 2017).  
 
1.6 Why randomised controlled trials are important 
 
The early 1990s saw the rise of evidence-based practice in health care with high quality 
randomised control trials being placed towards the top of the evidence pyramid. Evidence- 
based practice challenged traditional unsystematic approaches to care which could lead to 
poor patient outcomes by arguing clinical decisions needed to be based on research 
evidence (Guyatt et al., 1992). In the UK, randomised controlled trials receive the greatest 
funding and support from the National Institute for Health Research Clinical Research 
Network which illustrates their importance in evidence-based practice (see chapter five for 
further details) (National Institute for Health Research, 2019c).  There are various versions 
of the evidence pyramid but most represent a hierarchy related to the study design’s risk of 
bias (internal validity) (Murad et al., 2016).  
36 
 
The key purpose of randomised controlled trials is to test whether an intervention is 
effective. This is achieved by assessing and expressing causality between an independent 
and dependent variable/s. For example, whether a pain control medication, the         
independent variable, improves the patient’s pain scores and quality of life, the dependent       
variables. A key characteristic of randomised controlled trials is that known and unknown 
confounding variables (bias) are intended to be distributed equally through the 
randomisation process. Randomisation does not eliminate confounding variables but 
distributes such variables equally so reducing the overall bias in the trial (Bennett, 2007). 
This gives greater confidence that any effects are due to the intervention rather than a 
result of some other known or unknown variable (Torgerson, 2008) with the treatment 
effect being the additional change that occurs in the intervention group compared to the 
control group (King, 2000). This is the reason why randomised controlled trials are placed 
towards the top of the pyramid in evidence-based practice.   
In comparison, quasi-experimental studies such as pre and post-test designs or 
observational studies are used to identify whether a relationship or association exists 
between variables rather than a causal effect (Bennett, 2007; Costantini, 2007; Torgerson, 
2008). Non randomised study designs are seen to have less internal validity because they 
can reportedly overestimate treatment/intervention effects (Concato et al., 2000; 
Torgerson, 2008). This is the reason why they are situated lower down the evidence 
pyramid.  
There have been a number of criticisms of the evidence-based movement and its over 
reliance on randomised controlled trial methodology. There is often an assumption that 
trials are of a high quality and there is no risk of bias but this is dependent on how well the 
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trial is conducted as illustrated by the use of risk of bias tools in systematic reviews of 
randomised controlled trials (Sterne et al., 2019). Other criticisms include; how trial findings 
may not be useful for clinical decision making as tightly controlled trial populations are likely 
to differ from patients in the real world who may have multiple morbidities, how statistically 
significant benefits may only be minimal in clinical practice and how it ignores the role and 
value of clinical experience and judgement and individualised patient care. The risk of bias 
‘quality mark’ can also be misused by those with a vested interest, for example, 
pharmaceutical companies only publishing positive rather than negative trial findings for 
financial gain (Greenhalgh et al., 2014). The idea that too much trust is placed on the 
randomised controlled design (Deaton & Cartwright, 2018) and the need for evidence-based 
practice to be built on a wider range of study types, including qualitative research to explore 
‘why things work’, has been recognised (Greenhalgh et al., 2014). 
 
1.7 Randomised controlled trial study designs and characteristics 
 
Randomised controlled trials can have different designs and characteristics and these are 
summarised in table 3 with an example from the palliative care literature. This information 
has been provided to contextualise the recruitment process and its associated challenges.  
 
Table 3: Randomised controlled trial study designs and characteristics with a palliative care exemplar 
 






Ask whether the intervention can work under ideal conditions (Loudon et al., 
2015). Characterised by tightly defined inclusion/exclusion criteria, usually 
testing drugs with a placebo as a control arm (Torgerson, 2008).   
‘Efficacy of oral risperidone, haloperidol, or 
placebo for symptoms of delirium among 
patients in palliative care: A randomized clinical 
trial’ (Agar et al., 2017) 
Pragmatic 
randomised 




Ask whether the intervention works under usual conditions so aiming to increase 
the trials applicability in ‘real world’ settings (Loudon et al., 2015). Pragmatic 
trials frequently include complex interventions. (Ford & Norrie, 2016) with the 
comparator being usual care (Loudon et al., 2015). *It is important to note that 
the explanatory/pragmatic trial distinction is a continuum rather than a 
dichotomy (Loudon et al., 2015). 
‘Early palliative care and quality of life of 
advanced cancer patients: A multi-center 




In a double blind trial, the participant, the researchers/clinicians are not aware of 
the intervention allocation. In a single blinded study generally either the 
researcher or participant/clinician is not aware. In an un-blinded trial both the 
participant and the researcher/clinician know the intervention allocation. 
(Friedman et al., 2010). 
Single blinded example (research staff blinded 
to intervention allocation) 
Emergency department–initiated palliative 
care in advanced cancer: a randomized clinical 
trial (Grudzen et al., 2016) 
Placebo/sham 
trials  
Participants are randomly allocated to an active or placebo drug so that patients 
and researchers/clinicians can be blinded to the group allocation so reducing the 
Hawthorne/patient preference effect (Torgerson, 2008). The Hawthorne effect is 
a change in behaviour as a response to observation and assessment (Sedgwick & 
Greenwood, 2015). Patients can also be given a ‘sham’ intervention (Torgerson, 
2008). (see cross over trial example) 
‘Oral medicinal cannabinoids to relieve 
symptom burden in the palliative care of 
patients with advanced cancer: a double-blind, 
placebo controlled, randomised clinical trial of 
efficacy and safety of cannabidiol (CBD)’(Good 






A feasibility trial ‘asks whether something can be done, should we proceed with it, 
and if so, how.’ A pilot study asks the same questions but incorporates a future 
study or part of a future study on a smaller scale (Eldridge et al., 2016) (p.1). 
‘A group intervention to improve quality of life 
for people with advanced dementia living in 
care homes: the Namaste feasibility cluster 
RCT’ (Froggatt et al., 2020) 
Cross-over trial Patients are randomised to a sequence of treatments after a ‘washout’ period. 
The condition being studied needs to be relatively stable and the intervention 
short-acting (Hui et al., 2015). 
‘Transcutaneous electrical nerve stimulation 
for advanced cancer pain inpatients in 
specialist palliative care—a blinded, 
randomized, sham-controlled pilot cross-over 
trial’ (Siemens et al., 2020) 
No of 1 trial A cross-over trial that involves an individual participant being randomised to 
receive the study interventions in different orders. Sometimes data can be 
aggregated from multiple patients completing an N-of-1 trial. (Duan et al., 2013). 
Unit of randomisation is the treatment order. Role in examining rare symptoms 
in palliative care patients (Hui et al., 2015).  
‘The effect of methylphenidate on fatigue in 
advanced cancer: An aggregated N-of-1 trial’ 
(Mitchell et al., 2015) 
Wait list/fast 




Patients are randomised to either an early intervention group or a late 
intervention group that is characterised by an observation period (the control) 
followed by the study intervention. Often used to examine complex health 
interventions (Higginson & Booth, 2011; Hui et al., 2015).  
How effective are volunteers at supporting 
people in their last year of life? A pragmatic 
randomised wait-list trial in palliative care 






A trial where clusters of individuals such as a nursing home or hospital rather 
than individuals themselves are randomised to different arms (Torgerson, 2008). 
Popular design in pragmatic trials (Ford & Norrie, 2016). The intervention may be 
provided at the cluster and/or individual level. Outcomes are measured at the 
individual cluster member level (Weijer et al., 2012).  
 
‘The action study protocol: Advance care 
planning - An innovative palliative care 
intervention to improve quality of life in 
oncology a multi-centre cluster randomized 







All clusters receive the new intervention, yet the moment at which they do so is 
determined by random assignment. Pragmatic constraints may also influence 
assignment. In cohort stepped-wedge cluster trials, all participants are exposed 
to both the control and the intervention (Eichner et al., 2019) while in cross-
sectional designs, new participants are included after each step (de Hoop et al., 
2015).  
Cross-sectional design: ‘Assessing the impact of 
a Carer Support Needs Assessment Tool 
(CSNAT) intervention in palliative home care: a 





Two or more different interventions are evaluated using the same participant 
sample (Torgerson, 2008) (p.xii).   
Delivery strategies to optimize resource 
utilization and performance status for patients 
with advanced life-limiting illness: results from 
the "palliative care trial’’ (Abernethy et al., 
2013) 
Participant 
preference trial  
Participant preferences are taken into account by asking them before 
randomisation and by only randomising those who do not have a preference so 
letting those with a preference have their preferred intervention (p. xiv) 
(Torgerson, 2008).  
Advance care planning uptake among patients 
with severe lung disease: a randomised patient 
preference trial of a nurse-led, facilitated 
advance care planning intervention (Sinclair et 
al., 2017) 
Zelen method Participants are randomised before consent, consent only sought from those 
receiving the intervention (Torgerson, 2008). Control group participants remain 
in the study without being informed of the randomisation procedure as they are 
receiving usual care. Those who refuse consent in the intervention group are 
reassigned to the control group. (Zelen, 1979). 
‘Multi-center randomized controlled trial for 
advanced cancer patients receiving parenteral 
nutrition (PN) versus oral feeding (OF): Results 




1.8 The challenges of randomised controlled trials in palliative care 
 
A randomised controlled trial is seen as the ‘gold standard’ for evaluating the safety and 
effectiveness of a health and social care intervention because its central tenet is to reduce 
bias (Torgerson, 2008; Treweek et al., 2013). It has been suggested that randomised 
controlled trials can often be impractical and may even be unethical in the palliative care 
population because of the characteristics of the study design (Aoun & Nekolaichuk, 2014; 
Hadley et al., 2009). Trials can encounter recruitment difficulties, which is discussed in detail 
in section 1.12, and experience high rates of attrition. 
 
1.8.1 High rates of attrition 
 
Palliative care trials can experience high rates of attrition because of high mortality rates 
and symptom burden not related to the trial. Statistical power may be reduced or may not 
be achieved because of patients withdrawing from the study before the evaluation of the 
main study outcomes due to death, illness or for other reasons (Oriani et al., 2020). 
Statistical power relates to the chances of observing any statistically significant difference 
between the intervention and control group if in fact that difference exists (Torgerson, 
2008). Treatment effects may be biased and the generalisability of study findings may be 
impacted as there may be significant differences between the trials arms because of 
attrition (Hussain et al., 2016). Attrition can also be an issue in other research designs in 
palliative care (Harrop, Noble, et al., 2016; Higginson & Booth, 2011) but specific guidance 
has been produced to help manage attrition reporting and interpretation in palliative care 
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trials (Preston et al., 2013). This high risk of attrition means it is crucial for palliative care 
trials to achieve their recruitment targets to try and achieve statistical power.   
 
1.8.2 Internal and external validity 
 
The complex balance between maintaining the internal and external validity of a trial is not 
a problem unique to palliative care (Ford & Norrie, 2016). In palliative care, multiple 
interventions or treatments may be implemented to address the patient’s diverse and 
complex needs which can make it difficult to determine the effects of one intervention 
among many (Visser et al., 2015). Explanatory symptom control trials (see table 3) taking 
place in specialist centres with narrow eligibility criteria are seen to have good internal 
validity but poor external validity (Kirkham & Abel, 1997). While concerns about the internal 
validity of a palliative care trial where there is considerable heterogeneity between patients 
receiving the same intervention has also been raised (Hadley et al., 2009; Visser et al., 
2015). Pragmatic trial designs (see table 3) with broad eligibility criteria testing complex 
interventions are seen to help address the generalisability concerns of a traditional 
explanatory randomised controlled trial (Torgerson, 2008). Finding eligible patients may be 
less challenging in pragmatic designs but they may require a larger sample size to 
understand any differences between groups in the trial population (Ford & Norrie, 2016). 
Using qualitative research within these type of trials is recommended (Craig et al., 2008) and 
has been used to inform intervention content and delivery, trial design, conduct and 
processes (including recruitment processes), study outcomes and measures and the target 
condition for the trial (O'Cathain et al., 2013). Qualitative research has been adopted in 
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trials of complex interventions in palliative care including to explore recruitment issues 
(Fliedner et al., 2019; Froggatt et al., 2020).  
 
1.8.3 Blinding and the use of placebo 
 
In randomised controlled trials, participants may be blinded to the intervention allocation 
and placebos can also be used (see table 3) which has implications for the recruitment and 
informed consent process The use of blinding acknowledges the influence on study 
outcomes of patient and researcher subjective beliefs and expectations of the treatment 
under investigation (Sanderson et al., 2013). It may not always be possible to conceal 
treatment allocation from trial participants as the intervention may be, for example, a 
clinical service and only the statistician carrying out the analysis may be blinded (Froggatt et 
al., 2020; Johnsen et al., 2019). 
Blinded placebo controlled trials are seen as the gold standard in clinical medicine because 
they reduce the risk of bias during data collection and assessment and so increase internal 
validity (Friedman et al., 2010; Torgerson, 2008).  
 
1.8.4 Ethical issues related to randomised controlled trial methodology 
 
Some health care professionals believe it is unethical to carry out randomised controlled 
trials. This is also an issue in palliative care with some clinicians feeling uncomfortable about 
randomising palliative care patients, particularly those that are dying, to a control arm. This 
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is because the control group is excluded from receiving a potentially beneficial intervention.  
This is in addition to concerns about overburdening palliative care patients with research 
procedures, such as questionnaire completion or additional tests, at a difficult time in their 
lives. Patients and carers may share these concerns and worry they are missing out on a 
potentially beneficial intervention through the randomisation process. Clinical equipoise 
needs to exist for a randomised controlled trial to be ethically justified, the idea that there is 
‘uncertainty in the relevant community of experts as to the preferred practice’ (Weijer et al., 
2012)(p.7). Clinicians, patients and carers can struggle to understand the concept of clinical 
equipoise.  The challenge of maintaining clinical equipoise during the recruitment process is 
discussed in detail in section 1.12.2 below. 
Whether it is ethically justifiable to carry out and recruit patients to placebo controlled trials 
in palliative care has been debated in the literature (Hardy, 1997; Kirkham & Abel, 1997). 
Friedman et al (2010) argue that two situations need to exist to justify the use of a placebo 
in a trial; participants need to be aware as part of the informed consent process that they 
may be allocated to a placebo and no standard evidenced based treatment exists. If a 
proven standard therapy exists, the placebo and the intervention being tested should be 
used in conjunction with this standard treatment such as the continued use of radiotherapy 
in a trial of pregabalin versus placebo for cancer related bone pain (Fallon et al., 2016). 
Hardy (1997) contended that including palliative care patients in placebo trials was justified 
because many if not most treatments are based on anecdote and physician preferences and 
because of the power of the placebo effect. The placebo effect describes ‘the phenomenon 
in which patients' symptoms may improve while receiving an inactive substance in a clinical 
trial’ (p.722) because of complex psychobiological responses (Sanderson et al., 2013). 
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Patients may also experience nocebo effects which refers to a situation where the patient 
experiences adverse effects while receiving a placebo (Sanderson et al., 2013). Placebo trials 
that show the effectiveness and safety of a symptom control medication despite known high 
placebo response rates can provide stronger evidence for the treatments use in clinical 
practice (Currow et al., 2017; Sanderson et al., 2013). Negative results from adequately 
powered trials can still be viewed as important as they can inform clinical decision making 
and prevent patients from experiencing unwarranted side effects (Sanderson et al., 2013; 
Visser et al., 2015). For example, in a placebo controlled trial of Octreotide for inoperable 
bowel obstruction in advanced cancer, no statistical or clinical significant difference was 
found between those receiving the placebo and those receiving Octreotide (Currow et al., 
2015). Kirkham and Abel (1997) challenged the idea that placebo control trials are the only 
way to assess how well a symptom control medication works in practice especially given the 
ethical and practical difficulties of carrying out this type of study in a palliative care 
population.  
Whether trial findings actually influence clinical practice has been discussed in the literature 
(Campbell et al., 2018; Visser et al., 2015). The continued use of anti-muscarinic drugs for 
death rattle, upper respiratory tract secretion accumulation with noisy breathing, illustrates 
the challenges of implementing research findings into clinical practice. They are still used 
despite evidence suggesting there is no benefit and there is a risk of adverse effects (Visser 





1.8.5 Alternative randomised controlled trial designs 
 
Alternative randomised controlled trial designs have been suggested to address some of the 
concerns associated with traditional trial designs that can have a negative impact on the 
recruitment process. These issues include ethical concerns regarding randomisation and 
withholding a potentially beneficial treatment or intervention from palliative care patients 
and their carers (Deutsch et al., 2020).  Wait list or fast track trials (see table 3) with short 
waiting times are seen to have a role in improving recruitment to palliative care trials. It has 
been proposed that a wait list or fast track trial design may be more acceptable to patients, 
clinicians and ethics committees as all patients are offered the intervention at some point in 
time (M. Farquhar et al., 2009; Higginson & Booth, 2011; Torgerson, 2008; Veronese et al., 
2017). This is when it would be viewed as unethical to withhold an intervention when 
previous research has suggested it could potentially be beneficial. In the palliative care 
context, sufficient patients in the waiting group need to survive long enough to receive the 
intervention (Higginson & Booth, 2011). Ethical concerns about wait list designs have still 
been raised as patients may deteriorate or die before they receive the intervention 
(McWhinney et al., 1994). In cross-over trials of short acting drugs or interventions, all 
patients also have the option to try all the treatments on offer but may need to be in the 
study for longer which could influence their decision to participate (Hui et al., 2015). 
In the real world, patients may have strong preferences for or against a particular 
intervention which can influence trial acceptability and therefore the trial recruitment 
process. If they are not allocated to their preferred trial arm they may experience ‘resentful 
demoralisation’ (Torgerson, 2008). This term describes the impact of the person’s 
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disappointment of being randomised to their non-preferred arm on study outcomes (Rebers 
et al., 2016). Patient preference trials can be used to manage patient expectations that can 
bias the results of the study and be detrimental to the recruitment process (Torgerson, 
2008). A Zelen trial design also aims to deal with preference effects and recruitment 
challenges (Torgerson, 2008) and their role in the palliative care setting is discussed in the 
literature review in chapter two. 
The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials 
argues that in cluster trials, those in the usual care arm ‘must not be deprived of effective 
care or programs to which they would have access if there were no study being conducted’ 
(Weijer et al., 2012) (p.7). Step wedge cluster trials are seen as an option to increase 
clinician and organisational acceptability of a trial as all organisational clusters receive the 
intervention sequentially (Grande et al., 2017). Other trial designs have been seen as an 
attractive option in the palliative care setting as they require smaller sample sizes to reach 
power such as a cross-over or aggregated N of 1 trials (Hui et al., 2015; Mitchell et al., 2015).   
 
1.8.6 Alternative research methods in the palliative care context 
 
Given the challenges of carrying out and recruiting to randomised controlled trials in 
palliative care, it has been suggested that other research methods should be considered 
(Black, 1996; Hadley et al., 2009). The use of existing data sets and secondary analysis to 
evaluate clinical practice have been recommended, where appropriate, as this approach has 
the potential to produce information more quickly and cost effectively than a trial 
(Higginson et al., 2013). High quality prospective observational studies that measure 
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clinically useful outcomes have been seen as an alternative to randomised controlled trials 
(Costantini, 2007; Hadley et al., 2009; May et al., 2015). For example, a prospective cohort 
study compares the experience of patients exposed to a study intervention such as a 
palliative home care service with other patients not exposed to the intervention with data 
being collected prospectively, retrospectively or both (Costantini, 2007). Patients are then 
followed up from intervention exposure to the outcome of interest such as the proportion 
of home deaths. If the intervention group has a higher or lower frequency of home deaths 
than the control group, then an association between the palliative home care service and 
proportion of home deaths is evident (Costantini, 2007). Matching cases and controls for 
some patient characteristics attempts to reduce the effect of a potential selection bias. The 
evidence base in palliative care is also deficient of good quality observational studies (Visser 
et al., 2015). 
The use of ‘big data’ sets such as large healthcare registers linked to multiple data 
sources are currently being explored in end-of-life care research which may support 
this type of study design (European Association for Palliative Care, 2020). Using 
routinely collected data to measure study outcomes may be problematic as, for example, 
the intensity and prevalence of symptoms may be poorly documented in health care records 
(Mazzocato et al., 2001). The role of routine clinical data in research needs to be further 
explored, including its use in randomised controlled trials. For example, how it can be used 
in trials as outcome data, as a recruitment strategy to target eligible participants, and to 
improve the incidence of missing data (Mc Cord et al., 2018; Wright-Hughes et al., 2018). In 
order to increase the evidence base in palliative care, there has been a call for high quality 
studies that use all the available methodological tools available, including randomisation 
when possible (Aoun & Nekolaichuk, 2014; Costantini, 2007; Lovell et al., 2020). The 
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advantages and limitations of each research methodology need to be considered when 
designing a study to answer a clinical question (Costantini, 2007).  
 
1.8.7 My view of the role of randomised controlled trials in palliative care 
 
My view is that there is a need for evidence-based practice to be built on a wide range of 
study types, including randomised controlled trials. Trials are increasingly being used in 
palliative care so there is a need to understand the recruitment process and its associated 
challenges. As discussed previously, I have worked on a number of trials that have struggled 
to achieve their recruitment targets and believe if a trial fails to recruit its target then this 
has ethical implications for patients and carers. Seriously ill patients and their carers will 
have taken part in a research study where it has not been determined by the end of the trial 
whether the intervention does more good than harm. This is why my research focuses on 
trial recruitment issues from the health care professional’s perspective, a key barrier to the 
randomised controlled trials use and implementation in clinical practice.   
 
1.9 Why recruitment is important  
 
Recruiting sufficient numbers of participants is important in all study designs but meeting 
trial recruitment targets is especially important to ensure the trial is adequately powered to 
detect a clinical benefit that is statistically significant (Torgerson, 2008). This requirement is 
reflected in the CONSORT reporting guidelines for randomised controlled trials (Schulz et al., 
2010). There are also ethical concerns related to underpowered trials as researchers have 
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exposed participants to an intervention with uncertain benefit and on study completion may 
still be unable to determine whether the intervention does more good than harm (Carlisle et 
al., 2014; Treweek et al., 2018). Struggling to reach estimated recruitment targets also 
means the trial has the potential to be slow and expensive (Healy et al., 2018; Higginson et 
al., 2013). One report highlighted that nearly half (45%) of Health Technology Assessment 
program and UK Medical Research Council funded trials received an extension of some kind 
(Sully et al., 2013). There are many examples of palliative care randomised controlled trials 
experiencing slow recruitment rates (Agar et al., 2017; Currow et al., 2019; Johnson et al., 
2019) with trials sometimes requiring a change to their study design to try and achieve 
power (Ferreira et al., 2020; Westcombe et al., 2003) or being abandoned altogether (Bull et 
al., 2019; Snowden & Young, 2017).   
 
1.10 Definition of recruitment 
 
Recruitment is the enrolment of an individual person meeting specific inclusion criteria into 
a research study (National Institute for Health Research, 2019c). This definition is an 
oversimplification of the term and does not reflect the ‘interactional’ nature of recruitment 
(Donovan  et al., 2014). Recruitment is not characterised by a single event and is often a 
lengthy and complex process. It occurs in real time, in real clinical settings and it can be a 
difficult activity as it disrupts the usual clinician/patient relationship (Donovan  et al., 2014). 
The process of recruitment typically involves three steps; identifying, approaching and 
consenting participants. It is usually carried out by health care professionals within clinical 
recruitment centres (Preston et al., 2016). Clinical recruitment centres are clinical settings, 
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such as a hospital or a hospice, where recruitment activity takes place. They are also 
referred to as a trial or research site in the literature (Bruhn et al., 2019). There may be 
clinicians within the clinical recruitment centres, such as research nurses, whose primary 
role is to recruit participants to research studies (Spilsbury et al., 2008). Recruitment may 
also be carried out by researchers directly involved in the trial in conjunction with the 
patient’s usual clinical care team as illustrated in this study of mirtazapine for chronic or 
refractory breathlessness (Lovell et al., 2020). 
Initially, a potential participant will be assessed against the eligibility criteria outlined in the 
trial’s protocol. Once eligibility has been assessed and it has been confirmed the potential 
participant meets the eligibility criteria, they will be approached or contacted about the trial 
(Preston et al., 2016). Verbal and written information will be provided about the trial 
(Donovan  et al., 2014). Thirdly, a discussion about a decision to participate in the trial will 
occur and if the participant wishes to take part they will be usually asked to sign a consent 
form (Donovan  et al., 2014; Preston et al., 2016).  
Written informed consent is only legally required in pharmaceutical trials which is reflected 
in this definition of informed consent outlined in international Good Clinical Practice 
guidance for the conduct of pharmaceutical trials: 
‘A process by which a subject voluntarily confirms his or her willingness to participate 
in a particular trial, after having been informed of all aspects of the trial that are 
relevant to the subject's decision to participate. Informed consent is documented by 




For other types of research studies, consent can be written, oral or implied (Health Research 
Authority, 2020; Preston et al., 2020). The COVID 19 pandemic and its social distancing 
requirements have led to remote informed consent procedures being implemented that 
involve the use of verbal and/or electronic consent (Fernandez Lynch et al., 2020). 
The Declaration of Helsinki (2013) recommends that participants receive information about 
the aims, the methods and the benefits and risks of the study as well as what will happen 
after the study has ended. Information should be given about sources of funding, conflicts 
of interest and the researcher’s institutional affiliations. The potential participant must be 
informed of the right to refuse to participate in the study and the right to withdraw consent 
at any time without reprisal (World Medical Association, 2018). In the UK, there is a growing 
recognition that the amount of information provided to participants when seeking consent 
should be proportionate to the type of study being offered (Health Research Authority, 
2020). There are also wider calls for simplification of participation information sheets and 
consent processes even in randomised controlled trials (Dal-Ré et al., 2019; O'Sullivan et al., 
2020; Valerie et al., 2011). 
Ethical guidance on what information should be disclosed to participants taking part in a 
cluster randomised controlled trial during the informed consent process has been produced 
but continues to be debated (van der Graaf et al., 2015; Weijer & Taljaard, 2019). Research 
ethics committees can waiver consent if obtaining informed consent is not feasible and 
taking part in the study poses only minimal risk (Rebers et al., 2016; Weijer et al., 2012). 
Participants can be blinded to their allocation status if they are recruited after cluster 
randomisation if there are concerns about contamination and the study only poses minimal 
risk (Weijer & Taljaard, 2019). Contamination refers to a situation where control participants 
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may change their behaviour because they have learnt about the intervention arm so 
compromising validity (van der Graaf et al., 2015).  
 
1.11 Adults with impaired capacity to consent to research studies 
 
The palliative care population has a high prevalence of cognitive impairment (Currow et al., 
2011) with a recent study finding that at least 66% of patients with advanced cancer 
admitted to a palliative and supportive care unit lacked decision making capacity (Goswami 
et al., 2020). Evans et al (2020) describe how there is a ‘spectrum of capacity’ in end-of-life 
care research that ranges from those who have the potential and are anticipated to lose 
capacity to those who lack capacity. The legislation, ethical review processes and 
terminology that governs research involving adults that lack capacity to consent can be 
complex, variable and jurisdiction specific (Evans et al., 2020; Shepherd, 2020a). Advance 
consent (Van Esch et al., 2018) and/or proxy/consultee assent (Froggatt et al., 2020) 
procedures may be used to allow patients to participate in research, even at the end of life, 
so ensuring patient autonomy is respected (Currow et al., 2011). For example, in England 
and Wales in non-pharmaceutical trials, advance consent procedures can be used when it is 
anticipated that patients may lose capacity during a study. Patients are asked if they were to 
lose capacity in the future whether they would wish to continue in the trial. If so they are 
asked to nominate a consultee who the researchers can approach to ask their opinion on 
the patients continued participation in the trial (Department for Constitutional Affairs, 2007; 
Gysels et al., 2013). In pharmaceutical trials, under European legislation (European 
Parliament the Council of the European Union, 2014)  consent to participate in a study is 
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presumed to remain legally valid after loss of capacity but consultee review is seen as good 
practice (Evans et al., 2020). Given the high prevalence of cognitive impairment in the 
palliative care population, there have calls for advance consent processes to be extended to 
all types of palliative care research (Gysels et al., 2013). 
 
1.12 The challenges of recruitment in randomised controlled trials  
 
Recruitment has been identified as one of the prominent challenges in palliative and end-of 
life-care research. All types of palliative care studies can experience recruitment challenges 
(Edwards et al., 2019; Kaiser et al., 2020; Steinhauser et al., 2006; Stone et al., 2013) but 
recruiting to palliative care randomised controlled trials can be especially difficult (Currow 
et al., 2011; Grande & Todd, 2000; Higginson et al., 2013). Achieving recruitment targets to 
trials can be a struggle in any setting (Treweek et al., 2018) and in the non-palliative care 
literature, there are many reports of trials struggling to meet their recruitment targets 
(Carlisle et al., 2014; McDonald et al., 2006; Sully et al., 2013; Walters et al., 2017). In one 
review of randomised controlled trials funded and published by the UK's National Institute 
for Health Research Health Technology Assessment Programme, the final recruitment target 
sample size was achieved in 56% (85/151) of the trials (Walters et al., 2017). In a more 
recent review, 31% of stepped-wedge cluster trials did not reach their planned recruitment 
targets (Eichner et al., 2019). Figures can differ between reports and it is estimated that less 
than half of randomised controlled trials are actually likely to achieve their recruitment 
targets (Treweek et al., 2018). In the Bouca-Machado et al (2017) review discussed in 
section 1.5, of the 107 included palliative care trials, only 53.3% of studies reported a 
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sample size calculation. Of the 57 studies that had reported a sample size calculation, only 
36.8% (n=21) reached the estimated target. The challenges of recruiting to palliative care 
randomised controlled trials is also evident in the number of underpowered studies 
reported in systematic reviews of palliative care interventions (Haun et al., 2017; 
Kavalieratos et al., 2016). 
 
1.12.1 Limited pool of eligible participants 
 
In palliative care trials, often large numbers of patients need to be screened against the 
inclusion and exclusion criteria to identify those who may be eligible to participate. 
McCaffrey et al (2016) estimated from their experiences of recruitment in four 
pharmaceutical symptom control trials that approximately 50 specialist palliative care 
patients need to be referred to the trial for one person to be potentially eligible to 
participate. This is because thresholds of symptom severity may need to be reached for the 
patient to be eligible and study criteria related to other assessments and treatments, 
including disease modifying treatments, may influence eligibility (McCaffrey et al., 2016). 
This is in addition to the contextual factors that can influence palliative care research 
generally such as patient frailty, symptom burden, limited life expectancy, prognostic 
uncertainty, acknowledgement of the patient’s mortality, competing demands and 





1.12.2 Maintaining clinical equipoise        
 
There are also issues associated with randomised controlled trials that are not unique to 
palliative care that can be magnified in this population because of these underlying 
contextual factors (Currow et al., 2011). These include patient, carer and health care 
professional concerns about randomisation, blinding and placebos. As discussed in section 
1.8.4, clinical equipoise provides the justification for carrying out randomised controlled 
trials, the idea that there must be real uncertainty as to whether the new treatment is 
superior to no treatment or existing treatments (Grande & Todd, 2000). Patients, carers and 
health care professionals can deny and struggle with the concept of clinical equipoise. In the 
general literature, there are reports of clinicians holding strong preconceived views about 
the merits of a particular treatment or service and find balancing the researcher and 
clinician role challenging (Donovan et al., 2014; Elliott et al., 2018). There are also reports of 
patients having strong preferences for a particular treatment arm with patients often being 
keen to receive the new intervention (Harrop, Kelly, et al., 2016; Norris et al., 2019; 
Paramasivan et al., 2011). This lack of neutrality or clinical equipoise among patients and 
clinicians in palliative care trials is also raised as an issue in the literature (Deutsch et al., 
2020; Grande & Todd, 2000; Harrop, Noble, et al., 2016; LeBlanc et al., 2010). In a non-
placebo pharmaceutical trial, 10 patients with advanced cancer were interviewed about 
their reasons for participating in the trial. Altruism was a secondary motivating factor 
behind hope of medical benefit (Harrop, Noble, et al., 2016). Research ethics committees 
can also struggle with the concept of equipoise as illustrated in a recent trial of sustained 
release morphine for chronic breathlessness. One committee required that all participants 
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had access to rescue immediate release morphine for symptom control (Ferreira et al., 
2020).  
 
1.12.3 Recruitment challenges associated with blinding and placebos 
 
In the general literature, a systematic review of recruitment strategies found open trials 
rather than blinded, placebo trials improved recruitment (Treweek et al., 2018). There is 
some evidence in the literature that the use of blinding and placebos can act as a deterrent 
when recruiting to a palliative care trial. A survey of the views of advanced cancer patients 
and their relatives towards taking part in hypothetical research found that about one-half 
were deterred by the concepts of  ‘randomisation’, ‘placebo-control’ and ‘blinding’ (White 
et al., 2008) . A similar survey of palliative care clinicians found less than half of non-medical 
health care professionals would be willing to refer to blinded or placebo-controlled studies 
(White  et al., 2008). More recently, patients who had taken part in a feasibility placebo 
controlled trial of mirtazapine for breathlessness in advanced disease were mostly accepting 
of the fact they may receive the placebo but this was not always the case (Lovell et al., 
2020). 
 
1.13 Strategies to facilitate recruitment to trials 
 
What strategies may facilitate recruitment to trials (Boland et al., 2015; Treweek et al., 
2018) or to research studies in general (Preston et al., 2016) is hampered by a lack of high-
quality evidence. The use of telephone reminders to people who do not respond to a postal 
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invitation increased recruitment in one review (Treweek et al., 2018). The use of a memory 
aid, contact before arrival, cluster consent and ‘opt out’ consent improved recruitment of 
people with cancer or organ failure into trials (Boland et al., 2015). Strategies that reduce 
the demand on health care professionals such as a clinical recruiter or automated alert 
system were seen as the most promising strategies in a review focusing on research studies 
in general but the studies that were assessed were at high risk of bias (Preston et al., 2016). 
In a Delphi survey of UK Clinical Trials Units, methods to boost recruitment was identified as 
the highest priority for trials methodology research (Tudur Smith et al., 2014). More 
recently, in the UK and Ireland, the Prioritising Recruitment in Randomised Trials Priority 
Setting Partnership brought together relevant stakeholders, including members of the 
public, to identify unanswered questions around trial recruitment research (Healy et al., 
2018). The top 10 prioritised research questions are outlined in the table below.  
 
Table 4: The top 10 research questions from the Prioritising recruitment in Randomised 
trials study (PRioRiTy) (Healy et al, 2018) 
 
 
1. How can randomised trials become part of routine care and best utilise current 
clinical care pathways? 
 
2. What information should trialists communicate to members of the public who are 
being invited to take part in a randomised trial in order to improve recruitment to 
the trial? 
 
3. Does patient/public involvement in planning a randomised trial improve 
recruitment? 
 
4. What are the best approaches for designing and delivering information to 




5. What are the barriers and enablers for clinicians/healthcare professionals in 
helping conduct randomised trials? 
 
6. What are the key motivators influencing members of the public’s decisions to take 
part in a randomised trial? 
 
7. What are the best approaches to ensure inclusion and participation of under-
represented or vulnerable groups in randomised trials? 
 
8. What are the best ways to predict recruitment rates to a randomised trial and 
what impact do such predictions have on recruitment? 
 
9. What are the best approaches to optimise the informed consent process when 
recruiting participants to randomised trials? 
 
10. What are the advantages and disadvantages to using technology during the 
recruitment process? 
 
How the recommendations above fit with this study’s research question, methodology and 
findings is discussed in the following chapters.  
 
1.14 Theoretical frameworks to inform the trial recruitment process 
 
In the general trial literature, it has been suggested that theoretical frameworks may 
improve our understanding of complex recruitment processes. Tramm et al (2013) argue 
that the Medical Research Council’s Complex Intervention Framework can be applied to the 
trial recruitment context (Craig et al., 2013; Tramm et al., 2013). This framework was not 
used in this study as the aim of this PhD was not to develop and evaluate a recruitment 
intervention.   
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There have been calls to use theoretical concepts from the marketing and business world to 
address trial recruitment challenges (Francis et al., 2007; Galli et al., 2014; McDonald et al., 
2011). Marketing focuses on meeting customers’ needs by understanding the factors that 
influence customer purchasing decisions (Galli et al., 2014). It has been proposed that 
running a trial can be like running a business so applying marketing principles to trial 
recruitment processes may lead to improvements in recruitment rates (Francis et al., 2007; 
McDonald et al., 2011). Using marketing theory to inform trial recruitment processes would 
appear to clash with the altruistic principles of health care (McDonald et al., 2011), 
particularly in the context of palliative and end-of-life care. This is because the purpose of 
commercial marketing is to make a profit by encouraging, with some even arguing 
manipulating, customers into purchasing goods and services that are on offer. Giving 
palliative care patients and carers the ‘hard sell’ and convincing them to take part in a trial 
they may not wish to take part in would clearly be unethical in the context of health care 
and therefore would not be an appropriate approach to follow.   
 
1.14.1 ‘Social Marketing Mix Framework’ 
 
Social marketing has been used in public health for many years and applies commercial 
marketing principles to programmes that aim to influence the behaviour of a particular 
audience to improve their welfare or that of society as a whole rather than for financial gain 
(Grier & Bryant, 2005; Nichols et al., 2004). The ‘Social Marketing Mix’, adopted from 
commercial marketing, is a key concept within social marketing and is viewed as ‘central to 
the planning and implementation of an integrated marketing strategy’ (Grier & Bryant, 
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2005) (p. 322). Social marketing has traditionally focused on applying the four ‘Ps’ of 
marketing: product, price, place and promotion (Gordon, 2012).  
The ‘Social Marketing Mix Framework’ has been seen as a potentially useful theoretical 
framework to help organise and plan recruitment activities as well as help to identify factors 
that can be adjusted to maximise enrolment. There are different versions used in the trial 
recruitment literature (Galli et al., 2014; Tompkins et al., 2019) but the version chosen for 
this study was that outlined by Nichols et al (2004) which uses ‘6 Ps’ (see table 5). These are; 
Identifying participants, Product, Price, Place, Promoting the study and Working with 
Partners. This framework was chosen for a number of reasons. This study focuses on the key 
role that health care professionals play in the recruitment process and this framework 
recognises the importance of ‘Working with Partners’. Peplau’s theory of interpersonal 
relations has been used to understand the nurse-patient relationship during the trial 
recruitment and retention process. This theoretical framework was not chosen as this study 
does not focus purely on the nursing workforce or explore the issue of trial retention 
(Penckofer et al., 2011). 
The ‘Social Marketing Mix Framework’ was also chosen as it has the potential to offer a 
patient centred approach to the trial recruitment process. Nichols et al (2004) challenge the 
idea that applying marketing principles to the trial recruitment process in health care is 
controversial. They argue that it actually puts the patient or carer at the centre of the 
research process as it requires the researcher to focus on ‘the needs, wants, and preferences 
of the target audience’ (Nichols et al., 2004)(p.10). For example, has the researcher 
considered whether the intervention or ‘Product’ being trialled is what the patient or carer 
wants and have they minimised the ‘Price’ of taking part in the trial for participants. The 
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purpose of social marketing is to facilitate voluntary rather than coercive behaviour change, 
ideally by involving consumers in the design, implementation and evaluation process (Grier 
& Bryant, 2005). 
There are limited theories of trial recruitment available with the ‘Social Marketing Mix 
Framework’ being the only one used in a similar population.  It has been applied to trials 
recruiting the carers of patients with Alzheimer’s disease (Etkin et al., 2012; Nichols et al., 
2004; Schulz et al., 2003) so aligning more closely with the palliative care population. In 
addition, elements of this framework have been used in a successfully recruiting palliative 
care service delivery trial (LeBlanc et al., 2013). On a personal level, this approach ‘made 
sense’ to me as a palliative care researcher and previous palliative care research nurse. The 
business model approach to trial recruitment developed by Francis et al (2007) was another 
possible theoretical framework. This approach was not chosen as it has been applied to 
trauma and smoking cessation trials and the characteristics of these studies are quite 
different to palliative care trials which is reflected in their framework. 
Using the principles of community based participatory research to recruit ‘hard to reach 
populations’, such as dementia caregivers and/or ethnic minority groups, is another 
approach suggested in the literature (Grill & Galvin, 2014). This framework was not chosen 
as it was expected, given the patient population, that recruitment would largely take place 






Table 5: The '6 Ps' of the ‘Social Marketing Mix Framework’ 
 
Elements  Definitions  
Identifying participants  Defining the target audience (p.4). 
Product  





The product’s competition: 
 
The intervention is the product (its scientific, theoretical basis, 
does it meet the needs of the target audience?), the product 
must address a problem that is perceived as serious and 
amenable to the intervention (p.4).  
 
The amount of competition for the participant’s time and 
energy (p.5). 
Price  The cost to the potential participant of taking part in the study 
(e.g. financial, time, physical and emotional effort). Things need 
to consider: type of costs and how to minimise the costs (p.5-6).  
Place (Improving accessibility)  ‘The location where the participant will receive information 
about, or engage in, the intervention’ (p.6).  
Promoting the study 
 
‘Identify the acceptable avenues that reach the target 
population’ (p.7). 
Working with partners   ‘Partners are defined as organisations involved with a social 
change effort or serving as conduits to target audiences’ (p.8). 
Things to consider: partner education, partner referrals and 
recruitment and barriers to partnering.  
 
 
1.15 Stakeholder engagement 
 
I recognise the importance of and have personal experience of engaging public and 
professional stakeholders in the planning, ongoing management and dissemination activities 
of palliative randomised controlled trials (Froggatt et al., 2020; Korfage IJ, 2020). The 
research question in this thesis required health care professional stakeholders with 
experience of palliative care trials. The decision was made not to engage additional health 
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care professional stakeholders in the development, ongoing management or analysis stage 
of this study. This approach was taken, as I, along with my supervisors, have relevant 
palliative care clinical and research experience. Given the small number of palliative care 
professionals involved in trial recruitment, recruiting stakeholders with relevant experience 
may have limited the already small pool of eligible participants. Health care professionals 
can be time poor and difficult to engage so this may have caused study delays. This study 
also had no funding to cover the cost of stakeholder engagement. The limitations of this 




There is a need to increase and improve the evidence base that underpins clinical practice in 
palliative care. High quality adequately powered randomised controlled trials can play a role 
in addressing this deficit by being the optimal method for assessing whether palliative care 
interventions are effective. The trial recruitment process is complex and is made up of a 
number of interconnected stages. Randomised controlled trials in palliative care, like those 
outside palliative care, can experience recruitment difficulties. Some of the recruitment 
challenges are not unique to palliative care but can be amplified in this vulnerable patient 
population. The barriers to recruitment in palliative care randomised controlled trials and 






Chapter two: Literature review 
2.1 Introduction 
 
In the previous chapter, the need for more high quality adequately powered randomised 
controlled trials to improve the evidence base in palliative care was highlighted. Why so 
many palliative care trials struggle or fail to achieve their recruitment targets is an important 
area of clinical practice that is poorly understood. The aim of this literature review is to 
identify, explore and synthesise what is known about recruitment issues in palliative care 
randomised controlled trials. This review is unique as it uses the ‘Social Marketing Mix 
Framework’, the chosen theoretical framework for this study, to explore recruitment 
barriers and facilitators in palliative care randomised controlled trials. This review has been 
peer reviewed and published (Dunleavy et al., 2018), presented at the 15th European 
Association for Palliative Care World congress in Madrid (oral presentation) (Dunleavy, 
2017) and the 4th International Clinical Trials Methodology Conference in Liverpool (poster 
presentation) (Dunleavy et al., 2017). The findings of the review informed the research 
question by identifying gaps in the current evidence base.   
 
2.2 Literature review methods 
 
A systematic approach is used in this literature review as it was guided by a review question 
and how the literature was identified, selected, appraised and synthesised are explicitly 
described (Jesson et al., 2011).  
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2.2.1 Aim of the review  
 
The aim of this review is to identify, explore and synthesise what is known about the 
recruitment barriers and facilitators in palliative care randomised controlled trials using the 
‘6 Ps’ of the ‘Social Marketing Mix Framework’.  
 
2.2.2 Review question 
 
What can the ‘6 Ps’ of the ‘Social Marketing Mix Framework’ tell us about the recruitment 
barriers and facilitators in palliative care randomised controlled trials? 
 
2.3 Literature review design 
 
2.3.1 Narrative synthesis 
 
The literature review is guided by Popay et al’s (2006) narrative synthesis framework as this 
approach facilitates the incorporation of research and non-research data. Initial searches 
indicated that the data to support the review question was likely to be narrative 
observations made by authors about recruitment issues rather than primary research data. 
This review is based on the premise that narrative observations can provide valuable 
insights into what the barriers and facilitators are to patient and carer recruitment to 
palliative care randomised controlled trials and the strategies that have been implemented 
to overcome them. 
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Narrative synthesis uses a textual approach to synthesis so that ‘studies addressing a 
different aspect of the same phenomenon can be narratively summarised and built up to 
provide a bigger picture of that phenomenon’ (Booth et al., 2012)(p.146). Popay et al (2006) 
developed a general framework made up of four elements to guide the process of narrative 
synthesis. They suggest it does not need to be followed in a linear fashion and is an iterative 
process (Popay et al., 2006). Table 6 provides an overview of how the four elements of the 
framework have been applied within this study. The process is discussed in more detail 
within the relevant sections below.   
Table 6: Narrative Synthesis Framework (Popay et al 2006) 
 
Element 1: The role of 
theory in evidence 
synthesis 
 
Theory in a review informs the data extraction process, 
contributes to the interpretation of findings and is valuable in 
assessing how widely applicable the findings may be in 
practice (p.12).The ‘6 Ps’ of the ‘Social Marketing Mix 
Framework’ was the chosen theory in this study.   
Element 2: Developing a 
preliminary synthesis 
 
Descriptive data about each included study was organised 
into a table. Relevant sections of included papers were coded 
line by line using predetermined and open codes. Codes were 
then organised into categories and refined to develop 
broader themes.  
Element 3: Exploring 
relationships within and 
between studies 
 
Tabulation allowed themes to be conceptually mapped within 
the chosen theoretical framework. This allowed the most 
common themes across all of the studies to be identified as 
well as those that apply to the patient, carer or health care 
professional. 
Element 4: Assessing the 
robustness of the 
synthesis 
 
Under this approach, this involves an overall assessment of 
the strength of the evidence for drawing conclusions on the 
basis of the narrative synthesis and being thorough while 
critical of the methodological approach used to synthesise 




2.4 Search Strategy 
 
Embase, Medline, psychINFO and CINAHL databases were searched from the 1st January 
1990 until the 8th October 2016 (see figure 1). The search concepts were palliative care and 
randomised controlled trials. The search included the terms palliat*, hospice* and ‘’terminal 
care’’ as they are seen as a robust and valid strategy to identify and retrieve palliative care 
literature (Sigurdardottir et al., 2014; Sladek et al., 2006; Tieman et al., 2008). The search 
terms used within Medline via EBSCO were palliat* or hospice* or terminal care or palliative 
care/or palliative medicine/or terminal care/ (not exploded) and randomi*ed controlled 
trial* or randomised controlled trial/ (publication and topic). The limits set were human, 
papers published between 01/01/1990 - 08/10/2016 and randomised controlled trials. A 
start date of 1990 was chosen for the search as two key palliative care trial methodological 
papers were published in the 1990s. It was felt that it was important to capture these two 
papers in the search strategy (McWhinney et al., 1994; Rinck et al., 1997). These papers 
highlighted that there were only a handful of palliative care randomised controlled trials 
carried out prior to 1990. The strategy was modified as necessary for the other databases 
searched (see appendix 1). The reference lists of the included studies were also hand 
searched to identify additional papers specifically focusing on recruitment to palliative care 






2.4.1 Study Eligibility 
 
The inclusion and exclusion criteria are listed in table 7. Titles and abstracts were screened 
by myself to identify potentially eligible papers and another reviewer independently verified 
10% of this search. I screened the remaining full papers to identify the final included papers. 
Any discrepancies when screening titles and abstracts were resolved through discussion and 
by obtaining the full text of the article for further clarification if necessary. 
 




 Adult cancer patients with incurable 
disease (defined by tumour staging) 
 Non-professional carers of cancer 
patients with incurable disease 




 Adults with a progressive, life 
threatening disease (defined by 
classifications of disease severity 
such as the New York Heart 
Association Functional Classification. 
NB this would include patients 
classed in the literature as ‘frail 
elderly’ if they were receiving an 
intervention that was clearly a 
palliative care intervention. 
Study Population 
 Adult cancer patients with 
potentially curable disease 
 Care of chronic non-life threatening 
conditions without a curative 
treatment option 
 Those studies including patients 
with both curable and incurable 
disease if it is impossible to 
distinguish findings between groups 
 Primary endpoint of the study is 
survival or tumour/disease 
response (NB would be included if 
the study is testing an intervention 
that is clearly a palliative care 
intervention (Radbruch, 2014). 
 Neo adjuvant or adjuvant 
chemotherapy studies 
 Palliative care randomised 
controlled trials only recruiting 
health professionals  
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 Non-professional carers of patients 
with a progressive, life threatening 
disease  
 Parents of children with a 
progressive, life threatening disease 
 
Study Design  
The types of papers listed below were 
included if they contained information 
about the barriers, facilitators or strategies 
to recruitment to palliative care randomised 
controlled trials: 
 Randomised controlled trials 
(pilot/feasibility studies as well as 
full scale palliative care trials) 
 Intervention studies testing 
recruitment strategies 
 Qualitative/observational studies   
that report barriers, facilitators or 
strategies to recruitment to 
palliative care randomised 
controlled trials. 
 Articles reporting narrative opinions 
and/or observations related to 
conducting a palliative care 





Study Design  
Non randomised trials 
 
 
2.5 Data Extraction 
 
NVivo 10 was used to support the data extraction and synthesis process. Descriptive data 
about each included study was extracted and organised into a table (see table 8). Interview 
data from patients taking part in a palliative care randomised controlled trial or 
professionals involved in recruitment to a trial and its subsequent analysis reported in the 
included qualitative papers was extracted. Data in the form of narrative observations 
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located in the discussion sections of randomised controlled trial result papers or 
retrospective reports of researchers’ experiences of recruiting to a trial were also extracted. 
The amount of data extracted was variable across the included studies. Data extraction was 
carried out by myself but 10% of the papers were independently verified by another 
reviewer. This was to improve the rigor of the review by a second reviewer checking 
understanding and interpretation of the data and for any data extraction errors  (Campbell 
et al., 2019). The same double coder, a medical professional, was used for screening titles 
and abstracts and data extraction. Any discrepancies in the data extraction process were 
resolved through discussion and there was no requirement to consult an independent 
arbiter.  
 
2.6 Data Synthesis 
 
2.6.1 Element 2: Developing a preliminary synthesis 
 
Following Popay et al’s approach, relevant sections of the included papers were initially 
coded line by line. A mixture of predetermined (priori) codes, the ‘6 Ps’ from the ‘Social 
Marketing Mix Framework’ and open codes were used to ensure important aspects of the 
data were not missed during coding (Gale et al., 2013). Initial codes were then organised 
into the overarching categories barriers, facilitators and strategies in NVivo. Strategies were 
viewed as interventions that were implemented to support facilitators and overcome 
barriers. Within these categories codes were merged as appropriate and refined into 
broader themes. Coding into themes was carried out by myself but 50 % of the papers 
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coded were then independently checked by a second reviewer. This was to improve the 
rigor of the review by verifying the interpretation of the findings (Campbell et al., 2019). 
 
2.6.2 Element 3: Exploring relationships within and between studies 
 
As recommended by Popay et al, tabulation allowed the overarching categories (barriers, 
facilitators and strategies) and the themes contained within them to be conceptually 
mapped with the ‘Social Marketing Mix Framework’ (see table 9). This allowed for the most 
common themes across all studies to be identified as well as how they apply to the patient, 
carer or health care professional. Potential strategies and facilitators that may help address 
identified barriers identified in the literature can also be visualised.    
 
2.7 Quality Assessment 
 
Trial papers were included to identify recruitment issues rather than assess robustness of 
findings therefore assessment of the methodological quality of these papers was not carried 
out. Reflecting Popay et al’s approach, a hierarchy of evidence tool was adapted to assess 
the level of evidence the identified barriers, facilitators and strategies in the literature were 
based on (see appendix 2)(Eagar et al., 2007). No papers were excluded based on their 
evidence scoring. This approach was used as the methodology of included papers was mixed 
and the majority contained non-research evidence. This process allowed judgements to be 
made about the quality of evidence and the weight that should be given to the extracted 



















Figure 1: PriSMA flowchart 
 
This review includes studies testing recruitment strategies (n=3), qualitative explorations of 
recruitment issues (n=3) and trial reports (n=14) reporting barriers and facilitators to 
recruitment. Most (n=28) were methodological papers exploring the design of exemplar 
Additional records identified 
through other sources  
(n = 10) 
Records after duplicates removed  
(n = 3342) 
Records screened  
(n = 3342) 
Records excluded  
(n = 2832) 
Full-text articles excluded 
(n = 462) 
(n = 9 not RCT,  
n = 66 not palliative care 
population, n = 387 no 
relevant recruitment 
information) 
Studies included in the 
qualitative synthesis  
(n = 48) 
Full-text articles assessed 
for eligibility  
(n = 510) 
Records identified through 
database searching  
(n = 3833) 
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trial/s. A contextual summary of the included papers with the level of evidence score noted 
is provided in table 8. The barriers, facilitators and strategies are mapped within the ‘6 Ps’ of 
the ‘Social Marketing Mix Framework’ in the narrative below. The greatest number of 
barriers, facilitators and strategies identified could be mapped within the ‘Working with 
Partners’ category and table 9 provides a visual overview of how the evidence is weighted 
within the ‘6 Ps’.  
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Article type & 
data extraction 
point 







Time to recruit 
sample 











strategies in a 
RCT. All of the 
article. 
To evaluate the 
safety and efficacy of 















N= not stated Intervention: Alvimopan 
laxative (2 arms with different 













participation in a 
RCT.  
All of the article. 
To investigate the 
effect of a nurse led 

































Intervention: a ‘family and 
coping-orientated palliative 
home care intervention’ 









3 Bakitas et al 
(2006), linked to 
Bakitas et 
al(2009) (US) 
A report of 
challenges faced 
during an ongoing 
RCT. Main 
section.   


















77 caregivers  
over 14 months 
Intervention: weekly telephone 
sessions with nurse. Optional 
shared medical appointments 
with palliative care nurse, 
physician and other persons 
living with advanced cancer. 
Control: usual care 






Article type & 
data extraction 
point 







Time to recruit 
sample 





4 Bakitas et 
al(2009), linked to 
Bakitas et al 
(2006)  (US)  
A report of 
baseline findings 
and solutions to 
methodological 
challenges faced 
during a RCT. 
Discussion 
section. 
To test an 


















N= 322 between 
November 2003 
and May 2007 
Intervention: a phone-based, 
nurse-led educational, care 
coordination palliative care 













































N=74 of 146 
eligible patients, 
not stated 
Intervention: 'palliative care 
approaches' Control: usual care 
not stated 2 a 
6 Bausewein et al 
(2010)  
(Germany) 
A paper reporting 
the findings from 





To determine the use, 
acceptance and 
effectiveness of a 
hand-held fan to 
relieve 
breathlessness, to 
evaluate recruitment.  
 
























recruited to the 
main study, 70 
took part in the 
RCT 
Intervention: hand held fan 











Article type & 
data extraction 
point 







Time to recruit 
sample 





7 Buss and Arnold 
(2004) (US) 
A retrospective 
report of the 
experiences of 
researchers who 
attempted to set 
up a RCT.  All of 
the article. 
To measure the 
safety and 













Failed in set up Intervention: anti emetic cream 
Control: placebo 
questionnaires 2 a 
8 Buss et al 
(2008)   
(US) 
A paper reporting 
the authors’ 
experiences of 






To examine the 
impact of CHESS on 
caregiver outcomes 

















enrolled in the 
study 
Intervention: a web-based 
information and support system 
(CHESS) Study 1 CHESS and 
clinician rapport or CHESS 
Study 2 CHESS and clinician 
rapport or control access to 
computer/internet 
survey 2 a  







A paper reporting 
the findings of a 
phase II RCT. 
Discussion 
section. 
To assess the 
feasibility of early 




management of noisy 
breathing (NB) at the 
end-of-life. 










patients in the 
terminal 









N=from April to 
November 2001, 
49 consented 
21  randomised   
Intervention: Participants while 
well and their proxies provided 
written informed consent. If NB 
were encountered, people were 
randomised to 200 mcg 
octreotide or 400 mcg hyoscine 
hydrobromide subcutaneously. 
If subsequent treatment was 











Article type & 
data extraction 
point 







Time to recruit 
sample 





10 Cook et al 
(2002) (UK) 
A retrospective 
report of the 
experiences of 
researchers trying 
to recruit to a 
RCT. Introduction. 
To assess the effects 















N=4 over 5 
months 
not stated not stated 2 a 
11Currow et al 
(2006), linked to 







approach used in 








based interventions.  

















The ‘Palliative Care Trial’ 
evaluated three interventions: 
case conferences, general 
practitioner education, and 
patient education 
questionnaires  2 a 
12 Daniels and 
Exley (2001) 
(UK) 
A paper reporting 





involved in  
recruitment to a 
RCT. 
All of the article. 




involved in  
recruitment to a RCT. 
Parent Study: a RCT 
to evaluate the 
effectiveness of a 
new community 


















1 researcher  
 
N=10 nurses and 
1 researcher  
 










Article type & 
data extraction 
point 







Time to recruit 
sample 





13 Farquhar et al 
(2009) linked to 
Farquhar et al 
(2011) 
(UK) 
A paper reporting 
the findings from 
a RCT. Discussion 
section. 
To test the feasibility 
of a single-blinded 
fast track pragmatic 



















N=14 patients  
12 carers 
Intervention: a breathlessness 
intervention service 
immediately for eight weeks or 
after an eight week period on a 
waiting list during which time 




14  Farquhar et al 
(2011) linked to 








strategies used in 
a RCT. All of the 
poster. 
To test a 
breathlessness 
intervention service 
for advanced disease. 
Phase II pilot 
single-blind 
fast track RCT 
and phase III 
RCT 
Phase II COPD 






N=not stated Intervention: a breathlessness 
intervention service Control: 
not stated 
not stated  2 a 








To determine the 




care outcomes for 




















All participants received a 
packet of linguistically matched 
materials on palliative care. In 
addition, intervention 
participants received up to five 
home visits from the bilingual, 














Article type & 
data extraction 
point 







Time to recruit 
sample 





16 Fowell et al 
(2006)   
(UK) 
A paper reporting 
the findings of a 
feasibility study 







To explore the 
feasibility of cluster 
randomisation and 
Zelen’s design for 
trials with dying 
patients. 
Feasibility 













N= 6, all in the 
cluster arm 
Both units used cluster 
randomisation or randomised 
consent for three months and 
then ‘crossed over’ designs for 




17 Goldstein et al 
(2014) (US) 









To evaluate the effect 
of a communication 
intervention on ACP 





















each site (6 
sites) 
N=not stated Intervention: aimed at 
clinicians, interactive 
educational session, reminders 
and individualized feedback 
Control: no specific 
communication training, 










recruitment to a 





To compare the 






















Expressive supportive therapy 
combined with educational 
materials and usual care. 
Control: educational materials 
and usual care alone. 






Article type & 
data extraction 
point 







Time to recruit 
sample 










learned during an 
ongoing RCT. 
Main section. 
To compare the 
effect of home 
hospice care with 
such care 
supplemented with 










N= 200 over 
4 years 
N= 75 patients 
in two years 
Intervention: usual care 
supplemented by five daily 
massages Control: usual care 
questionnaires 
and daily logs 
via a touch 
screen laptop.    
2 a 
20 Hanson et al 
(2014) 
 (US) 
A paper reporting 
the findings of a 
qualitative study. 
All of the paper. 
Qualitative study: To 
describe barriers and 
strategies for 
recruitment during a 
palliative care RCT. 
Parent study: a RCT 
where patients are 
randomised to 
discontinue or 
continue on statins. 
Qualitative 
study    
   
Parent study: 





























study: N=18 site 




















21 Hardy et al 
(1998)  
(UK) 
A paper reporting 


























Trial 1: 25 
patients over 36 
months Trial 2: 





placebo, normal saline  if 
obstruction still present at day 
5, the patient was ‘crossed 
over’ to the other arm 






Article type & 
data extraction 
point 







Time to recruit 
sample 













whether a new 





















N= 52, one year Intervention: an innovative 
palliative care service Control:  
the above after a > 3 month 
wait and until then received 
standard best practice 
interviews 2 a 







with reference to 
ongoing RCT. 
Main body 
To investigate a 
support and 
information 
programme for lay 










N=110 N=106 Intervention: nursing support 
and information programme 
Control: standard community 
palliative care support 
questionnaires 2a 






the impact of 
using different 
recruitment 
strategies. All of 
the article. 
To compare 
knowledge of those 
who had interacted 


























Intervention: pharmacists who 
had extra education in palliative 
care Control: pharmacists who 
had no additional education 
not stated 2a 
25 Jones et al 
(2011)  
(UK) 
A paper reporting 
findings of a RCT. 
Discussion 
section.   
To test the 
acceptability and 
feasibility of a patient 
















N= 77 Intervention: structured ACP 







Article type & 
data extraction 
point 







Time to recruit 
sample 





26 Jones et al 
(2013) 
(UK) 
A paper reporting 





To test the 





















N=41 over one 
year 
Intervention: complex 
rehabilitation intervention plus 
usual care Control: usual care 
alone. Those in the control arm 
joined a wait-list and were 
offered the intervention three 
months after randomisation. 
questionnaires 2a 


































medicine unit organised care 
Control: conventional care 
questionnaires 2 a 
28 Kruse et al 
(2013) 
(US) 
A report outlining 
challenges faced 












caregivers and the 
hospice care team 
alters caregivers' 





















Intervention: biweekly team 
meetings through video or 










Article type & 
data extraction 
point 







Time to recruit 
sample 





29 Kutner et al 









during a RCT. 
Main body. 
To investigate the 




















N= 380 over 36 
months 
Intervention: massage therapy  
Control: simple touch 
not stated 2 a 
30 Latimer et al 
(1998)  
(Canada) 
A paper reporting 
the findings from 





To determine the 
effectiveness and 













N= 90 (45 
each arm) 
over 2 years 
N= 46 
randomised 
over 2 years 
Intervention: the’ Patient Care 
Travelling Record’ Control: 
usual care 
questionnaires  2a 
31 LeBlanc et al 




Abernethy (2005)  
(Australia) 
A retrospective 
report of the 
recruitment 
challenges faced 
during a RCT and 
how they were 
approached and 
overcome.  All of 
the paper. 
To test different 
service delivery 
models to improve 
pain control in the 
palliative setting. 



























over 26 months 
Intervention: (1) individualized 
interdisciplinary case 
conference with their GP versus 
control, (2) educational 
outreach visitation to GPs about 
pain management versus 
control, (3) structured 
educational visitation for 
patients and caregivers about 
pain management versus 
control 






Article type & 
data extraction 
point 







Time to recruit 
sample 





32 Lee et al 
(2013)  
(New Zealand) 
A paper reporting 







To assess the 
feasibility of 
conducting a Phase III 
RCT investigating the 





















over  8 
months 
N=9 enrolled Intervention: gastrografin 
Control: placebo 
questionnaires 2 a 
33 McMillan and 
Weitzner (2003)  
(US) 




after the first year 
of a RCT with an 




















N= 846 in 28 
months 
N=  125 patient/ 
caregiver dyads 
over 9 months 
Intervention: standard care plus 
supportive visits or standard 
care plus teaching of a method 
of coping with patient 
symptoms 
Control: standard care 
questionnaires 2 a 
34 McWhinney et 
al(1994) (Canada) 
A report outlining 
the challenges of 
carrying out RCTs 





To evaluate a 
palliative care home 
support team. 
RCT with wait 
list design 
 











N=146 Intervention: palliative care 
home support team 
Control: received intervention 
after one month  
 
questionnaire, 









Article type & 
data extraction 
point 







Time to recruit 
sample 





35 Miller and 
Chibnall (2003), 
linked to Miller et 
al (2005) 
(US) 
A letter outlining 
the researchers’ 
experiences of 
recruiting to a 




















Intervention: tool designed to 
help patients prepare for `a 
good death’  Control: not stated 
not stated 2 a 
36 Miller et al 




A paper reporting 
the findings of a 
RCT. Discussion 
section. 
To evaluate the 

















N=98 Intervention: a group 
intervention entitled ‘Life-
Threatening Illness Supportive-
Affective Group Experience’ for 
reducing patient spiritual, 
emotional and death related 
distress. Control-standard care 
questionnaires  2 a 
37 Mitchell and 
Abernethy (2005)  
linked to LeBlanc 
et al (2013) and 







study of two 
palliative care 




QCC and PCT: To 
assess the effect of 
case conferences that 
included GPs and the 
palliative care team.   





























(72%) of the 
target July 2001-








QCC Intervention: case 
conferences conducted at 
routine palliative care team 





conference including GP 
conducted at patient’s home.  










as part of 








Article type & 
data extraction 
point 







Time to recruit 
sample 






















A paper reporting 
the findings of a 
feasibility study 
to inform the 




To identify the most 





To identify the 
practicalities of 

























If at least 15 
randomised 












N= 5 December 

















Ongoing Low Molecular Weight 
Heparin (LMWH) treatment for 
CAT versus cessation of LMWH 
at 6 months’ treatment 
blood tests, 
diary cards, QOL 
questionnaires 
3 
39 Philip et al 
(2006)  
(Australia) 
A paper reporting 
the findings of a 
RCT. Discussion 
section. 
To examine the effect 
of oxygen versus air 
















N=50 N=51 over 5 
years 
Randomised to receive either 
air or oxygen via nasal prongs 
for 15 minutes. Then, following 
a 30-minute interval without 
gas, repeat measurements 
were taken with crossover to 













Article type & 
data extraction 
point 







Time to recruit 
sample 





40 Prentice et al 
(2004) (UK) 
A paper reporting 







cream is more 
effective than 
placebo in reducing 























N= 31  patients Intervention: a single 
application of benzydamine 
hydrochloride 3% cream to the 
painful pressure area. Control: 
placebo cream to the painful 
pressure area. 
pain scales 2 a 




A paper detailing 
a method of 
obtaining 
advance consent 
for a RCT and the 
interim 
recruitment  
results. All of the 
paper. 
A feasibility study of 
an advance consent 
process to support a 
RCT of 
two anti-muscarinic 
drugs  in the 



























the study in 
three years. 





Of these, 15 
developed 
death rattle and 
were 
randomised 
Intervention: to receive either 
hyoscine or glycopyrronium at 
the time of death 













during a RCT and 
the strategies 
used to overcome 
them.    
Main body. 


























Intervention: palliative care 
needs evaluation conducted by 
an interdisciplinary team, 
followed by ongoing nurse case 












Article type & 
data extraction 
point 







Time to recruit 
sample 





43 Sampson et al 
(2011)  
(UK) 
A paper reporting 
the findings of a 
RCT. Discussion 
section. 
To assess the 
feasibility  



























Intervention: a palliative care 
patient assessment which 
informed an ACP discussion 
with the carer Control: usual 
care 
questionnaires  2 a 
44 Shelby James 















N/A 14 clinical 
studies were 
discussed, 12  
of which were 
double-blind 
RCTs 






more than 500 
participants 
across 12 sites in 
8 Phase III 
studies. 
N/A N/A 2 b  
45 Storey (2004)  
(US) 
A letter outlining 
the challenges 
faced by a 
researcher while 
trying to recruit 
to three RCTs. All 
of the letter. 
not stated 1 Placebo RCT 
 











1 hospices  








1 Intervention: Mexilitine. for 
severe neuropathic pain 
Control: Placebo 
2 Intervention:  psychological 
intervention to increase 
forgiveness Control: not stated. 
3 Intervention: low dose 
oxycodone for breathlessness in 






Article type & 
data extraction 
point 







Time to recruit 
sample 





2  cancer 
centre and a 
hospice 
3 hospital that 
specializes in 
cardiac care 
3  no patients in 
a year 
advanced heart failure Control: 
not stated 
46 
Vermandere et al 
(2016)  
(the Netherlands) 
A paper reporting 
the findings of a 
RCT. Discussion 
section. 
To investigate the 
effect of a structured 
spiritual history 
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2.8.1 Identifying participants: defining the target audience 
 
The challenge of participant identification and complex inclusion criteria were raised as 
issues in the literature (Baskin et al., 1998; Goldstein et al., 2014; Hanson et al., 2014; Jones 
et al., 2013; Lee et al., 2013; Sampson et al., 2011; Vermandere et al., 2016; Zambroski et 
al., 2014). This can relate to the difficulty of predicting prognosis as part of the trial’s 
eligibility assessment (Currow et al., 2006; Goldstein et al., 2014; Gorman et al., 2008; 
Hanson et al., 2014; Latimer et al., 1998; McWhinney et al., 1994), how palliative care is 
defined in a particular country (Vermandere et al., 2016), too narrow and/or ambiguous 
inclusion criteria (Goldstein et al., 2014; Lee et al., 2013) and lack of suitable carer 
(Zambroski et al., 2014) or surrogate to gain proxy consent (Baskin et al., 1998; Sampson et 
al., 2011).  
Including broad study eligibility criteria in your protocol was seen as a facilitator to 
recruitment as it ensured a high percentage of patients screened met the study’s inclusion 
criteria (LeBlanc et al., 2013; Shelby-James et al., 2012). The use of a physician 
prognostication tool to help define and identify those patients with an advanced life limiting 
illness who were likely to die within the next 12 months, alongside face to face screening by 
a clinician, was used as successful strategy in a trial of an interdisciplinary palliative care 






2.8.2 Product: defining the product 
 
A number of papers highlighted high refusal rates as an issue amongst potential trial 
participants (Ammari et al., 2015; Bausewein et al., 2010; Buss et al., 2008; Currow et al., 
2006; Kutner et al., 2010; Noble  et al., 2015; Westcombe et al., 2003). The lack of clinical 
equipoise was cited as a possible reason for this, with concerns about being randomised to 
their non-preferred arm, which could be the intervention or control arm, having an 
influence on whether or not patients agreed to take part (Noble  et al., 2015; Westcombe et 
al., 2003). A lack of belief in the intervention (Bausewein et al., 2010; Buss et al., 2008) and 
the lack of an acceptable control (Bausewein et al., 2010) were reasons for patients 
declining to take part. These concerns about the intervention, the control and 
randomisation also apply to health care professionals and may be one of the reasons for 
their gatekeeping as discussed in section 2.8.8.1 below. The feeling the intervention was not 
needed at that particular time (Ammari et al., 2015; Buss et al., 2008; Noble  et al., 2015) 
and competing priorities (Kutner et al., 2010) were also cited as reasons for patient refusal.  
Intervention and control arms that replicated clinical practice in recruitment sites as closely 
as possible were seen to be more likely to be successful (Shelby-James et al., 2012). If in 
recruitment sites clinical practice varied significantly from the processes outlined in the 
protocol, clinicians were likely to limit the number of participants they approached or avoid 
approaching them altogether (Shelby-James et al., 2012). Offering a palliative care symptom 
control intervention to a group of patients who normally have limited access to such 
specialist input was suggested as another possible facilitator (M. C. Farquhar et al., 2009). 
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A number of study design strategies were seen to help address recruitment barriers. A fast 
track design with a short lead in time may have increased the response rate in a trial of a 
breathless intervention service by addressing the issue of clinical equipoise and patient 
preferences. All patients and families knew they were going to get the intervention either 
straight away or only after a short 8 week wait (M. C. Farquhar et al., 2009). There were 
reports of researchers simplifying their study design during the recruitment phase of the 
trial. They reduced the number of study arms to reduce the number of participants required 
to ensure statistical power was achieved (Buss et al., 2008; Westcombe et al., 2003). There 
were strategies specifically suggested to help improve recruitment rates in drug trials. 
Giving patients the option to enter an open label extension study after taking part in a 
placebo controlled symptom control trial was seen as important as enrolment was delayed 
for many patients until this was put into place (Abernethy et al., 2010).  An extension study 
follows the main trial and allows an unlicensed drug to be continued to be prescribed to all 
of those enrolled in the extension study (Taylor & Wainwright, 2005). Clinician’s fears that 
patients will be left with uncontrolled symptoms if they are randomised to the control arm 
can be reduced with the inclusion of rescue medications in the study design (Shelby-James 
et al., 2012).  
 
2.8.3 Product: The product’s competition 
 
A barrier to recruitment was potential participants being able to access information or 
support services similar to those being offered as part of a study in the recruitment centre 
or local area. Patients were able to access similar therapies and support services without 
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having to accept the restriction of randomisation (Goodwin et al., 2000; Westcombe et al., 
2003). Competing trials recruiting from a similar patient population was also seen as barrier 
in one paper (Goodwin et al., 2000). 
 
2.8.4 Price: Type of costs  
 
Patients and carers being too burdened by the illness to participate in the trial was a 
substantial barrier to recruitment (Ammari et al., 2015; Hanson et al., 2014; Latimer et al., 
1998; McMillan & Weitzner, 2003; Noble  et al., 2015). The reality of having to deal with the 
unpredictable nature of the patient’s disease in the recruitment process was also a barrier 
to recruitment (Latimer et al., 1998; Philip et al., 2006). The right time to approach patients 
and carers about the trial was seen as an issue in one study (Buss et al., 2008), with patients 
citing the time around their initial diagnosis being the wrong time whilst others offered the 
intervention at the end of treatment would have preferred the intervention earlier. Carers 
feeling protective towards their loved ones could lead to gatekeeping with reports of carers 
blocking researcher access to the patient (Hanson et al., 2014; McMillan & Weitzner, 2003; 
Zambroski et al., 2014). These findings correspond with a review focusing on gatekeeping in 
palliative care research generally (Kars et al., 2016). In addition, this review identified 
‘gatekeeping’ by patients also as an issue in studies that aimed to recruit patient/carer 
dyads. This took the form of patients refusing to allow their carers to be approached about 
the study (Hudson et al., 2001). They could also express concerns about the additional 
burden the study would place on their carer as well as making a decision that the carer 
would not derive any benefit from being involved in the research (Buss et al., 2008). 
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2.8.5 Price: Minimising the costs 
 
There was consensus among a group of palliative care trial experts that recruitment success 
depended on minimising the burden of taking part in a trial for patients, carers and clinical 
staff (Shelby-James et al., 2012). This involved limiting what was required from those 
participants who agreed to take part in a study such as minimising the number of 
questionnaires to be completed and using routine clinical data where possible. Strategies to 
minimise the burden of taking part in the study for participants were related to the 
informed consent process. Recruitment over the phone using verbal consent procedures 
was seen as a successful recruitment strategy for enrolling carers as they were sometimes 
unavailable at the time of patient consent (Riopelle et al., 2011). This allowed carers to be 
contacted and recruited at a later point in time and it prevented the delays which can be 
associated with face to face consent. The use of advance consent to improve recruitment 
rates has been used in two feasibility trials (Clark et al., 2008; Rees & Hardy, 2003). It was 
found to be a workable consent process for patients who are unable to give consent at the 
time of randomisation. The use of Zelen consent (only those randomised to the 
experimental treatment need to be individually consented) versus cluster consent was 
tested within a feasibility trial (Fowell et al., 2006). The findings suggested cluster 
randomisation may be a more helpful approach for increasing recruitment rates in trials 
with dying patients as nurses were reluctant to approach dying patients for consent to 




2.8.6 Place: Improving accessibility 
 
The type of setting where recruitment took place could act as a barrier to recruitment. The 
issue of travel was identified as a reason for patients declining to take part in a quality of life 
trial in an oncology hospital as these types of interventions can often be provided locally 
while cancer treatment trials are only available in oncology units (Westcombe et al., 2003). 
Late referral to hospice services was also seen as a barrier to recruitment as patients were 
often too ill to take part in the study (Storey, 2004; Zambroski et al., 2014). Hospice 
catchment areas could also be too small to provide the necessary pool of potentially eligible 
patients (Zambroski et al., 2014). Attempting to recruit participants during hospitalisation 
was seen to be challenging as building rapport and trust with participants during such a 
stressful time can be difficult (Fischer et al., 2015; Sampson et al., 2011). The role of 
specialist palliative care as a hospital consulting rather than admitting service was a barrier 
to recruitment in a trial recruiting patients with malignant bowel obstruction (Lee et al., 
2013). In contrast, recruiting participants after discharge was seen as more difficult in a 
couple of papers (Hanson et al., 2014; McMillan & Weitzner, 2003) with the feeling 
participants can be less receptive (Hanson et al., 2014). The physical environment and the 
often complex nature of patient consultations in the outpatient setting are seen to make 
approaching participants more difficult (Hanson et al., 2014; Latimer et al., 1998). 
Increasing the number of clinical recruitment centres during the trial to increase the pool of 
potential participants was a strategy employed by a number of studies to improve their 
recruitment rates (Abernethy et al., 2010; Goodwin et al., 2000; Westcombe et al., 2003). 
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Some studies were set up as multi centre studies but this did not always guarantee 
recruitment success (Hussainy & Marriott, 2009; Mitchell & Abernethy, 2005).   
 
2.8.7 Promoting the study 
 
The importance of paying attention to key and careful messaging when discussing a trial 
with patients, carers and clinicians to provide reassurance and to address any concerns was 
seen as important (Abernethy et al., 2010; M. C. Farquhar et al., 2009; Gorman et al., 2008; 
Hanson et al., 2014; Kutner et al., 2010; LeBlanc et al., 2013; Shelby-James et al., 2012). This 
includes, for example, using the term study rather than trial, stressing to patients they can 
withdraw from the trial at any time without negatively affecting their care, using 
standardised wording to explain the concept of randomisation and blinding to patients 
(Abernethy et al., 2010; LeBlanc et al., 2013) and explaining to clinicians the benefits of 
taking part in research for patients (Abernethy et al., 2010; Shelby-James et al., 2012). The 
use of role play and scripts to ensure those involved in the recruitment process use pre-
defined key messaging when introducing a study to patients and carers is seen as a useful 
strategy (Abernethy et al., 2010; Fischer et al., 2015; Kruse et al., 2013; LeBlanc et al., 2013; 
Mitchell & Abernethy, 2005; Shelby-James et al., 2012). One study described how it had 
refined its recruitment script during its pilot study to avoid introducing terms such as 
hospice and end-of-life care early on and decided to focus on quality of life instead (Fischer 
et al., 2015). Recruiting staff also need to ensure they are flexible and demonstrate 
respectful persistence (Hanson et al., 2014; Riopelle et al., 2011) while developing a rapport 
with the patient (Riopelle et al., 2011) when promoting a trial. 
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2.8.8 Working with partners 
 
This aspect of the ‘Social Marketing Mix Framework’ is divided into three areas: barriers to 
partnering, partner education and partner referrals and recruitment.  
 
2.8.8.1 Barriers to partnering 
 
‘Gatekeeping’ was seen as a barrier to trial recruitment with the majority of papers 
identifying health care professional gatekeeping as the most difficult issue to overcome 
(Buss & Arnold, 2004; Cook et al., 2002; Goodwin et al., 2000; Hanson et al., 2014; Hudson 
et al., 2001; Hussainy & Marriott, 2009; Jones et al., 2013; Jones et al., 2011; Kutner et al., 
2010; Latimer et al., 1998; Miller et al., 2005; Prentice et al., 2004; Vermandere et al., 2016; 
Westcombe et al., 2003). This was related to the professionals fear of over burdening 
patients (Buss & Arnold, 2004; Goodwin et al., 2000; Hanson et al., 2014; Hussainy & 
Marriott, 2009; Kutner et al., 2010; Latimer et al., 1998; Westcombe et al., 2003), lack of 
belief in research (Buss & Arnold, 2004; Hussainy & Marriott, 2009), seeing patients as being 
too poorly (Cook et al., 2002; Daniels & Exley, 2001; Hanson et al., 2014; Prentice et al., 
2004) or emotionally distressed (Daniels & Exley, 2001; Latimer et al., 1998) or too stressed 
to be approached (Hudson et al., 2001). Lack of confidence discussing a challenging study 
(Fowell et al., 2006; Jones et al., 2011) and fear of discussing prognosis (Jones et al., 2013; 




Concerns regarding randomisation (Daniels & Exley, 2001; Goodwin et al., 2000; Westcombe 
et al., 2003), the use of placebo (Buss & Arnold, 2004; Hardy et al., 1998; Storey, 2004), a 
lack of belief in the intervention (Goodwin et al., 2000; Miller et al., 2005; Westcombe et al., 
2003) and in clinical equipoise (Goodwin et al., 2000; Jones et al., 2013; Westcombe et al., 
2003) were also highlighted as possible reasons for health care professional gatekeeping.  
Gatekeeping by research ethics committees could also be an issue. Research ethics 
committees play an important role in ensuring ethical standards are met in research and the 
rights of those taking part are protected. They were seen at times not to have a good 
understanding of palliative care research which led to a misapplication of their gatekeeping 
role (Lee & Kristjanson, 2003). This resulted in overly paternalistic recruitment procedures 
being put in place such as face to face consent in the community by a Doctor (Buss & 
Arnold, 2004) and insisting patients were informed they had a prognosis of six months or 
less before they could be approached (Storey, 2004).  
Recruiting to a palliative care trial is seen as a costly and labour-intensive process. A large 
number of patients have to be screened from a variety of settings in order to find the 
participants that are eventually recruited to the study. The majority of research staff time is 
spent screening and consenting rather than carrying out the intervention and collecting data 
(Clark et al., 2008; Daniels & Exley, 2001; Hanson et al., 2014; McMillan & Weitzner, 2003; 
Zambroski et al., 2014). Not having the necessary staff available due to staff turnover or 
holidays (Mitchell & Abernethy, 2005), clinical staff being too busy (Fischer et al., 2015) or 




2.8.8.2 Partner education 
 
Personal and repeated contact with referral sources was seen as crucial strategy to create 
and maintain enthusiasm and motivation throughout the life of the study as well as address 
any concerns that may develop (Daniels & Exley, 2001; Jordhøy et al., 1999; LeBlanc et al., 
2013; Mitchell & Abernethy, 2005; Prentice et al., 2004). The approaches used included 
presentations, regular meetings and involvement of clinical staff in the study design and 
procedure development (LeBlanc et al., 2013). Identifying an enthusiastic study champion to 
assist access to potential participants and help promote the study among patients and 
clinicians was also seen as a valuable strategy (Hanson et al., 2014; Kutner et al., 2010; 
Miller & Chibnall, 2003; Westcombe et al., 2003). 
 
2.8.8.3 Partner referrals and recruitment  
 
Having research staff on site to provide logistical and practical support to enhance study 
recruitment is the strategy discussed most frequently in the literature (Abernethy et al., 
2010; Bakitas et al., 2009; Bakitas et al., 2006; Currow et al., 2006; Farquhar et al., 2011; 
Hanson et al., 2014; Jordhøy et al., 1999; Kruse et al., 2013; Kutner et al., 2010; LeBlanc et 
al., 2013; Miller & Chibnall, 2003; Mitchell & Abernethy, 2005; Westcombe et al., 2003). 
Some authors have seen this intervention as the one that had the greatest impact on their 
recruitment rates (Abernethy et al., 2010; Farquhar et al., 2011). It can be seen to relieve 
the excessive burden of recruitment on busy clinical staff (Abernethy et al., 2010; Currow et 
al., 2006; Farquhar et al., 2011; Jordhøy et al., 1999; LeBlanc et al., 2013), help address the 
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issue of gatekeeping (Bakitas et al., 2009; Bakitas et al., 2006; Mitchell & Abernethy, 2005), 
support relationship building (Abernethy et al., 2010; Farquhar et al., 2011; Kruse et al., 
2013), help keep a trial visible (Westcombe et al., 2003), allow direct access to participants 
(Hanson et al., 2014) and provide consistency (LeBlanc et al., 2013). But it is important to 
note that in some trials this does not always appear to be the case and the issue of 
gatekeeping remained a problem despite the presence of a research nurse (Cook et al., 
2002). The issue of research staff not being available at the ‘right time’ to approach 
potential participants was sometimes seen as a problem with patients being discharged or 
transferred to another department before they were able to be approached (Ammari et al., 
2015). 
Having the support of lead clinicians is seen as a facilitator to recruitment as this enhanced 
patient acceptance of the trial (Bakitas et al., 2006; Buss et al., 2008; M. C. Farquhar et al., 
2009; Fischer et al., 2015; Goodwin et al., 2000; Hanson et al., 2014; Higginson et al., 2008) 
and promoted a research culture in the recruitment sites (Goodwin et al., 2000). Financial 
incentives for study site staff were used as a strategy in one study to attempt to improve 
sluggish recruitment with mixed results across sites (Kutner et al., 2010). Monthly 
recruitment progress reports sent to individual sites were also used in one study and it was 
felt this encouraged ‘healthy competition and camaraderie’ (Kutner et al., 2010). 
Identifying and finding potential participants is one of the most significant recruitment 
challenges in palliative care trials with the approaches used dependent on local resources 
and systems. A number of screening strategies are suggested which include ‘active 
questioning’ to identify patients with a particular symptom (Abernethy et al., 2010) or those 
who are on specific medication rather than relying purely on clinical notes (Hanson et al., 
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2014). Reviewing clinical lists or notes which may include electronic database searches if the 
facilities are available (Hanson et al., 2014; Kutner et al., 2010; Zambroski et al., 2014). 
Other strategies included incorporating the screening process into the regular palliative care 
service triage process (LeBlanc et al., 2013; Mitchell & Abernethy, 2005), using a screening 
algorithm (Abernethy et al., 2010) and simplifying and minimising the screening process for 
clinicians (LeBlanc et al., 2013). 
The usefulness of a national palliative care clinical trial’s cooperative made up of experts in 
the field of palliative care trial research was recognised in one study. This resource was seen 
to help improve recruitment as it facilitated team based support, the sharing and 




Table 9: Barriers and facilitators to recruitment identified from the literature review conceptually mapped within the ‘6 Ps’ of the ‘Social 
Marketing Mix Framework’. 







Identifying participants who 
meet the study inclusion 
criteria 
Patient : Goldstein et al (2014),  Zambroski et al (2014), Jones et al (2013)  Hanson et al (2014), Lee et 
al (2013), Vermandere et al (2016), Carer : Baskin at al (1998), Sampson et al (2011), Zambroski et al 
(2014) 
Difficulty predicting prognosis Patient : Currow et al (2006), Goldstein et al (2014), Gorman et al (2008), Latimer et al (1998), Hanson 
et al (2014), McWhinney et al (1994) 
Facilitator 
Broad study eligibility criteria  Patient : LeBlanc et al (2013), Shelby James et al (2012) 
Strategy 
Physician prognostication tool  Patient: Riopelle et al (2011) 





Participants not interested Patient : Currow et al (2006), Kutner et al (2010) , Westcombe et al (2003), Bausewein et al (2010), 
Noble et al (2015), Buss et al (2008), Ammari et al (2015) Carers: Buss et al (2008) 
Clinical equipoise Patient : Noble et al (2015), Bausewein et al (2010), Westcombe et el (2003), Buss et al (2008) 
Partners : Buss and Arnold (2004),  Goodwin et al (2000), Westcombe et al (2003), Hardy et al (1998), 

















Trial replicates clinical practice 
as much as possible 
Partners: Shelby James et al (2012) 
Offer a desirable and novel 
intervention  
Patients: Farquhar et al (2009) 
Strategy 
Fast track randomised 
controlled trial 
Patients: Farquhar et al (2009) Carers: Farquhar et al (2009) 
Simplify design Patients: Westcombe et al (2003), Buss et al (2008) 
Extension study Patients: Abernethy et al (2010), Partners: Abernethy et al (2010)  
Rescue medication Patients: Shelby James et al (2012), Partners: Shelby James et al (2012) 
Barrier  
Competing services Patients : Goodwin et al (2000), Westcombe et al (2003) 





Patient’s condition/illness Patients : McMillan and Weitzner (2003) Latimer et al (1998), Philip et al (2006), Hanson et al (2014), 







Gatekeeping  Patients : Buss et al (2008), Hudson et al (2001), Carers: McMillan and Weitzner (2003), Zambroski et 
al (2014), Hanson et al (2014) 
Facilitator 
Minimise study burden  Patients: Shelby James et al (2012), Carers: Shelby James et al (2012), Partners: Shelby James et al 
(2012) 
Strategy 
Verbal consent  Carers: Riopelle et al (2011)   
Advance consent  Patients: Rees and Hardy (2003), Clark et al (2008), Carers: Clark et al (2008) 
Cluster consent  Patients: Fowell et al (2006), Partners: Fowell et al (2006) 
4 Place Barrier 
Type of recruitment setting  
 
Patient : Cancer centre: Westcombe et al (2003), Hospice: Storey (2004), Zambroski et al (2014), 
Hospital Inpatients: Fischer et al (2015), Sampson et al (2011), Lee et al (2013), Community: Hanson et 
al (2014), McMillan and Weitzner (2003), Hospital Outpatients: Latimer et al (1998), Hanson et al 
(2014)   Carer : Hospital Inpatients: Sampson et al (2011), Hospice: Zambroski et al (2014), Hospital 
Outpatients: Latimer et al (1998) 
 
Strategy 
Increase number of clinical 
recruitment centres  
Patient: Abernethy et al (2010), Goodwin et al (2000), Mitchell and Abernethy (2005), Hussainy and 













Key/careful messaging  Patient : Abernethy et al (2010), Gorman et al (2008), LeBlanc et al (2013), Farquhar et al (2009), 
Hanson et al (2014), Kutner et al (2010), Carer : Abernethy et al (2010), Kutner et al (2010), LeBlanc et 
al (2013), Partner : Abernethy et al (2010), Gorman et al (2008), Kutner et al (2010), LeBlanc et al 
(2013), Shelby James et al (2012) 
Flexibility and respectful 
persistence  
Patient : Riopelle et al (2011), Hanson et al (2014)  
Rapport between researcher 
and participant  
Patient: Riopelle et al (2011), Partner: Riopelle et al (2011) 
Strategy 
Role play/scripts Partner : Fischer et al (2015), Abernethy et al (2010), Kruse et al (2013) LeBlanc et al (2013), Mitchell 









Health care professional 
gatekeeping  
 
Partner: Buss and Arnold (2004), Cook et al (2002), Goodwin et al (2000), Hussainy and Marriott 
(2009), Kutner et al (2010), Westcombe et al (2003), Jones et al (2011), Latimer et al (1998), Miller et 
al (2005), Daniels and Exley (2001), Hanson et al (2014), Prentice et al (2004), Jones et al (2013), 
Fowell et al (2006), Hudson et al (2001), Vermadere et al (2016), Hardy et al (1998), Storey (2004), 
Jordhoy et al (1999) 
Gatekeeping by research ethics 
committee 















Resources: labour intensive  Partner : McMillan and Weitzner (2003), Clark et al (2008), Hanson et al (2014), Daniels and Exley 
(2001), Zambroski et al (2014)  
Resources: research or clinical 
staff availability 
Partner: Mitchell and Abernethy (2005), Fischer et al (2015), Lee et al (2013), Hardy et al (1998) 
Strategy   
Personal repeated contact with 
referral sources  
Partner: Jordhoy et al (1999), LeBlanc et al (2013), Mitchell and Abernethy (2005), Prentice et al 
(2004), Daniels and Exley (2001) 
Study champion  Partner : Hanson et al (2014), Kutner et al (2010), Westcombe et al (2003), Miller and Chibnall (2003) 
Facilitator   
Support of lead clinicians Partner: Bakitas et al (2006), Goodwin et al (2000), Buss et al (2008), Fischer et al (2015), Higginson et 
al (2008), Farquhar et al (2009), Hanson et al (2014) 
Support of a palliative care 
clinical trials cooperative 
Partner: Hanson et al (2014) 
Strategy  
Active questioning Partner : Abernethy et al, (2010) Hanson et al (2014) 
Review clinic/hospital 
lists/clinical notes 
Partner : Kutner et al (2010), Hanson et al (2014),  Zambroski et al (2014)  
Clinical triage nurse Partner : LeBlanc et al (2013), Mitchell and Abernethy (2005)  
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Screening algorithm Partner : Abernethy et al (2010) 
Minimal screening for clinicians Partner : LeBlanc et al (2013) 
Financial incentives  Partner : Kutner et al (2010) 
Recruitment progress reports Partner: Kutner et al (2010) 
Research staff on site Partner: Abernethy et al (2010),  Ammari et al (2015), Bakitas et al, (2006), Bakitas et al (2009), Cook 
et al (2002), Currow et al (2006), Farquhar et al (2011), Jordhoy et al (1999), Kruse et al (2013), Kutner 
et al (2010), LeBlanc et al (2013), Miller and Chibnell (2003), Mitchell and Abernethy (2005),  
Westcombe et al (2003), Hanson et al (2014)  
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2.9 Discussion  
 
The findings of this review have shown that the barriers to recruitment and the potential 
facilitators and strategies that may help to overcome them described in the literature are 
largely based on anecdotal evidence. The majority of evidence that currently informs our 
understanding of the palliative care trial recruitment process is based on trial reports or 
methodological papers that explore the design of exemplar trial/s rather than primary 
research data. The review findings suggest that there are likely to be issues to consider for 
most palliative care trials but further methodological research is needed. These issues 
include; the need to pay attention to key and careful messaging when promoting a trial; the 
need to plan for adequate resources to find eligible participants, ensuring you have the 
support of the lead clinician and having research staff on site.  
The greatest number of barriers, facilitators and strategies identified within the literature 
could be mapped within the ‘Working with Partners’ category. This highlights the 
fundamental role that health care professionals play in the recruitment process. Their key 
role has also been recognised in the general trial recruitment literature (Fletcher et al., 
2012). Health care professional gatekeeping was identified as the most difficult issue to 
overcome in the majority of papers. This review builds upon the qualitative review carried 
out by Kars et al (2016) into gatekeeping in palliative care research. 
The findings also indicated that the ‘Social Marketing Mix Framework’ may help researchers 
better understand the processes underpinning recruitment to palliative care trials. For 
example, one of the challenges identified in the literature was the issue of high refusal rates 
and this was not always related to the patient’s condition. Their refusal sometimes 
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appeared to be related to their concerns about the ‘product’ which in social marketing 
terms, as discussed previously, relates to the intervention that is being offered in the study.  
As discussed in chapter one, the lack of clinical equipoise and the influence of patient 
preferences on decision making can also act as a barrier to recruitment in trials outside 
palliative care (Harrop, Kelly, et al., 2016; Norris et al., 2019; Paramasivan et al., 2011). 
Under the ‘Social Marketing Mix Framework’ ensuring the ‘product’ meets the needs of the 
target audience is a key consideration when designing a study. This is reflected in the 
increasing requirement for patient and public involvement representatives to be involved in 
the study design process (Crocker et al., 2018). Patient and public involvement has been 
defined as research that is carried out ‘with’ or ‘by’ members of the public which includes 
patients and carers (National Institute for Health Research-INVOLVE, 2019). Patient and 
public involvement may improve the acceptability of a trial (Crocker et al., 2018). This may 
have a positive impact on trial recruitment rates but further research is required to explore 
its impact both in (Chambers et al., 2019) and outside the context of palliative care (Healy et 
al., 2018).  
‘Working with partners’ with its focus on ‘partner education’, ‘partner referrals and 
recruitment’ and ‘barriers to partnering’ is a key aspect of  the marketing framework applied 
in this review and is linked to the concepts of ‘Place’ and ‘Promotion’. For example, this 
refers to the location where recruitment activity takes place as well as the way in which the 
health care professional presents the study to the patient. ‘Product’ and ‘Price’ are applied 
to the patient and/or carer and not the ‘partner’ under this framework. The findings of this 
review suggest that this may not fully capture the complexities of recruitment in palliative 
care. For example, clinicians may struggle to accept the intervention or randomisation and 
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may feel the emotional costs of approaching a patient or carer at a difficult time in their 
lives. This may make it hard for them to balance the costs of taking part in the study with 
the potential benefits the study may have for patients and carers.   
This review has highlighted the need for more methodological research focusing on 
recruitment issues in palliative care randomised controlled trials, including the role of health 
care professionals in the recruitment process. This priority for research has been 
subsequently reflected in the PRioRiTy study recommendations (see table 4) as discussed in 
the previous chapter (Healy et al., 2018).  Whether and how the ‘Social Marketing Mix 
Framework’ applies to the palliative care trial recruitment process also needs further 
exploration. 
 
2.9.1 Strengths and limitations of the review 
 
To the authors knowledge this was the first review to synthesise the evidence related to the 
barriers and facilitators to recruitment to randomised controlled trials in palliative care. This 
review is unique in palliative care as it uses a theoretical framework to explore the barriers 
and facilitators to trial recruitment. Using theory in the review process can help the 
reviewer and reader assess how applicable and generalisable the findings of the review are 
to clinical practice. Reviews that focus purely on ‘tested’ recruitment strategies or 
interventions are important but their findings can be complemented by work that adopts a 
more qualitative approach as they have the potential to ‘elicit and identify the hidden 
challenges’ that make up this important clinical activity (Donovan  et al., 2014). This has 
been illustrated in a recent Cochrane qualitative synthesis review exploring the complexity 
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of factors that influence a person's decision whether to participate in a trial (Houghton et 
al., 2020). The search strategy and approach used was thorough in this review, however, I 
do not claim to have identified and reviewed all published palliative care randomised 
controlled trial papers for reported barriers and facilitators to recruitment. Initial searches 
of the literature identified that including non-randomised controlled clinical trials in the 
search strategy created too many ‘hits’ for a single researcher to review. By limiting the 
focus of the search to randomised controlled trials may have meant important barriers and 
facilitators to palliative care clinical trial recruitment may have been missed. Unfortunately, 
funding was not available in this study for two independent reviewers to extract data from 
the full data set. This may have meant data related to the barriers and facilitators to 
palliative care trial recruitment may have been missed. The review findings are largely based 
on researcher anecdotal evidence so should be interpreted with caution. This is the level of 
evidence that is currently underpinning our understanding of recruitment issues in palliative 
care randomised controlled trials.  
The review has not been updated following the initial search because examining large 
numbers of trial papers only identified a small number of papers that included descriptions 
of recruitment issues. Following the review, a number of strategies have been used to keep 
up to date with the current recruitment literature. These include monthly email updates 
from Pub Med and relevant journals, citation tracking of papers, checking the reference lists 
of papers and following the work of key authors. The current trial recruitment literature is 







Most of the evidence related to the barriers and facilitators to recruitment in palliative care 
randomised controlled trials is anecdotal. There can be multiple reasons for why a trial may 
struggle to reach its recruitment targets, including patient related factors such as patient 
preferences. This review has highlighted, as in the general trial literature, the key role that 
health care professionals play in the recruitment process. More methodological research is 
needed to explore trial recruitment issues in palliative care. This includes, as also recognised 
in the general trial literature, research that captures the perspectives of health care 
professionals involved in the recruitment process.  
Without further methodological research it is likely palliative care trials will continue to 
struggle to reach their recruitment targets. The findings of the review suggest that the 
‘Social Marketing Mix Framework’ can help guide researchers when planning and 
implementing their recruitment strategy but whether and how the framework applies to the 




Chapter three: Choice of research methods 
3.1 Introduction 
 
In this chapter, the research question and the aims of the study are outlined. The types of 
research design and methods available to address the research question are discussed. Why 
the chosen approach was identified as the most suitable to answer the research question is 
outlined. The key features of the chosen research design are described along with how they 
reflect the epistemological and ontological stance taken in this study. How the chosen 
research methods were operationalised in practice is examined in the next chapter.  
 
3.2 Research question and study aims 
 
As highlighted in the previous two chapters, health care professionals play a crucial role in 
the recruitment of patients and carers to research studies and the reasons why they do or 
do not identify and approach potential participants is complex (Preston et al., 2016). There 
is little understanding of the process of recruitment in randomised controlled trials and the 
influence recruiters may have on it (Donovan  et al., 2014) and this is especially so in the 
field of palliative care. This is illustrated by the findings of the literature review in the 
previous chapter which found the current evidence base to be largely anecdotal. In this 
study, the aim is to develop a better understanding of which health care professional 





How do health care professionals recruit patients and their family carers to palliative care 
randomised controlled trials and why do they use certain strategies during the recruitment 
process?   
Study Aims  
 To identify how health care professionals involved in the recruitment process 
undertake the recruitment of patients and family carers to palliative care 
randomised controlled trials.  
 To explore why health care professionals involved in the recruitment process choose 
to implement particular recruitment strategies, and the factors that influence their 
choices, when recruiting to palliative care randomised controlled trials.  
The research question aligns with the priorities set by the Prioritising Recruitment in 
Randomised Trials study as discussed in chapter one (Healy et al., 2018; Hennessy et al., 
2018). Most notably priorities 5 and 7:  
5. ‘What are the barriers and enablers for clinicians/healthcare professionals in   
helping conduct randomised trials?’ 
 
7. ‘What are the best approaches to ensure inclusion and participation of under-
represented or vulnerable groups in randomised trials?’ 
 
Clinicians attitudes towards participation in palliative care research and why, for example, 
they may act as gatekeepers has also been highlighted as an area of clinical practice that 




3.3 Study design 
 
3.3.1 Choosing an appropriate study design 
 
Once the research question has been developed, the next phase of the research process is 
to decide on the most appropriate study design to address the research question posed. 
Bryman (2012) argues that a decision about an appropriate study design is based on the 
importance attached to a number of priorities. These priorities include; whether there is a 
need to express causality between variables; generalise beyond the study population; 
understand behaviours and their meanings in their social context and/or the need to study 
phenomena and their interconnections over time (Bryman, 2012). As illustrated in table 10, 
there are a number of research designs that can be used to answer research questions 






Table 10: An overview of research designs and research strategies (adapted from Bryman (2012)) 
Research 
Designs  
Research strategies (typical forms) 
 
Types of trial recruitment research questions the research 
designs/strategies can address.  
Experimental  Randomised controlled trial 
 
Could be used to understand if an intervention aimed at recruiting staff, 
such as a training programme, affects recruitment rates. 
Quasi 
experimental  
E.g. Non-randomised controlled trials, controlled 
and uncontrolled before and after (pre-post) and 
time-series designs 
Could be used to understand if an intervention aimed at recruiting staff, 








Quantitative strategies: surveys, structured 
observation, content analysis 
 
Qualitative strategies: interviews, focus groups, 
content analysis 
A survey, for example, could be used to explore recruiting staff’s views 
and experiences of recruiting to a palliative care trial.   
 
Interviews or focus groups, for example, could be used to explore in 
more depth, recruiting staff’s views and experiences of recruiting to a 




Quantitative strategies: surveys on a sample 
more than once (includes cohort studies), 
documentary content analysis focusing on 
different time periods 
 
Qualitative strategies: interviews more than once, 
documentary content analysis focusing on 
different time periods, ethnography 
A survey could be used, for example, to explore at more than one time 
point recruiting staff’s views and experiences of recruiting to a palliative 
care trial.  
 
 
Interviews or focus groups, for example, could be used to explore in 
more depth at more than one time point recruiting staff’s views and 
experiences of recruiting to a palliative care trial.  
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A non-experimental approach was the most appropriate to follow in this study as there was 
no intervention to be tested. As a result, there was no requirement to assess and express 
causality between an independent and dependent variable. Quantitative surveys have been 
used outside palliative care to identify recruiting staff’s perceptions of the barriers and 
facilitators to trial recruitment and potential recruitment strategies (Isaksson et al., 2019; 
Kaur et al., 2012). The aims of this study were concerned with understanding the personal 
experiences and behaviours of health care professionals during the trial recruitment 
process. It also aimed to understand the meanings and motivations behind these personal 
experiences and behaviours in their social context.  
Social context relates to factors such as the recruitment setting or relationships between 
professional groups. A research design that incorporated qualitative strategies seemed the 
most appropriate approach to ‘elicit and identify the hidden challenges’ that make up clinical 
activity such as recruitment (Donovan  et al., 2014) (p.1) and address the research question. 
Authors have argued that using qualitative research, both standalone and embedded within 
a trial, can contribute to a better understanding of trial recruitment issues (Hennessy et al., 
2018; O'Cathain, 2018). There is no coherent definition of qualitative research, it can have a 
range of meanings and acts as an umbrella term for a number of different approaches 
(Aspers & Corte, 2019). Qualitative research focuses on how people understand and give 
meaning to their social world (Ritchie & Lewis, 2003). Aspers and Corte (2019) argue that 
qualitative research;  
‘..tends to focus on meanings and motivations that underlie cultural symbols, 
personal experiences, phenomena and detailed understanding of processes in the 
social world’ (p.146) 
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Qualitative approaches are also iterative and provide the flexibility to explore new areas of 
enquiry that may emerge during a research study (Aspers & Corte, 2019; Bryman, 2012). 
Different qualitative approaches could have been used in this study to explore trial 
recruitment issues. For example, grounded theory could have been used to develop a 
theory to explain how clinicians undertake the process of recruitment as illustrated in a 
study exploring nurses views of wound care research (Lamb et al., 2016). An interpretative 
phenomenological approach could have been used to explain how recruiting staff 
experience working on a palliative care trial, as illustrated in a recent study exploring 
paramedics views of an emergency care trial (Charlton et al., 2019). An ethnographic design 
could have been used to observe recruitment interactions within their clinical settings to 
understand how health care professionals and palliative care patients discuss and deliberate 
about trial participation (Garrett et al., 2020). In this study, the decision was taken to use a 
qualitative case study approach. This approach has been used by a number of nurse 
researchers in the palliative care setting (Brogan et al., 2019). It has also been used to 
explore and understand recruitment processes in non-palliative care randomised controlled 
trials (Campbell et al., 2007; Rooshenas et al., 2019). The decision to use a case study 
approach was especially influenced by a National Institute for Health Research Health 
Technology Assessment funded study. This study aimed to identify factors associated with 
good and poor recruitment to multicentre trials. Within this study, they used a case study 
approach to understand, through the opinions of study coordinating and recruiting staff in 
four diverse exemplar trials, trial recruitment challenges and facilitators (Campbell et al., 
2007).  
Choice of research design is influenced by the epistemological and ontological ‘tendencies’ 
or orientations of the researcher (Bryman, 2012) and researchers should explicitly state 
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their philosophical approach (Brogan et al., 2019; Carolan et al., 2016). Epistemology relates 
to the nature of knowledge and how knowledge is acquired while ontology refers to the 
researchers view of the nature of the social world and what we can know about it (Ritchie & 
Lewis, 2003).  
 
3.3.2 Epistemological and ontological issues in qualitative research 
 
As discussed previously, qualitative research, both standalone and embedded within a trial, 
has been used to understand trial recruitment issues. Some argue that it is not possible to 
combine qualitative and quantitative approaches within a trial because they fall within 
different paradigms (O'Cathain, 2018; Walshe, 2018). Choosing a standalone qualitative 
research design, as in this study, to explore recruitment issues in randomised controlled trials 
would also on appear on the surface to be epistemologically and ontologically incompatible.  
Trials are seen to fall within a positivist paradigm and those that believe in a positivist 
experimental approach accept that there is an orderly relationship between the cause, which 
is the intervention being trialled, and the effect, which is the study outcome (Maxwell & 
Mittapalli, 2010). There has been increasing recognition that context and social relationships 
can influence how causal pathways work in practice (O'Cathain, 2018; Paparini et al., 2020). 
This has led some researchers to embrace the use of qualitative research to help them 
understand how context and complexity can influence trial processes and interventions 
(O'Cathain, 2018; Wells et al., 2012) including in palliative care (Lim et al., 2017). Post 
positivists believe qualitative and quantitative research are compatible, but see qualitative 
research as playing a supportive role to quantitative research (Creswell & Poth, 2016; 
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O'Cathain, 2018). Post positivism focuses on theory testing, making comparisons across 
groups, validity, objectivity, limiting bias, and causal explanations so adopting a scientific 
approach to qualitative research (Creswell & Poth, 2016).  
Critical realists also believe that qualitative and quantitative research are compatible with 
some authors even arguing that critical realist trials are possible (Porter et al., 2017). Critical 
realism fits with my own ontological and epistemological ‘tendencies’ as a researcher. The 
case study research design has been associated with the critical realist philosophical 
framework (Easton, 2010; Elger, 2010). There are different approaches to critical realism but 
all have a number of common characteristics (Maxwell & Mittapalli, 2010). Critical realism 
combines a realist ontology with a constructivist epistemology (Maxwell & Mittapalli, 2010). 
Critical realists, like positivists and post positivists, believe there is a real world that exists 
independently of our beliefs, perceptions, theories, constructions and understanding 
(Maxwell & Mittapalli, 2010; Ritchie & Lewis, 2003). Critical realists believe that even though 
there is an external reality, it cannot be easily accessed in the social world. They accept that 
reality is socially constructed (Maxwell & Mittapalli, 2010) which means that entry to the 
social world is always ‘mediated and subjective’ (Bryman, 2012)(p.616). The social world is 
accessible to researchers via participant’s interpretations of the social world, which maybe 
further interpreted by the researcher. Different views will yield different types of 
understanding and this adds richness to our understanding of the various ways in which 
external reality is experienced by individuals within the social world (Ritchie & Lewis, 2003).  
Therefore, while critical realism rejects the idea of “multiple realities”, it accepts that there 
are valid perspectives on the world (Maxwell, 2009; Maxwell & Mittapalli, 2010). This 
contrasts with relativists and social constructivists who believe there are multiple realities 
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that are created as a result of ‘our lived experience and interactions with others’ (Creswell & 
Poth, 2016) (p.35). 
Bhaskar (2008), a prominent critical realist, believes there are three levels or domains of 
reality: the ‘empirical’, the ‘actual’ and the ‘real’. Critical realism aims to explain causality by 
understanding the causal mechanisms and processes by which an event or situation occurs 
(e.g. recruitment to a palliative care trial). The empirical level is what can be observed or 
experienced (e.g. a screening log showing eligible patients are not being approached). The 
‘actual’ level refers to what is known but cannot always be seen (e.g. evidence suggests 
clinician gatekeeping is a barrier to recruitment). Underpinning the ‘actual’ level are 
overlapping ‘generative mechanisms’ or social structures that are real but not directly 
accessible to observation (e.g. professional hierarchies, organisational culture, gender) 
(Bhaskar, 2008; Walsh & Evans, 2014). These ‘generative mechanisms’ contribute to the 
understanding of the ‘actual’ but are not definitive or fully explanatory (Walsh & Evans, 
2014). Individuals or social groups (e.g. research nurses) may have different responses to 
similar situations (e.g. approaching a palliative care patient about a trial). These differences 
may be due to personal or cultural characteristics (e.g. previous clinical experience, family 
history) that are causally relevant to the outcome (e.g. recruitment to a palliative care trial) 
(Maxwell & Mittapalli, 2010). Individuals have the power to decide how to act depending on 
their interpretation of the situation (Porter et al., 2017). Awareness of these social 
structures and individual influences can explain why things are happening at the empirical 
level (Walsh & Evans, 2014). Generative mechanisms are only apparent through their 
‘empirical’ effect so the use of hypotheses or theoretical propositions can be constructed to 
explore their effects (Bryman, 2012). The use of theoretical propositions in case study 
research is compared to hypothesis testing in experimental research and is explored in 
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further detail in section 3.4.1. Critical realists believe their approach to investigating 
causation is just as legitimate as a quantitative approach and can often be complementary 
(Maxwell & Mittapalli, 2010).  
 
3.4 Case study  
 
Case studies cross many disciplines and have been used to cover diverse topics and issues 
(Creswell & Poth, 2016; Harrison et al., 2017). They have been used, for example, in health 
care (Crowe et al., 2011; Paddock et al., 2019; Walshe et al., 2008), education (Merriam, 
1998), management (Takahashi & Araujo, 2019) and marketing (Easton, 2010). Case study is 
a research design or approach rather than a research method (Rosenberg & Yates, 2007) and 
must not be confused with case reports that are found in medical journals (Alpi & Evans, 
2019). It offers methodological flexibility as qualitative, quantitative or mixed methods may 
be used (Bryman, 2012; Rosenberg & Yates, 2007). The choice of method should reflect the 
issue being studied (Flyvbjerg, 2006) and can include interviews, surveys, documentation, 
observation and archival data such as patient clinical records (Yin, 2018). 
Case study is viewed as an appropriate study design to answer how and why research 
questions as posed in this study (Yin, 2018). As discussed previously, trial recruitment is a 
contemporary, interactional activity and process that occurs in clinical practice settings. 
Recruitment is a complex process that is potentially lengthy and is not a one off event 
(Donovan  et al., 2014). Multiple complex issues may influence the palliative care trial 
recruitment process and recruitment activity may occur in different clinical contexts as 
highlighted earlier. Case study aims to address complex contemporary phenomena, like 
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recruitment, within their real life clinical context (Crowe et al., 2011; Yin, 2018). Flyvbjerg 
(2006) believes that one of the strengths of the case study approach is that it can ‘close in’ 
on real-life events as they unfold in practice. It is useful when context is central to the study 
(Walshe et al., 2004) and when it is difficult to separate the case from the context in which it 
happens (Boblin et al., 2013). Assessing the context in which a trial takes place will lead to a 
greater understanding of the complexity of factors that are involved in the trial recruitment 
process (Campbell et al., 2007). The need to address complexity and context has led other 
researchers to use case study to explore trial related issues (Grant et al., 2020; Hagen et al., 
2019; Wells et al., 2012), including recruitment processes (Campbell et al., 2007; Rooshenas 
et al., 2019), as discussed previously. It has also been seen as a useful approach in under 
researched areas, as in this study (Walshe et al., 2004).   
 
3.4.1 Epistemological and ontological issues in case study research 
 
Case study research offers paradigmatic flexibility as well as methodological flexibility (Grant 
et al., 2020; Rosenberg & Yates, 2007; Thomas, 2011). Yin (2018) and Stake (1995), two of 
the seminal case study protagonists, have different epistemological and ontological 
assumptions underpinning their approaches. Stake’s approach to case study sits within a 
social constructivist paradigm and adopts a more flexible inductive approach to theory 
(Boblin et al., 2013; Harrison et al., 2017), seeing the conduct of case study research as more 
of an art (Creswell & Poth, 2016; Stake, 1995). This contrasts with Yin’s approach that 
mirrors the structured and systematic approach found in experimental research. He argues 
that the natural and social sciences should and are able to use the same kind of approaches 
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to collecting data and explaining phenomenon (Bryman, 2012). Authors have suggested that 
Yin is a post positivist (Boblin et al., 2013; Creswell & Poth, 2016; Harrison et al., 2017; Hyett 
et al., 2014), even though he does not discuss his epistemological and ontological 
‘tendencies’ apart from suggesting his approach sits generally within realism (Yin, 2018).  
Yin’s approach to case study appears to have critical realist traits, for example, he 
recommends the use of theoretical propositions or logic models to guide data collection and 
analysis to explore the deeper reasons for what can be observed (Pawson & Tilley, 1997; 
Walsh & Evans, 2014; Yin, 2018). The development of theoretical propositions involves the 
researcher predicting a theory about what may be learned from examining the case (Yin, 
2018)(p.24). Theoretical propositions can be linked to the literature, theory and/or 
generalisations based on the study findings with some also basing them on personal or 
professional experience (Baxter & Jack, 2008). Each theoretical proposition is examined for 
each case and not for all the cases together as in hypothesis testing research. If cases 
confirm emergent relationships this enhances confidence in the validity of the relationship 
while those that disconfirm provide the opportunity to refine and extend the theory 
(Eisenhardt, 1989). Yin (2018) recommends that the theoretical propositions are reviewed 
during the study and refined or rejected as appropriate. Yin’s approach to case study was 
chosen in this study as his assumptions about the nature of reality and knowledge, and how 






3.4.2 Types of case study 
 
Yin (2018) outlines how case studies can be single or multiple. A single case may be chosen 
as it represents a unique phenomenon or a specific issue or problem while multiple cases 
can be selected to illustrate a particular issue across the cases. Yin (2018) recommends that 
if possible, researchers should undertake a multiple rather than a single case study. Case 
studies can also be explanatory, exploratory or descriptive depending on the research 
question and the phenomenon or event being studied (Yin, 2018). An explanatory case 
study may be suitable when the researcher aims to evaluate an initiative in a naturalistic 
setting by explaining how the initiative works as well as identifying its outcomes (Crowe et 
al., 2011; Yin, 2018). As with the experimental research designs in table 10, this approach 
was not appropriate in this study as there was no recruitment intervention to implement or 
evaluate.  
An exploratory case study can be used as a pilot study to ascertain the questions to be asked 
or the data to be collected in a future research study which may not be another case study 
(Wells et al., 2012; Yin, 2018). A descriptive case study was chosen as this study aimed to 
describe how health care professionals recruit patients and their family carers to palliative 
care randomised controlled trials and explain why they use certain strategies during the 
recruitment process (Yin, 2012, 2018). A case study can also be prospective or retrospective. 
A prospective case study has a longitudinal design where the theoretical propositions are 
developed and tested against an ongoing social process (Bitektine, 2008) such as the 
implementation of a trial information video for potential study participants. There was some 
requirement in this study to identify the phenomena and its interconnections over time 
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(Bryman, 2012). A retrospective case study design was chosen to capture the order and 
sequence in which the palliative care trial recruitment process occurred. Within a single or 
multiple case design, there can also be single or multiple units of analysis. In a case study, 
the unit of analysis is ‘the case’ but there can be lesser units of analysis within the main 
case. Yin (2018) terms single unit of analysis cases as ‘holistic’ designs and multiple units of 
analysis as ‘embedded’ designs. The definition of the unit of analysis needs to be made a 
priori especially in multiple case studies so cross case comparisons can be made (Takahashi 
& Araujo, 2019; Yin, 2018). 
The case study design chosen in this study was a retrospective, descriptive, qualitative 
multiple case study with embedded units of analysis. The reasons why a multiple case study 
design with embedded units of analysis was chosen is discussed in the next chapter. How 
the case was defined in this study along with the working research methods and the 




Recruitment issues in palliative care trials could be studied using a wide variety of research 
designs and strategies. A non-experimental approach was identified as the most suitable to 
address the aims of this study, as there was not a need to express causality between 
variables. A qualitative approach was chosen, specifically a qualitative case study approach, 
as it enables the researcher to answer how and why questions and explore a complex 
phenomenon, like recruitment, in their real-life clinical context. Yin’s case study approach 
was chosen as its ontological and epistemological underpinnings best reflect those of the 
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researcher and the topic of the research. How the research design was operationalised in 




















Chapter four: Working research methods 
4.1 Introduction 
 
The case study design chosen for this study was a retrospective, descriptive, qualitative 
multiple case study with embedded units of analysis (Yin, 2018). In this chapter, how this 
case study research design was operationalised in practice is outlined. How the case was 
defined along with the working research methods and the rationale for their use is explored 
in detail below.  
 
4.2 The research question and study aims 
 
The research question the case study design needed to address was: 
How do health care professionals recruit patients and their family carers to palliative care 
randomised controlled trials and why do they use certain strategies during the recruitment 
process?   
The aims of the study were to:  
 To identify how health care professionals involved in the recruitment process 
undertake the recruitment of patients and family carers to palliative care randomised 
controlled trials.  
 To explore why health care professionals involved in the recruitment process choose 
to implement particular recruitment strategies, and the factors that influence their 
choices, when recruiting to palliative care randomised controlled trials.  
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4.3 Study population 
 
4.3.1 Defining and bounding the case  
 
Case studies involve the in-depth exploration of a specific bounded system or case and how 
it relates to the environment (Flyvbjerg, 2006) or context (Stake, 1995; Yin, 2018). This 
bounded system or ‘case’ is the main focus of the research (Yin, 2018) and is ‘a specific, a 
complex, functioning thing’ (Stake, 1995) (p.2). A case can be, for example, a community, an 
organisation, a person, an event or a specific project (Stake, 1995; Yin, 2018). A case may be 
bounded by factors such as place, timeframe, relevant social group or organisation (Creswell 
& Poth, 2016; Crowe et al., 2011). The act of defining the case allows the researcher to 
make decisions about what makes up the case and what makes up the context to the case 
(Flyvbjerg, 2006). This allows the researcher to set priorities for data collection and analysis 
and allows for comparison of findings (Yin, 2018). This is similar to experimental research 
where the study population is clearly defined before data collection begins. In practice, 
defining your case can be challenging as it needs to ‘be a real world phenomenon that has 
some concrete manifestation’ rather than being an abstract concept such as recruitment 
(Yin, 2018)(p.31). Yin’s (2018) advice to discuss the choice of case with colleagues, such as 
supervisors, was followed. The findings of the literature review in chapter two allowed for 
decisions to be made about the boundaries of the case. The greatest number of barriers and 
facilitators to palliative care trial recruitment identified within the literature could be 
mapped within the ‘Working with Partners’ category. This finding highlighted the key role 
that health care professionals play in the recruitment process and why they have been 
chosen as the focus of the case. 
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The case in this study, ‘the real-life set of events from which data will be drawn’, was a 
palliative care randomised controlled trial (Yin, 2004) (p. xiv). There are examples in the 
literature where research studies (Hickman et al., 2012) and more specifically randomised 
controlled trials had been chosen as the case to explore study related issues (Wells et al., 
2012) including recruitment (Campbell et al., 2007). As discussed above, decisions need to 
be made about defining the boundaries of the case to distinguish between the phenomenon 
of interest and the context (Yin, 2018). Reflecting the study’s research question and 
theoretical propositions, the case in this study focuses specifically on those health care 
professionals directly or indirectly involved in recruitment within a palliative care 
randomised controlled trial. Palliative patients and carers, for example, fall outside the 
boundaries of the case and form part of the context of the case. The case was bounded by 
place as only UK based trials were to be included. The case was also bounded by time as 
trials needed to be either ongoing, recently closed (within 12 months) or set up during the 
data collection period. This was so health care professionals could recall their experiences of 
recruiting to a trial.  
As outlined in chapter one, defining a palliative trial can be challenging as there is no one 
clear definition of a palliative care trial population, intervention or study outcome and 
researchers need to decide on the definition they are going to use. Yin (2018) explains how 
the case needs to be defined clearly so that it can be operationalised in practice and he 
recommends using the literature as a guide. The definition below reflects how a palliative 





In summary, the case definition was (see table 12 for further details): 
 A palliative care randomised controlled trial aimed at adult patients with incurable 
cancer and/or advanced, progressive non-malignant disease and their family carers  
and either  
 A palliative care randomised controlled trial where the primary endpoint is symptom 
control and/or quality of life.  
or  
 A palliative care randomised controlled trial that tests an intervention that is clearly 
a palliative care intervention and the study primary endpoint is survival.  
 
 
4.4 Theoretical Propositions 
 
As discussed in the previous chapter, Yin (2018) borrows the use of theoretical propositions 
from experimental research. He recommends that pre-defined theoretical propositions are 
developed to guide data collection and analysis in all types of case study. He believes that 
focused research questions and theoretical propositions mean the case study is more likely 
to be manageable. Yin (2018) also argues that the use of theoretical propositions can 
strengthen a case study design by facilitating the process of analytical rather than statistical 
generalisation which is discussed later in this chapter.     
In this study, the initial theoretical propositions were influenced by the ‘6 Ps’ of the ‘Social 
Marketing Mix Framework’, the findings of the literature review outlined in chapter two and 
the wider trial recruitment literature (see table 11). Yin (2018) provides little practical 
guidance on how to generate theoretical propositions and how they work alongside an a 
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priori theoretical framework during the data collection and analysis process, as in this study.  
This lack of practical guidance influenced my decision to develop only a small number of 
theoretical propositions. Why these particular theoretical propositions were chosen and 
prioritised are presented in table 11. The theoretical propositions were revised and 
amended as the study progressed to reflect the study findings (Yin, 2018). The final 




Table 11: The initial theoretical propositions and why they were chosen 
Theoretical Proposition  ‘6 P’ Why chosen Example literature based on 
Study design influences how 
recruiting staff undertake the 
process of recruitment and the 
strategies they use. 
Product: defining 
the product 
Patient, carer and health care professional 
concerns about ‘the product’ are raised in the 
general and palliative care trial literature. The 
number of references within ‘Product: defining 
the product’ in the literature review in chapter 
two (see table 9) 
Palliative care: Noble et al 
(2015), Bausewein et al (2010), 
Westcombe et el (2003), Buss et 
al (2008) General: Norris et al 
2019 
The involvement of specific 
research staff in the recruitment 
process impacts on how well the 





Strategy discussed most frequently in the 
literature review in chapter two. 
Abernethy et al (2010),  Ammari 
et al (2015), Bakitas et al, (2006),  
Cook et al (2002) 
How recruiting staff undertake 
the recruitment of patients or 
carers is influenced by their 






To reflect the choice of recruiting staff as an 
embedded unit of analysis in this study. The 
influence of professional role on recruitment 
practices has been identified in the general trial 
literature.  
Donovan et al (2014) 
Where recruitment activity takes 
place may influence the 
recruitment process. 
 
Place To reflect the choice of clinical recruitment 
centres as an embedded unit of analysis in this 
study and the findings of the literature review in 
chapter two (see table 9) 
Storey (2004), Zambroski et al 
(2014), Fischer et al (2015), 




4.5 Sampling  
 
4.5.1 Sampling of the cases  
 
Yin (2018) argues that cases should be chosen that are most likely to address the research 
question and the aims of the study. A set of criteria for cases to qualify for inclusion into the 
study were developed and are outlined in table 12. 
 
Table 12: Inclusion criteria for the cases 
 
 Palliative care randomised controlled trials aimed at adult patients with incurable 
cancer and/or advanced, progressive non-malignant disease and their family 
carers will be included. 
 
and either  
 
 Palliative care randomised controlled trials where the primary endpoint is 




 Palliative care randomised controlled trials that test an intervention that is clearly 
a palliative care intervention and the study primary endpoint is survival will be 
included.  
 
 UK trials registered on relevant trial registers and databases. These databases 
were the National Institute for Health Research Portfolio database (renamed as UK 
Clinical Trials Gateway during the study), the International Standard Randomised 






Cases are purposively selected based on their characteristics so should be carefully screened 
(Stake, 1995; Yin, 2018). These characteristics may include, for example, the recruitment 
setting, the type of intervention, the number of recruitment centres and whether they have 
research nurse support. An excel spreadsheet was created and populated to facilitate and 
document the case identification process. Potential cases were consecutively screened and 
identified from the publicly accessible trial databases listed in table 12.   
Methodological and practical issues influenced how cases were identified and chosen in this 
study. The multiple case study approach is seen as a series of experiments with each case 
serving to confirm or disconfirm the hypothesis or theoretical propositions (Eisenhardt, 
1989). Yin (2018) argues that in multiple case studies, cases should be purposively selected 
in terms of replication logic rather than sampling logic. This is similar to the approach used 
in hypothesis testing research (Eisenhardt, 1989). Cases can be chosen to represent literal 
replication or theoretical replication. When using literal replication, selected cases are 
predicted to follow similar processes and therefore share the same results. This study used 
theoretical replication which involves selecting cases that are predicted to have different 
findings because of contrasting characteristics. Given the diverse nature of palliative care 
trials, this approach was viewed as the most suitable option for selecting cases in this study. 
 Trials that are either ongoing, recently closed (within 12 months) or set up during 
the data collection period. 
 
 Trials that have been open for at least four to six months to ensure enough time 
for a recruitment plan to have been trialled, assessed and changes implemented if 
required.  
 
 For trials that are closed, this will need to have happened within the previous 
twelve months to ensure participants are able to recall their experiences of 




In practice, only the main contrasting trial characteristics may be known during the 
screening process. Theoretical replication was also chosen because the findings from the 
study are seen as more robust if the cases corroborate each other. This is because the same 
experiences have been found in divergent cases (Yin, 2018).  
Cases were chosen that had a variety of study designs and were recruiting participants from 
different clinical settings. The eligible trials available at the time of screening and those 
approached are presented in appendix 9. Case selection was guided by the studies 
theoretical propositions, the findings of the literature review in chapter two and the wider 
trial literature. The chosen cases contrasting characteristics identified during the screening 
process are outlined in table 13. Exemplar references from the literature are included, 
where available, to support the choices made. The contrasting characteristics of the cases 
uncovered during data collection and analysis are described in further detail in chapter five 
and in appendix 14. Case selection was also influenced by practical issues such as the 
number of eligible trials available in the UK at the time of sampling. A small number of trials 
could not be included as myself and my supervisors were involved in the trials. Trial 
databases were not always up to date so multiple databases needed to be used to screen 
for eligibility. Case selection and recruitment occurred in series rather than parallel
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Table 13: The chosen cases main contrasting characteristics identified during the screening process with examples from the literature. 
 Study intervention (Product)  Trial population 
(Identifying 
participants) 
Recruitment setting (Place) Chief Investigator (Partner 
referrals and recruitment)* 
Case 
1 
Challenges of using a placebo  
Non pharmaceutical symptom control 
intervention versus placebo (Buss & Arnold, 
2004; Hardy et al., 1998)    
 
Advanced cancer Challenges of recruiting from a 
hospice setting (Storey, 2004; 
Zambroski et al., 2014)  
 
Single centre trial  
Lead clinician (Bakitas et al., 
2006; Higginson et al., 2008) 
Case 
2 
Challenges of maintaining clinical equipoise  
Parallel trial of a complex intervention versus 
standard care (Goodwin et al., 2000; Jones et al., 
2013; Westcombe et al., 2003)  
 
Advanced cancer  Challenges of recruiting from a  
hospital outpatient setting (Hanson 
et al., 2014; Latimer et al., 1998) 
 




Challenges of promoting a palliative care trial  
Cluster trial of a complex intervention versus 





Challenges of recruiting from a 
hospital inpatient setting (Fischer et 
al., 2015; Sampson et al., 2011) 
 
Feasibility multi-centre trial 
Academic 
 
* Accurate details about the type of professionals involved in the recruitment process (Donovan  et al., 2014) and whether the trial had 
dedicated recruiting staff (Cook et al., 2002; Jordhøy et al., 1999) was not available during the screening process. 
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4.5.2 Sampling of individual participants within the cases 
 
The aim was to sample a diverse mixture of professionals from each of the cases, with 
different roles in the recruitment process, from both the study coordinating centre and 
clinical recruitment centres (see table 14 for individual participant inclusion criteria) 
Table 14: Inclusion criteria for the individual participants 
 
Staff involved in the recruitment of patients or carers in the selected ‘cases’ from the 
study coordinating centre and clinical recruitment centres will be included such as the 
Chief Investigator, Trial Manager, Clinical Research Associate, Principal Investigator, 
Research Nurse or other clinicians. 
18 years of age or over 
Be able to read and communicate in English 
 
Snowball sampling was used to select participants from the eligible population within each 
case (Mason, 2018). Snowball sampling can be useful in case study research as it allows for 
flexibility when the researcher does not know, as in this study, who they need to approach 
at the start of their research (Yin, 2018). The Chief Investigator of each case was initially 
asked to identify eligible staff within the study coordinating centre and clinical recruitment 
centres. These staff members were then approached and asked to propose other individuals 
who had experience relevant to the study (Bryman, 2012). Recruitment of participants 
ceased within the case when the pool of potentially eligible participants who were willing to 




4.5.2 Sampling procedure for trial documentary data 
 
A preliminary assessment of what documents were available online in the public domain 
were made for each ‘case’ such as a published protocol (Mason, 2018; Yin, 2018). Snowball 
sampling was then used to select documents from the pool of potentially relevant trial 
documents within the case that were not accessible online. Those participants who had 
agreed to take part in the study were asked to identify documents that they felt may be 




4.6.1 Recruitment of the Chief Investigator and study coordinating centre staff 
 
The Chief Investigators of the selected cases were approached by email to see if they were 
interested in taking part in the study. All of the Chief Investigators approached had contact 
details that were available online in the public domain. The research ethics committee 
approved email and supporting documentation, including the approval letter, were sent to 
the Chief Investigators. A reminder email was sent after 2-3 weeks if there was no response. 
The Chief Investigators of the selected three cases agreed to participate in the study. They 
were then asked to facilitate access to their study coordinating centre staff and the clinical 
recruitment centres involved in their trial. The Chief Investigator forwarded the study 
information to eligible study coordinating centre staff and/or passed on their contact details 
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with permission. Those contacted were asked to reply by email or telephone if they were 
interested in taking part in the study.  
 
4.6.2 Recruitment of Principal Investigators and clinicians within the clinical recruitment 
centres 
 
The Chief Investigator forwarded the study information to the Principal Investigators in the 
clinical recruitment centres. This process was facilitated by the trial coordinator 
/administrator in cases two and three. A couple of Principal Investigators were also 
contacted directly about the study in case two as their details were available in the public 
domain. If the Principal Investigators agreed to be contacted, they were sent an email with 
the study information. If the Principal Investigator agreed to support the study, the 
necessary organisational approval was obtained. The Principal Investigators were asked if 
they would be willing to take part in an interview and facilitate access to the relevant 
personnel involved in the recruitment process within their clinical area. In practice, the Chief 
Investigator also forwarded the study information to research nurses in the clinical 
recruitment centres and some of these got in contact directly to say they were interested in 
taking part in the study. All potential participants, including those identified as a result of 
snowballing sampling, received the study information and were asked to reply by email or 





4.7 Methods of data collection 
 
One of the key principles of case study research is the use of multiple sources of evidence to 
corroborate study findings and to gain an understanding of the complex issues, systems and 
perspectives that make up a process such as recruitment. This study used two 
complementary sources of evidence to address the research question (Yin, 2018). These 
were semi-structured interviews carried out over the telephone and trial related 
documentary evidence. Multiple perspectives of the recruitment process were also derived 
from the various accounts given by study coordinating centre and recruiting staff involved in 
the chosen cases who were interviewed in this study (Ritchie & Lewis, 2003). Data were 
collected from each case consecutively.  
 
4.7.1 Semi structured Interviews 
 
In case study, interview data is one of the most important sources of evidence as they can 
help address how and why questions (Yin, 2018). Interviewing captures participant’s 
experiences, motivations (Silverman, 2013) and perspectives of social phenomenon such as 
the recruitment process (Yin, 2018). The process of interviewing also fits with the critical 
realist ontological and epistemological stance taken in this study as the social world is only 
accessible via participant’s interpretations of the social world, which maybe further 
interpreted by the interviewer (Ritchie & Lewis, 2003). The aim of interviewing a diverse 
group of professionals involved in the recruitment process was to yield different types of 
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understanding. This process adds richness to our understanding of the various ways in which 
external reality is experienced by individuals within the social world (Ritchie & Lewis, 2003).  
The interviews in this study were semi structured and took the form of a guided 
conversation (Yin, 2018). Semi structured interviews were used as the study had a clear 
focus of interest and to ensure that comparisons could be made across the cases (Bryman, 
2012). McIntosh and Morse (2015) argue that it is the replicability and flexibility of semi- 
structured interviews that means pertinent and rich data are obtained. An interview topic 
guide was developed at the start of the study that reflected the research question and the 
literature review in chapter two (McIntosh & Morse, 2015). The topics covered included;  
recruitment procedures, exploration of phraseology used to discuss the trial with 
participants, how well the trial has recruited, factors that have helped or hindered 
recruitment, recruitment strategies and lessons learnt (see appendix 8).  
The topic guide contained a number of open questions to generate discussion and was 
flexible enough to reflect individual trial characteristics and the professional role of the 
interviewee (Creswell & Poth, 2016; McIntosh & Morse, 2015). The topic guide was also 
iterative to respond to participant’s responses and to allow the pursuit of new areas of 
inquiry during the study (Bryman, 2012). Two mock interviews took place with researcher 
colleagues to practice the interview and to ensure the topic guide was fit for purpose 
(McIntosh & Morse, 2015). Brief notes were made during the interview (Oltmann, 2016) and 





4.7.2 Telephone interviews 
 
The interviews were carried out over the telephone as this was seen as the best approach 
for this particular study for a number of reasons which are discussed below. Qualitative 
telephone interviews have been seen as a less attractive option to face-to-face interviews 
because of concerns about the depth and quality of the data collected (Novick, 2008; 
Oltmann, 2016). Creating a comfortable environment and building rapport are seen as 
important when carrying out interviews (Bryman, 2012). This can be more problematic in 
telephone interviews as the researcher is unable to use visual gestures to build rapport 
(Novick, 2008). Rapport was built prior to the interview by email and time was spent at the 
start of the interview discussing the study. Straightforward questions about the participant’s 
recruitment experience were used at the start of the interview to build rapport (McIntosh & 
Morse, 2015). Non-threatening open ‘how’ questions were also used to try and understand 
participant behaviours and actions rather than asking participants directly why they acted in 
a certain way (Yin, 2018).   
Telephone interviews may help participants feel more comfortable and more open to 
discussing their views and experiences of a particular issue because of the virtual nature of 
communication (Trier-Bieniek, 2012). This applies to both nurses (Mealer & Jones, 2014) 
and doctors (Crowe et al., 2017). Visual cues such as body language or facial expression 
cannot be used to help interpret participant responses during telephone interviews (Novick, 
2008; Oltmann, 2016). Unscripted probes were used to explore participant views and 
experiences more deeply (McIntosh & Morse, 2015), as well as the use of pauses and silence 
to allow participants time to consider their responses (Mason, 2018). Semi structured 
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qualitative telephone interviews led to rich and descriptive accounts of participant’s 
experiences of recruiting patients and carers to palliative care randomised controlled trials. 
Participants spoke openly about their experiences and the challenges they faced recruiting 
vulnerable patients and carers to trials.  
On a practical level, face-to-face interviews were not an option in this study as the data 
collection sites were not local to Lancaster University and no funding was available for data 
collection (Novick, 2008; Oltmann, 2016). Carrying out the interviews via the internet was an 
option but the research ethics committee had concerns about the security of 
communication software such as Skype and clinicians usually have limited access to these 
type of systems. It is likely this option would have now been more acceptable to research 
ethics committees and clinicians, as these methods of communication are now the norm 
because of the restrictions imposed by the COVID 19 pandemic.    
Telephone interviews allowed for geographically dispersed participants to be included in the 
study at minimal cost (Novick, 2008; Oltmann, 2016). There were occasions when the 
interviews were interrupted, cancelled and rearranged at short notice and took place in the 
interviewees own time. Telephone interviews allowed for greater flexibility and 
responsiveness as eligible participants were usually time poor (Oltmann, 2016). Participants 
were asked how much time they had available at the start of the interview and asked 
whether they had time to continue during the conversation (Signorelli et al., 2018). The 
importance of researchers being flexible to maximise recruitment and data collection 
opportunities in clinical settings has been recognised (Barclay et al., 2019; Broyles et al., 
2011; Coyne et al., 2016; Signorelli et al., 2018). Data collection would have been more 
challenging in this study without the use of telephone interviewing. 
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4.7.3 Collection of trial documents  
 
Documents related to trial recruitment were collated as they revealed how the recruitment 
process and the strategies supporting it were formally expressed and communicated 
(Mason, 2018). Participants who agreed to take part in the study were asked to identify and 
provide documentation that they felt would be relevant to the research question. Case 
related documentation available in the public domain was also accessed from the internet. 
Reviewing trial documentation also lead to the identification of new areas of inquiry to 
pursue in the interviews (Yin, 2018). Documentation was largely provided by the study 
coordinating centre to ensure the research ethics committee proof of ownership 
requirement was met. In practice, carrying out the interviews face to face may have made 
documentary evidence collection easier as staff needed to feel comfortable and be fully 
bought into the idea of sharing documentation.  As a result, the documents collected in this 
study were largely the ‘official’ trial documents rather than documentation created by 




Yin (2018) believes that in case study research the aim must be to minimise personal biases 
as much as possible. Reflexivity is an ongoing process that involves the researcher reflecting 
on how their choice of method as well as their values, biases, decisions and presence in the 
research situation may have influenced the knowledge of the social world they have 
generated (Bryman, 2012). Being sensitive to the researcher’s ‘cultural, political and social 
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context’ is also important (Bryman, 2012)(p. 393). Researcher biases and assumptions can 
influence the research topic and method chosen as well as how the data is collected, 
analysed, interpreted and presented (Borbasi et al., 2005; Bryman, 2012).  
The importance of critical reflection and self-awareness during the study design, data 
collection and analysis process was recognised especially as my own ‘personal biography’ 
involved working as a palliative care research nurse in a hospice setting (Mauthner & 
Doucet, 2003). This experience strongly influenced the topic and focus of my research as I 
had some insight into the challenges faced when recruiting patients and carers to trials in 
palliative care. In addition, my ‘personal biography’ also included experience as a specialist 
nurse in a hospital and community setting which involved managing the complex physical 
and psychosocial needs of palliative care patients and their carers and working closely with 
members of the multi-disciplinary team. During my research, I was no longer involved in 
direct patient care but was working as a research associate on a number of palliative care 
trials.  
Nurses can bring nursing specific qualities, skills and knowledge to the research process 
which can create methodological, practical and ethical challenges (Borbasi et al., 2005). For 
example, nurses can find it less challenging to communicate and ‘fit in’ with clinicians but 
this can raise issues of how involved they should become with research participants to build 
rapport (Borbasi et al., 2005). A researcher needs to be aware of and reflect on the 
relationship that exists between themselves and the interviewee (Creswell & Poth, 2016). 
Regular supervision meetings provided the opportunity to discuss some of the foreseen as 
well as some of the unforeseen challenges that could potentially occur during the research 
process. The decision was made at the start of the study not to disclose my professional 
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background to participants but inform them if they asked and agree to answer questions at 
the end of the interview. The stance taken in this study reflected the view that being truly 
objective is not possible and that researchers should be mindful of subjectivity throughout 
the research process to try and limit its effect (Bourke, 2014). This aligns with Yin’s view that 
researcher bias must be avoided but recognising this may not be fully possible.  
During the interviews, it was important to be alert to the fact that professional role can 
influence how you interact with other clinicians and may prevent you from asking certain 
questions or clarifying responses. Being over familiar with the clinical setting and the focus 
of the research can also mean important issues are disregarded (Borbasi et al., 2005). 
Supervisor feedback on the initial interview transcripts was also used to facilitate the 
process of reflexivity. Detailed reflexive notes were made after each interview to reflect on 
such issues and to consider areas to explore in future interviews. Reflexive notes were used 
to document the choices and decisions that were made during the data analysis and 
interpretation process. The use of charting during within and cross-case analysis also 
provided an audit trail of how the findings were reached (Ritchie & Lewis, 2003). Sharing, 
discussing and reflecting on the analysis during supervision meetings enhanced the process 
of reflexivity which proved invaluable especially when ‘in the thick’ of the analysis process 







4.9 Ethical considerations 
 
4.9.1 Research ethics and governance approval 
 
As this study did not involve patients or carers, NHS research ethics committee approval was 
not required. Research ethics committee approval was obtained from the Lancaster 
University Faculty of Health and Medicine Research Ethics Committee (Reference number: 
FHMREC15042, 22nd February 2016). The ethics committee wanted reassurance that any 
contact details not in the public domain where only passed on to the researcher if the 
person had given their permission for this to occur. They also wanted reassurance that 
permission had been obtained from necessary parties to access and use trial documentation 
that was not available in the public domain. This study did involve NHS staff so 
organisational approval was obtained for all research sites via the Health Research 
Authority. Organisational approval was also obtained from the one hospice site taking part 




The research ethics committee permitted the use of verbal consent in this study as it was a 
assessed as a low risk study (Preston et al., 2020). Verbal consent has been used in previous 
qualitative telephone interview studies with nurses (Mealer & Jones, 2014) and interviews 
with trial staff about their experiences of recruiting to a trial (Hanson et al., 2014). Those 
who gave permission to be contacted about the study were sent the participation 
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information sheet and consent form via email (Signorelli et al., 2018). If the participant 
expressed an interest in taking part in the study either by email and/or telephone, an 
appointment was made to carry out the telephone interview. Prior to commencing the 
interview, the study was discussed with participants and any questions or queries were 
answered. If the participant wished to take part in the interview, verbal consent was 
recorded on the digital recorder prior to any data collection taking place. Process consent 
was also followed in this study with participation renegotiated as appropriate during the 
interview. The requirement for participants to complete and return a consent form to take 
part in the study would have acted as a barrier to recruitment.   
 
4.9.3 Risks, benefits and burdens 
 
There were no direct benefits for those taking part in the study but it appeared that some 
participants valued the opportunity to talk about their experiences of recruiting to a 
palliative care trial. This assumption is based on their willingness to take part in the study 
and spend time away from their busy clinical workloads talking about their experiences. On 
the surface, the topic of this study did not appear sensitive but there were occasions when 
some participants expressed how recruiting to a palliative care trial could be emotionally 
challenging. No participants became distressed during the interviews but this response had 
not been expected when planning the study. This may have been because of my own clinical 
background where interacting with palliative care patients and their carers is the norm. In 
the participant information sheet, it was explained that if something was disclosed during 
the interview that made the researcher concerned the participant or someone else was at 
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risk of harm confidentiality would be broken. This did not occur during the study and there 
was no requirement to break confidentiality. There were concerns that staff may feel 
obliged to take part in the study if their manager, clinical lead or organisation were 
supporting the study but the number of participants who declined to take part suggests this 




Whether and how to maintain anonymity in case study research can be an issue as a 
description of the case may lead to the case and individual participants being identified (Yin, 
2018). Given the small number of palliative care trials in the UK, it was recognised that 
participants and the trial may be identified because of information that is available about 
the trial in the public domain. This was highlighted in the participation information and 
consent form. The decision was taken to anonymise the case, clinical recruitment centres 
and individual participants and this assurance was included in the participant information 
and consent form. I was concerned that Chief Investigators may be reluctant to take part in 
this study if the trial was not anonymised. I was also concerned that study coordinating 
centre and recruiting staff would be reluctant to take part if they knew they could be 
potentially identifiable. I was also mindful that participant responses may not have been as 
open and honest if they knew the trial was not going to be anonymised. 
 A number of strategies were used to anonymise the cases, the participants and the trial 
documentation. How best to optimise and ensure anonymisation was discussed at length 
with my PhD supervisors. In order to maintain anonymity, detailed information about the 
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characteristics of the cases is not provided in the study findings. Each trial was allocated a 
number identifier; case one, case two and case three. Characteristics of the individual 
clinical recruitment centres are also not provided in the results as this could potentially lead 
to the clinical recruitment centres and their participants being identified. Individual clinical 
recruitment centres were allocated a number identifier to facilitate analysis but this was 
removed in the presentation of findings. Individual participant characteristics, apart from 
their professional role, are also not included in the findings to disguise their identity. 
Participants are identified by their professional role, the order of interview and the case 
number such as Specialist nurse one, case two. Identifying information was removed from 
trial documentation during analysis. Documentation is identified by the name of the 
document and the case number such as protocol, case three. A small number of trial 
characteristics were deliberately modified to maintain anonymity. These changes do not 
impact on the interpretation of the study findings.  
During the study, all data (both paper and electronic) were treated as confidential and 
stored securely. Electronic data was stored on a secure University password protected 
computer and paper data in a locked cabinet. Transcripts were anonymised before 
uploading to NVivo, by removing identifying characteristics such as the participant’s name, 
the name of the trial and the name of the clinical recruitment centre. A Lancaster University 






4.10 Data analysis  
 
Data analysis was iterative in this study as this allowed for refinement of interview 
questions, review and updating of theoretical propositions and the opportunity to pursue 
new areas of inquiry (Evers & van Staa, 2010). It also helped shape the selection of cases 
including the number of cases needed and their characteristics (Paterson, 2010 ).  
Yin (2018) recommends a number of strategies when analysing case study data. In this study 
within case analysis, embedded units of analysis, cross-case analysis and pattern matching 
were used (Yin, 2018). Framework analysis was the analytical approach used to facilitate this 
process (Gale et al., 2013; Ritchie & Lewis, 2003). 
 
4.10.1 Within case analysis 
 
Yin (2018) recommends that within case analysis occurs before cross-case analysis but 
provides little guidance for the researcher on how to operationalise this process in practice. 
The purpose of carrying out within case analysis is to identify each case’s individual 
characteristics and patterns before identifying general patterns that occur across all of the 
cases (Paterson, 2010 ). For each case, the perspectives of the individual participants were 
examined independently and then across the participants for a within-case comparison. A 
standalone description of each of the cases was written up before the following case was 




4.10.2 Framework analysis 
 
Framework analysis, a form of thematic analysis, was chosen as it provides a systematic but 
flexible approach to data analysis and facilitates pattern matching (Ritchie & Lewis, 2003; 
Smith & Firth, 2011; Ward et al., 2013). The aims of qualitative thematic analysis approaches 
are to identify similarities, differences and relationships in the data so that descriptive 
and/or explanatory conclusions can be drawn (Gale et al., 2013). Framework analysis 
provides the researcher with the structure and process to compare and contrast the data 
within and across cases. It is also suited to the thematic analysis of semi-structured 
interview transcripts and documentary evidence as collected in this study (Ritchie & Lewis, 
2003). Framework analysis is not aligned with a particular theoretical, epistemological or 
ontological approach and allows for inductive or deductive thematic analysis or both as in 
this study (Gale et al., 2013; Parkinson et al., 2016; Ritchie & Lewis, 2003).  
Framework analysis is made up of a number of stages and processes that Ritchie and Lewis 
(2003), the developers of the method, term the ‘analytic hierarchy’. This process is not 
linear but continuous and iterative and the researcher is required to move up and down the 
steps in the ‘analytic hierarchy’ throughout the analysis process (Ritchie & Lewis, 2003). The 
first stages involve managing the data where the raw data is reviewed, labelled, sorted and 
synthesised. Following on from this the researcher develops descriptive accounts by 
identifying key dimensions/elements, refining categories and developing classifications. 
Thirdly, the researcher develops explanations about why the data took the forms that are 




4.10.3 Managing the data 
 
The purpose of the initial data management activities are to identify initial categories, 
concepts and ideas. NVivo 11 was used to support the data management processes (Bazeley 
& Jackson, 2013). All of the interviews were digitally audio recorded and transcribed 
verbatim. All of the transcripts were checked against the original audio recording for 
accuracy. The first two transcripts were transcribed by the researcher to facilitate 
familiarisation with the data while a professional transcriber was used for the further 
transcripts. The term framework analysis comes from the conceptual framework which 
forms the central part of the method. The conceptual framework is used to classify and 
organise data according to the main classifications, subdivided by related categories. In this 
study, part of the framework existed before analysis and the rest was developed during the 
analysis process. The pre-existing framework comprised a number of classifications that 
reflected the ‘6 Ps’ of the ‘Social Marketing Mix Framework’. How and why additional 
overarching classifications were inductively developed during the analysis process and 
added to the pre-existing conceptual framework is discussed in more detail below.  
The initial transcripts, trial documents and reflective notes were read and re read to identify 
recurring categories. Memos were used throughout the analysis process to capture 
thoughts and observations about the data (Yin, 2018). The categories identified were a 
mixture of predetermined ‘a priori’ index categories identified from the systematic review in 
chapter two, ‘in vivo’ index categories that reflected the language and the terms used by the 
participants and index categories that captured the essence of what was being discussed. 
The index categories were grouped into clusters around similar and interrelated ideas or 
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concepts and arranged within the appropriate classifications, reflecting the ‘6 Ps’ of the 
‘Social Marketing Mix Framework’, in a tree diagram structure (Gale et al., 2013). The 
conceptual framework was then applied systematically to the subsequent transcripts and 
documentary evidence. Ritchie and Lewis (2003) use the term indexing rather than coding 
to describe the activity of labelling the raw data and index categories rather than codes. The 
conceptual framework was reviewed, refined and discussed with my supervisors throughout 
the data analysis process to optimise methodological rigor (Morse, 2015).  
The next stage was to summarise or synthesise the original data into charts through an 
activity called charting. The framework matrix function in NVivo 11 was used to produce the 
charts. The software produces a spreadsheet of the categories contained within the 
conceptual framework and places the indexed data within each cell. Each respondent is 
allocated a row while each category is displayed in a separate column (Miles & Huberman, 
1994; Yin, 2018). Both interview and documentary data were synthesised within each cell 
and care was taken to ensure the summarised data reflected the original terms, thoughts 
and views of participants (Ritchie & Lewis, 2003) (see appendix 11 for an example). In this 
study, charts were created for each of the cases to facilitate within case analysis, analysis of 
the embedded units within the cases and cross-case analysis. 
 
4.10.4 Developing descriptive and explanatory accounts of the data 
 
Ritchie and Lewis (2003) recommend that the charted data be interrogated further to 
identify and map key elements/dimensions of a particular phenomenon or category. This 
process leads to a refinement of the framework’s categories and sub categories and how 
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they are organised within the conceptual framework. The template suggested by Ritchie and 
Lewis was used to facilitate this process (see appendix 12 for an example). The charted data 
was scrutinised again within case and then it was compared across all three cases. This 
process led to further refinement of the categories/sub categories and how they were 
organised within the classifications (see appendix 13 for the final analytical framework). The 
original transcripts and documentation as well as the summarised data were revisited 
throughout data analysis process to check context and assumptions as well as aid 
interpretation.  
The next stage involves searching for and developing explanations for how and why 
particular phenomenon or patterns occur in the data. Reasons can be related to situational 
or contextual factors and/or dispositional factors such as the individual’s behaviour, 
intentions or motivations. In this study, explicit reasons were sometimes given by 
participants in their interview responses and/or they were contained within trial 
documentation. A number of strategies were used to develop explanations such as 
examining why an issue was mentioned by some participants and not others, why there was 
repeated coexistence of two sets of phenomena and why apparently unconnected 
categories were interweaved. 
 
4.10.6 Embedded units of analysis within the cases 
 
This case study was designed with two embedded units of analysis; recruiting staff and 
clinical recruitment centres. Clinical recruitment centres and recruiting staff were chosen as 
embedded units of analysis within the selected cases as these were the focus of recruitment 
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activity. This decision reflected the assumption that the context in which recruitment 
activity takes place may make a difference to the recruitment process and professional role 
would influence how staff undertake the process of recruitment and the strategies they use 
(Yin, 2018). The perspectives of different professional groups were examined and compared. 
For example, the differences and similarities between research nurses within a clinical 
recruitment centre were firstly explored. This was followed by an examination of the 
similarities and differences between research nurses across the clinical recruitment centres 
within the case. Moving and comparing the rows in the charts and writing up the cases 
facilitated this process. Clinical recruitment centres as a whole within the case were also 
compared with each other.   
 
4.10.7 Cross-case analysis 
 
Following within case analysis, a comparison of perspectives was conducted across all of the 
cases. Cross-case analysis also involved comparing the cases with each other as standalone 
entities (Chmiliar, 2010). The purpose of cross-case analysis is to identify commonalities and 
differences across the included cases. This process involves engaging with the data, 
detecting patterns within the data and allowing similarities and differences between the 
cases to be identified (Gale et al., 2013). The conceptual framework, reflecting ‘the 6P’s, was 
used to identify what categories were shared and what categories were unique to each case 
(Paterson, 2010 ). The findings generated from this process are then used to develop more 
general explanations of how and why a pattern or phenomenon may occur (Chmiliar, 2010). 
During within and cross-case analysis, the perspectives of outliers who did not fit with the 
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patterns that were emerging in the data were not ignored (Ritchie & Lewis, 2003). The data 
was interrogated further to try and identify and understand the reasons for why differences 
were occurring.  
Three additional linked overarching classifications derived interpretatively from the data 
were added to the pre-existing conceptual framework during the cross case analysis process 
(see figure 2). This was because the findings indicated that there were deeper underlying 
contextual reasons for the participant’s responses and behaviours that could not be fully 
explained by ‘the 6 Ps’ of the ‘Social Marketing Mix Framework’. These classifications were; 
‘emotional labour’, ‘paternalism’ and ‘professional hierarchies and power relationships 
between clinicians’. This interpretative cross case analysis forms the basis of chapter six 
while chapter five, a more descriptive cross case analysis, relates the study findings to the ‘6 
Ps’ of the ‘Social Marketing Mix Framework’.  
 
4.10.8 Pattern matching  
 
Pattern matching is a data analysis strategy recommended in the theoretical literature (Hak 
& Dul, 2010). Yin (2018) views it as the most desirable approach when carrying out case 
study research, even in descriptive case studies, as long as the expected pattern is specified 
prior to data collection. In pattern matching, the researcher compares a findings based 
pattern with a predicted pattern based on the studies theoretical propositions (Yin, 2018).  
Pattern matching logic is drawn from hypothesis testing but it does not use statistical testing 
methods (Almutairi et al., 2014). The analyst decides whether the patterns match so 
confirming the theoretical propositions or that they do not match so disconfirming the 
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theoretical propositions (Hak & Dul, 2010). The purpose of pattern matching is not just 
about confirming or disconfirming the theoretical propositions but explaining why the 
patterns are matched or not (Almutairi et al., 2014). Yin has been accused of being vague 
when explaining his analytical techniques (Evers & van Staa, 2010) and it can be challenging 
to implement the pattern matching technique in practice (Almutairi et al., 2014). Yin (2018) 
does suggest that the pattern matching process can focus on more major matches or 
mismatches rather than subtle patterns. In this study, for each of the individual cases and 
then across the three cases empirically based patterns were compared to the studies 
theoretical propositions (Evers & van Staa, 2010; Paterson, 2010 ; Yin, 2018). As discussed 
previously, the theoretical propositions were influenced by and reflected the ‘6 Ps’ of the 
‘Social Marketing Framework’. One of the challenges for researchers when using a 
predefined conceptual framework is not to force fit the study findings into this framework 
(Bitektine, 2008; Crowe et al., 2011). The theoretical propositions were modified during the 
study to reflect the study’s findings,  including the newly developed interpretative 
classifications discussed above, and the updated propositions are outlined in chapter seven 
(Yin, 2018).  
 
4.10.9 Number of cases included in this case study 
 
Three diverse cases were included and analysed in this study for methodological and 
practical reasons. Yin explains how the case is not a sample of one and generalisation occurs 
through a process called ‘analytic generalisation’ rather than statistical generalisation as in 
experimental studies. This is when previously developed theory, the theoretical propositions 
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rather than grand theory, are used as a template with which to compare the study findings 
(Yin, 2012, 2018). Using a multiple rather than a single case study approach is seen to 
improve the potential for theory building, as comparisons can be made across all the cases 
(Bryman, 2012; Yin, 2018). Like in experimental research, the more cases included in the 
research the greater confidence or certainty there is in the study’s findings (Yin, 2012). 
Resource issues also influenced the number of cases included in this study which Yin (2018) 
acknowledges can also be an influencing factor.   
 
4.11 Addressing the issue of rigour in case study research 
 
There are no mutually agreed standards for assessing the quality of qualitative research or 
the strategies researchers should follow to demonstrate methodological rigour (Ritchie & 
Lewis, 2003) and this also applies to case study research (Bryman, 2012; Riege, 2003). In 
empirical social research, terms such as validity, reliability and generalisability are used to 
address the issue of rigour (Morse, 2015). Some have argued that a set of criteria unique to 
qualitative research needs to be developed as qualitative and quantitative research sit 
within different paradigms (Lincoln & Guba, 1985). Others believe fixed criteria should be let 
go completely or are not appropriate as concepts such as validity are socially constructed so  
diverse context dependent perspectives of validity should be promoted (Sparkes, 2001).  
Researchers need some way of demonstrating that they have paid attention to the 
methodological rigour of their study. Creswell and Poth (2016) argue that researchers 
should use the approach they are comfortable with and reference their terms and 
strategies. This study adopts the replication perspective (Sparkes, 2001), the idea that terms 
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and concepts used in quantitative research are compatible with qualitative research (Morse, 
2015). This approach recognises, however, that different strategies may be used to achieve 
and demonstrate methodological rigour (Morse et al., 2002; Sparkes, 2001). The replication 
perspective has been chosen for a number of reasons. Firstly, this viewpoint fits with Yin’s 
approach as he argues that the tests of construct validity, external validity and reliability are 
relevant to descriptive case studies though he does argue that the concept of internal 
validity only applies to explanatory case studies as this relates to causal relationships (Yin, 
2018). Secondly, authors argue that this approach fits within the critical realist view of how 
rigour can be produced and assessed (Porter, 2007; Riege, 2003). Thirdly, these 
standardised criteria provide a shared language so those reading the study findings are able 
to assess whether the results are sufficiently accurate to implement into clinical practice 
(Porter, 2007). 
Creswell and Poth (2016) suggest the use of multiple validation strategies but do not 
recommend which ones should be used. Morse (2015) believes that the ‘indiscriminate use 
of strategies with any type of qualitative research’ is harmful to methodological rigor (p. 
1219). Table 15 shows the tactics suggested by Yin that have been employed in this study. 
His recommendation to share the findings of the case study report with participants to 
enhance accuracy and increase construct validity was not followed. Authors have 
questioned the value of this strategy, referred to as respondent or member checking in the 
literature, as the data has been synthesised, abstracted and interpreted by the researcher 
so the individual participant may not agree or recognise their story (Morse, 2015; Morse et 
al., 2002).  
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Table 15: Case study tactics for four design tests (adapted from Yin, 2018) 









Identifying the correct 
operational measure for 
the concepts being 
studied (Yin, 2018).  
 Multiple sources of evidence were used to build construct measures that defined and 
distinguished them from other constructs. Multiple sources of evidence were used to 
generate, refine and substantiate study categories and theoretical propositions by 
interviewing professionals with different roles in the recruitment process as well as 
collecting and analysing trial documentation (Eisenhardt, 1989).  
 
 A chain of evidence was maintained to track how the data was categorised, charted and 
interpreted to promote greater transparency (Eisenhardt, 1989). NVivo 11 was used to 
support the process as well version controlling documentation.   
External validity  External validity is 
concerned with whether 
the study findings can be 
generalised beyond the 
context of the study (Yin, 
2018).  
 By using replication logic in multiple case studies. In this study, theoretical replication 
was used. The idea that if the same experiences have been found in divergent cases the 
study findings are more robust and generalisable (Yin, 2018). 
Reliability 
 
Being able to 
demonstrate that if the 
same research methods 
were used the findings 
would be same. The aim is 
to minimise the errors 
and biases in a study (Yin, 
2018).  
• A case study protocol was developed that contained detailed information about how the 
case was defined, recruitment processes, data collection and analysis procedures.  
 
• A case study database was developed. This comprised; an excel spreadsheet to track 
interview invitations and responses; NVivo files to store anonymised raw data, excel and 
word charts containing summarised data, anonymised transcripts of the interviews.  
 
• The use of reflexivity as discussed above. 
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4.12 Conclusion  
 
The case study design used in this study was a retrospective, descriptive, qualitative 
multiple case study with embedded units of analysis. The case was a palliative care 
randomised controlled trial with a specific focus on those health care professionals directly 
or indirectly involved in recruitment within the trial. Theoretical propositions were used to 
guide data collection and analysis. Data collection involved the use of semi-structured 
telephone interviews with study coordinating centre and recruiting staff and trial 
documentation. Framework analysis was used to facilitate within and across case analysis. 












Chapter five: Cross-case analysis findings in relation to the ‘6 Ps’ of 
the ‘Social Marketing Mix Framework.’ 
5.1 Introduction 
 
The findings from this cross-case analysis are presented in this chapter and the following 
chapter. Data from each of the three cases is dispersed throughout the study findings (Yin, 
2018). The cross-case analysis findings have been presented at the European Association for 
Palliative Care World Research Congress (see page 13 for further details). 
An ‘abbreviated vignette’ of each of the three cases is presented initially to provide 
contextual information for the cross-case analysis (Yin, 2018). A more detailed within case 
analysis is presented in appendix 14.  The summaries highlight the differences in clinical 
setting and study design between the three cases. The cases were purposively selected 
because of these differences to reflect the concept of theoretical replication as discussed in 
the previous chapter (Yin, 2018).  
In this chapter, the cross-case analysis findings are explored in relation to the ‘6 Ps’ of the 
‘Social Marketing Mix Framework’, as this was the a priori framework used in this study. The 
findings are presented within the overarching classifications that reflect the ‘6 Ps’ but they 
have been reordered to reflect the study findings. The categories identified during the 
analysis process are discussed within the relevant classification. The analysis is presented in 
eight sections: working with partners (partner referrals and recruitment); identifying 
participants; product (including product definition and competition); price (including type 
and minimisation); place; promoting the study; working with partners (barriers to 
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partnering) and finally working with partners (partner education). As discussed in chapter 
four, given the small number of palliative care trials that are carried out in the UK, detailed 
information about the trial and participant characteristics cannot be provided to maintain 
anonymity. Key case and participant characteristics and a list of trial documentation 
collected and analysed is presented in table 16 and in more detail in appendix 14. 
 
5.2 Case and participant characteristics and trial documentation collected and 
analysed  
 
Data collection occurred between March 2017 and June 2018 and 19 participants took part 
in a telephone interview (see table 16). The mean interview length was 39 minutes (range 












Table 16: Case and participant characteristics and trial documentation collected and analysed 
 Case one Case two Case three 
Recruitment setting Hospice inpatients Hospital outpatients Hospital inpatients 
Trial population  Advanced cancer patients Advanced cancer patients and their carers Advanced cancer and non-cancer 
patients (or proxy if required)  
Trial design Non-pharmaceutical placebo trial  Parallel trial of a complex non-
pharmaceutical intervention 
Feasibility cluster trial 
of a complex non-pharmaceutical 
intervention 
Recruitment target The recruitment rate was described as 
slow and at the time of data 
collection, approximately 83 % of the 
recruitment target had been met. This 
had taken a number of years to 
achieve and took longer than 
anticipated. 
Achieved over 30 months rather than the 
anticipated 24 months. 
Only 2 of the 4 sites reached their 
recruitment target with recruitment 
taking longer than the anticipated three 
months. One of the sites (intervention) 
took six months to reach its recruitment 
target while the other (control) took four 
and a half months. 











Senior academic=2  
Researcher=1 






Study protocol, patient information 
sheet, patient consent form, GP 
letter, UK Clinical Trials Gateway 
website, results paper. 
Study protocol, patient information sheet, 
patient consent form,  
carer Information sheet, carer consent 
form, carer GP letter, patient study 
Study protocol, patient information 
sheet (intervention and control), patient 
consent form, carer Information sheet 





recruitment poster, trial recruitment 
figures for each hospital site, monthly 
recruitment figures for site four, an 
invitation to participate in the trial for 
clinical recruitment centres,  
‘Frequently asked questions’ document 
for health care professionals, published 
protocol, published results papers, UK 
Clinical Trials Gateway website. 
form, consultee information sheet 
(control and intervention), consultee 
approval form for continued 
participation if capacity is lost,  
recruitment letter to bereaved relative,  
trial recruitment figures for each site,  
clinical scenarios and materials to 
support recruitment for health care 
professionals,  
published study conference posters, 
published results papers, UK Clinical 
Trials Gateway website 
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5.2.1 Case one ‘vignette’ 
 
Case one largely took place in a single voluntary organisation. The other organisation 
involved in the trial had only recruited a small number of patients and trial staff were unable 
to be interviewed because of staff shortages. All of the recruiting staff involved in the trial at 
the primary voluntary organisation agreed to take part in a telephone interview. All of the 
participants who were interviewed were experienced in recruiting to palliative care studies 
including trials.  
In summary in case one, medical staff, usually the Chief Investigator, would initially 
approach the patient about the trial in the inpatient unit:  
‘I think largely it’s for me to identify people on our ward rounds or when we go and 
see them. This is a study that is looking at hospice inpatients and then I’ll flag them 
up, I’ll mention the study to the patient and then flag them up to the research nurse 
to go and have a further chat with them.’ (Chief Investigator, case one) 
The research nurses would then discuss the study with the patient, provide written 
information and if the patient wished to enter the trial, they would then obtain written 
informed consent.  
5.2.2 Case two ‘vignette’ 
 
Case two was a large multi-centre trial and it was initially predicted that up to 10 hospital 
sites would be required to achieve the recruitment target. The trial actually required double 
that amount of sites to reach its target. 
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In this case study, five clinical recruitment centres out of the 18 that were approached via 
the study coordinating centre agreed to take part. Nine out of the 15 recruiting staff 
approached to take part agreed to participate in the interview. The main reason, when 
given, for staff declining to take part in the study was lack of time. The majority of the 
clinical recruitment centres that agreed to take part had met their recruitment targets. In 
these centres, the Principal Investigators were doctors apart from one site where the role 
was carried out by a specialist nurse. All of the interviewees were experienced in recruiting 
to oncology trials but case two was the first specific or ‘overtly’ (Specialist nurse two, case 
two) palliative care trial they had recruited to.  
In summary in case two, the lead medical clinician and/or specialist nurse would initially 
approach the patient and carer about the trial in the outpatient department. Depending on 
the clinical recruitment centre, the research nurse, specialist nurse or doctor would then 
follow the patient up and obtain written informed consent from those participants who 
wished to take part in the trial.  
 
5.2.3 Case three ‘vignette’ 
 
In case three, all of the study coordinating centre staff agreed to take part in a telephone 
interview and four out of the 11 recruiting staff approached agreed to participate in the 
study. All of the staff interviewed were from two of the clinical recruitment centres that had 
not reached their recruitment targets. One of these centres had been delayed opening due 
to staffing issues but once opened reached nearly half of its target within three months. 
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Four of the interviewees had prior experience of working on palliative care studies but only 
two had worked on a palliative care randomised controlled trial previously. 
In summary in case three, usually the trial would be initially introduced to the patient by the 
lead medical clinician. In the intervention arm, a specialist nurse was employed to 
coordinate the implementation of the intervention and they would sometimes introduce 
the trial to the patient. The research nurses would then approach the patient to discuss the 
study further and obtain written informed consent from those who wished to take part in 
the trial. If the patient lacked capacity, a consultee would be approached to provide proxy 
assent: 
‘…so you know if she’d been in (specialist nurse) she would say to me when I got on 
the ward right this patient’s done, fully discussed, documented, they’re aware of the 
study, you just need to go in and talk to them.’ (Research nurse one, case three) 
Some research nurses declined to work on the trial and the reasons why are explored in the 
next chapter.  
The cross-case analysis is now presented as it relates to the ‘6 Ps’ of the ‘Social Marketing 
Mix Framework’; working with partners (partner referrals and recruitment); identifying 
participants; product (including product definition and competition); price (including type 
and minimisation); place; promoting the study; working with partners (barriers to 





5.3 Working with partners: partner referrals and recruitment  
 
Partners are organisations that are involved with a social change effort or serve as conduits 
to target audiences within the ‘Social Marketing Mix framework’ (Nichols et al., 2004). 
Across the three cases, there were two analytical categories that were related to the 
theoretical classification of ‘Working with partners: partner referrals and recruitment’. 
These categories were ‘recruiting clinical recruitment centres’ and ‘identifying patients and 
carers’. 
 
5.3.1 Recruiting clinical recruitment centres 
 
In cases two and three, the Chief Investigators discussed how they identified clinical 
recruitment centres for their trials. In case two, some of the clinical recruitment centres 
were identified via the National Institute for Health Research (NIHR) Clinical Research 
Network. The Clinical Research Network provides financial and other practical support to 
help clinical recruitment centres recruit to high quality research studies in England (National 
Institute for Health Research, 2019a). How much network funding and support the clinical 
recruitment centres receive is determined by the number of participants they recruit and 
the study design. As discussed previously, randomised controlled trials receive the greatest 
funding and support from the Clinical Research Network (National Institute for Health 
Research, 2019c). The Chief Investigator in case two described how the trial was attractive 
to clinical recruitment centres as it was a randomised controlled trial and it involved 
recruiting both the patient and their carer. The centres would therefore potentially receive 
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more funding and support as a result of their involvement in the trial as both the patient 
and carer would be counted as participants and the study design was a randomised 
controlled trial. This information was reflected in the trial documentation that invited 
eligible clinical recruitment centres to participate: 
‘This study is on the NIHR portfolio and as such will generate benefits of associated 
NIHR network support and activity based funding. This study also involves recruiting 
the patient’s primary caregiver as a separate participant giving centres the 
opportunity to generate double the number of accruals for this RCT. In addition there 
will be a per patient tariff of £200 at randomisation and £50 on completion of all 
study paperwork amounting to a total of £250.’ (Invitation to participate in [name of 
case] palliative care trial document) 
In cases two and three, those clinicians who were interested in the topic of the research 
would approach the study coordinating centre to express an interest in taking part in the 
trial. The Chief Investigator in case two felt that an expression of interest from clinicians was 
not enough to guarantee suitable centres were recruited. Organisations also needed to 
demonstrate that they had a good reputation as a clinical recruitment centre. This required 
centres with a successful recruitment record, research infrastructure and experience of 
recruiting to similar trials. This viewpoint was supported by one of the research nurses in 
case one: 
‘…I think we’ve, over these few years, we’ve been able to establish ourselves within, 
sort of, the UK as a good site to recruit. And, so we’ve always recruited for studies 
that we’ve been participating in. And, I think, on the whole, I believe we’ve met our 
targets. But, again, because we’re only a small unit, our target might be four 
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patients. But, that we’ve, you know, still managed to achieve that.’ (Research nurse 
two, case one) 
In cases two and three, it was a requirement not only to have staff available with the 
necessary skills and expertise to recruit to the trial but also have access to staff who were 
able to deliver the intervention. This avoided the study coordinating centre having to invest 
a large amount of additional resources to set the recruitment centre up. In case two, the 
study coordinating centre used a formal screening log to assess clinical recruitment centre 
eligibility: 
‘The other thing then was to vet every centre as we did.., to make sure that they 
passed the test and that they’ve got a recruitment record and that we didn’t have to 
invest a great deal of resource to set them up in order to do the trial, ‘cos there’s no 
point having somebody with interest but no access to research method..’ (Chief 
Investigator, case two) 
 
5.3.2 Identifying patients and carers 
 
All of the study coordinating centres used screening logs to monitor recruitment activity 
within the clinical recruitment centres. Across the three cases, identifying potential 
participants was a role carried out by a variety of health care professionals that included 
research nurses, specialist nurses, doctors and inpatient nurses. In all three cases, routine 
multi-disciplinary team meetings were used to screen for potentially eligible participants: 
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‘After discussion of your case with a number of cancer specialists we have identified 
that you may be suitable to take part in this study.’ (Patient information sheet, case 
two) 
In cases one and two, recruiting staff used the meetings as a forum to screen patients for a 
number of studies. All of the clinical recruitment centres had access to research nurse 
support during the trials and research nurses attended multi-disciplinary team meetings to 
identify potential participants:  
'...they have a short ward handover meeting with the consultant and the 
occupational therapist, physios etc. and we were attending that and trying to pick 
patients out of there who would be eligible for the study.’  (Research nurse two, case 
three) 
In case two, research nurses were not always able to attend the multi-disciplinary meeting 
because of a lack of time. Systems were in place to ensure they still received referrals for 
potential participants from the meeting. The research nurses received these referrals via 
email or through discussions with medical or specialist nurse colleagues who had attended 
the meeting. Across all three cases, informal discussions between clinicians were also used 
as opportunities to screen for potentially eligible participants: 
‘Well I work very very closely with the oncologist and the research team and we 
always sort of like did a recce of the patients coming forward and before we even 
met the patients we would try and work out whether they were suitable for (name of 
case).’  (Specialist nurse one, case two) 
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There were other screening activities that occurred outside the formal multi-disciplinary 
team meetings. In case two, outpatient clinic referral lists were screened by research nurses 
and the study coordinating centre also ran a dedicated nurse led telephone line to answer 
eligibility queries from clinical recruitment centres. Following on from this initial screening 
process, the research nurses described how they would review the patient’s medical notes 
to confirm the potential participant met all of the inclusion criteria and did not meet any of 
the exclusion criteria. In case one, confirming eligibility also required checking with the 
patient that they were still symptomatic. Checking the patient was eligible for the trial was 
viewed by the research nurses as an important part of their role: 
‘…well we should have the time to scrutinise you know the inclusion, exclusion and 
look through the notes properly ‘cos there might be something and that’s what I like, 
you know doing things properly. I think it’s ‘cos I’m a control freak.’ (Research nurse 
four, case two) 
Across the three cases, there were additional contextual factors that influenced how clinical 
recruitment centres were recruited and how patients and carers were identified that are 
explored in the next chapter. 
 
5.4 Identifying participants: defining the target audience 
 
The category, ‘type of eligibility criteria’, influenced how the target audience was defined in 
each case. As the three cases were palliative care trials, they included patients with 
advanced disease. Predicting a patient’s prognosis was also a requirement when 
determining eligibility. In cases one and three, the eligibility criteria required the clinician to 
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estimate the patient’s prognosis while in case two the eligibility criteria contained a 
performance status scale to aid prognostication.  
The use of subjective criteria to predict a patient’s prognosis proved particularly problematic 
in case three. Medical staff were required to predict the patient’s risk of dying during the 
hospital admission. This proved especially challenging in the control arm as supporting and 
training medical staff to apply the trial’s subjective criteria could potentially lead to 
contamination. In this example, treatment contamination refers to a situation where 
clinicians in the control arm may learn about the intervention and adopt it into their clinical 
practice. This may lead to a type II error which leads to the rejection of an effective 
intervention because the observed effect size was neither statistically or clinically significant 
(Torgerson, 2001). 
‘Without this level of education and support there is wide variability on the 
interpretation of this criterion with tendency for prognostication rather than 
consideration of risk. However, providing this level of education and support would 
result in contamination in the control sites.’ (Protocol, case three) 
The inclusion criteria that required medical staff to predict that the patient was at risk of 
dying was removed from the control arm during the trial for pragmatic reasons, as one of 
the aims of the trial was to assess the feasibility of recruitment. Recruitment improved in 
one control site while the other control site was unable to continue in the study for practical 
reasons. In case one, to try and avoid contamination, patients were excluded from the study 
if they were sharing a room with someone already in the trial, as this could influence the 
results of the study: 
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‘If there was someone else in the room that was part of the study, we can’t put 
someone else into the study because you know they might compare (name of 
intervention) or talk about them or see each others and it would, it could possibly 
influence the study.’ (Research nurse one, case one) 
In case two, the Chief Investigator described how they had designed the study to ensure the 
eligibility criteria were ‘as inclusive as possible’ which one of the nurses felt made 
identifying patients for the trial ‘quite easy’ (Specialist nurse two, case two). Why clinicians 
find identifying eligible participants challenging in a palliative care trial is not fully explained 
by the ‘Social Marketing Mix Framework’ and is discussed further in the following chapter.  
 
5.5 Product: The product’s competition  
 
The amount of competition for the participant’s time and energy is an important factor to 
consider when applying the ‘Social Marketing Mix Framework’ (Nichols et al., 2004). There 
were two main categories that were relevant to the classification of ‘Product: the product’s 
competition’ and they relate to the issue of ‘competing treatment trials’ and ‘competing 
treatments’. In case two, competition from treatment trials was a notable barrier to 
recruitment. Organisations that were specialist centres could have multiple trials available 
with similar eligibility criteria. Recruiting staff prioritised discussing and recruiting patients 
to treatment trials over the trial in case two. They would also consider prioritising the trial 
that was struggling to meet the agreed recruitment target or was going to close to 
recruitment first. This was because clinical recruitment centres receive funding to meet 
individual trial recruitment targets as discussed above: 
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‘...so whenever we sign up to a trial we are asked to say how many patients we 
should be able to get into that trial in over a certain period of time, and so we have 
and we get sort of paid as a Trust and a research department for meeting those 
targets that we set. And so we sort of are constantly aware I guess that we have a 
certain number of patients to get into each trial, so I don’t think as a team that is at 
all at the forefront of any decisions that are made but potentially for trials that aren’t 
recruiting so well, and if someone was eligible for a few different trials that were not 
for the same thing, and equally could benefit that patient then I personally think 
sometimes we might lean towards the one that was maybe not recruiting so well you 
know to help with numbers.’ (Research nurse five, case two) 
In case two, competition from chemotherapy treatment was also an issue because of the 
study population. One of the exclusion criteria outlined in the protocol was having started 
chemotherapy treatment prior to consent. This could ‘make it tricky’ (Research nurse five, 
case two) for research nurses to recruit the patient before treatment was commenced. 
Patients were sometimes keen to start treatment and did not want to consider taking part 
in a palliative care trial at that time:  
‘….some would say there’s just so much going on now I can’t even think about this 
and I just want to get onto treatment and so declined...’ (Specialist nurse one, case 
two) 
Competing treatments were also an issue in case one as the protocol outlined how patients 
were ineligible for the trial if they or a close relative had used the intervention before. This 
was felt to exclude ‘quite a few people’ (Research nurse one, case one) because the 




5.6 Product: Defining the product 
 
Within the ‘Social Marketing Mix Framework’, the product is the intervention (Nichols et al., 
2004). The categories that were applicable to the classification of ‘Product: Defining the 
product’ were; ‘level of patient and carer interest in the trial’ and ‘maintaining clinical 
equipoise’. Across the three cases, recruiting staff described why they thought patients and 
carers were or were not interested in the ‘product’. In case one, the Chief Investigator felt 
patients were interested in the trial because it was not a drug trial and described how some 
patients liked to avoid drugs. They had carried out a pilot study prior to the main trial to 
assess its acceptability to patients. Patients were permitted to continue on their symptom 
control drugs, access extra medication if needed and access the intervention after the trial if 
they had found it helpful: 
‘You can continue normal medication and if you need extra (name of symptom) 
medication you can have it.’ (Patient information sheet, case one)  
In case two, recruiting staff reported variable levels of interest among patients and carers. 
Research nurses spoke about patients being interested in the trial as it included both 
patients and carers and ensured regular research nurse support, even in the control arm. 
The Chief Investigator commented on how nearly every carer agreed to participate in the 
trial along with the patient participant. This high carer response rate is supported by the 
recruitment data published in the trial’s findings paper. Research nurses described how 
some patients and carers were not interested in the trial as they felt they did not need what 
the intervention was offering them or because it was not a treatment trial. Some patients 
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did not want to commit to the extra hospital visits that were required while others were not 
interested in taking part in any trials: 
‘Some patients they will say to you, do you know what, no offence but I don’t want to 
be coming into hospital regularly, I just want to go and live my life and I’m feeling 
good at the moment and no thank you, I don’t want to participate and that’s 
absolutely fine, whereas others do want that extra support I guess and knowing that 
they have the research team available to them helps I think.’ (Research nurse one, 
case two) 
Recruiting staff reported that patients were not always in clinical equipoise and could have 
preconceived ideas about which arm of the trial they wanted to be allocated to. This could 
influence their level of interest in the trial. Recruiting staff also struggled with equipoise and 
managing patient expectations but the ‘Social Marketing Mix Framework’ does not explain 
this, as ‘Product’ does not apply to clinicians. 
 
5.7 Price: ‘Type of costs’ and Price: ‘Minimising the costs’ 
 
The concept of ‘Price’ is the cost to the potential participant of taking part in the trial and 
applies to the patient or carer (Nichols et al., 2004). Across all three cases, there were a 
number of categories that were related to the classifications of ‘Price: Type of Costs’ and 
‘Price: ‘Minimising the costs’. As the cases were palliative care trials, the type of costs were 
related to the ‘patient’s condition’ and the associated ‘costs for carers’. The importance of 
‘minimising patient burden’ and understanding the ‘participant’s motivations for taking part 
in the research’ was also recognised. 
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In cases one and three, recruiting staff felt that the patient’s unstable and fluctuating 
physical condition was a ‘cost’ for patients and influenced their ability to engage in the 
recruitment process. Patients were often fatigued and had variable levels of symptom 
burden which could be influenced by their diagnosis. Research nurses would read and go 
through the participation information sheets and consent forms with patients to try and 
minimise recruitment costs and burden: 
‘…I had a couple of oncology patients on our ward with lung CA [cancer], and you 
know they were very different, they were very different compared to most COPD 
[Chronic Obstructive Pulmonary Disease] secondary respiratory failure patients that I 
was seeing. You know they did, I mean she died unexpectedly but again I had to go 
and see her a couple of times because she was on cpap [continuous positive airway 
pressure] as well to try and go through the information leaflet, but you know she was 
up, she was walking around, she was able to hold a conversation, compared to my 
normal respiratory patients which can’t actually do that because they are so short of 
breath. You know she came in because she had side effects from a second round of 
chemo. She came up to us because she had lung CA [cancer]. So a very different 
patient, very different level of sickness.’(Research nurse one, case three) 
Recruiting staff felt that minimising study burden for patients was important to increase trial 
acceptability. In all three cases, patient and public involvement representatives had been 
involved in the development of the participant information sheets. Across the three cases, 
the lengths of the patient information sheets varied from 997 to 2545 words. They were all 
presented in A4 documents with a font size ranging from 11 to 16. Readability statistics 
indicated Flesch-Kincaid Grade Level scores and Flesch Reading Ease scores ranging from 
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7.7/68.4 to 9.8/59.7 respectively. Higher Flesch-Kincaid Grade Level scores and lower Flesch 
Reading Ease scores indicate poorer readability. The recommended reading level for 
participation information sheets is Flesch-Kincaid Grade Level 6, which equates to a reading 
age of 11–12 years (Ennis & Wykes, 2016), so the information sheets across the three cases 
were written at a level higher than the recommended reading age. 
In case three, research nurses were concerned about the length of the participant 
information sheets and consent forms. One of the research nurses suggested the use of 
implied consent as a potential strategy to reduce patient and carer burden as the study only 
involved collecting questionnaire data and information from the patient’s medical records. 
Implied consent refers to a situation where an informed participant signals by their 
behaviour that they agree to take part in the study. In this study, patients were able to 
provide explicit consent either in writing or verbally (if witnessed) (British Medical 
Association, 2018). Concerns about the costs of the consent process were fed back to the 
study coordinating centre by the research nurses and the Chief Investigator acknowledged 
that given the low risk nature of the intervention a simpler consent process may have been 
more suitable in this trial.  
The patient’s unstable and fluctuating condition could also influence the carer’s role in the 
trial and therefore the costs of participating for the carer. If the patient lacked capacity, the 
carer would be approached to see if they were willing to act as a personal consultee and 
provide proxy assent on the patient’s behalf. A personal consultee is a person who is 
involved in caring for the participant who lacks capacity, not professionally or for payment. 
Their role is to advise the researcher on what the participant’s wishes and feelings would be 
if they were able to consent for themselves, and on whether they should take part in the 
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study (Department for Constitutional Affairs, 2007). Research nurses and study coordinating 
centre staff reported that the costs of taking on the role of consultee could be too 
burdensome for some carers. Carers could be too busy to engage in the recruitment process 
because of competing demands on their time: 
‘…a relative would be like we’re quite busy with some other paperwork and we don’t 
know what’s going on, we need to get some you know equipment in place before 
discharge, so it’s most of the time they people do not have a problem about the topic 
of research, but it’s mostly about not having time or not having the energy to 
complete the questionnaires or even go through the consent process really.’ 
(Researcher, case three)  
All recruiting staff in case three felt the costs of data collection for patients was also an 
issue. Research nurses helped patients to complete questionnaires to try and minimise 
study burden. One of the Principal Investigators felt questionnaire burden ‘did put some 
people off’ (Doctor, case three) and was a reason for patients declining to take part in the 
study. Research nurses reflected on whether less burdensome approaches to data collection 
may have been more suitable in this study population:    
‘…I mean some of these people died like three or four days later or you’re asking 
them to read this or go through this document with you and I’m not saying treat 
people like idiots even though they’re dying, I’m not saying that at all, but what I’m 
saying is you know maybe they want to spend the time in other ways with the family 
instead of going through these documents, I don’t know, maybe like you’re doing 
with me, maybe a chat at the bedside, a recorded interview, would that have been 
better?’ (Research nurse three, case three) 
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In case one, a pilot study led the study coordinating centre to reduce the number of times 
patients were asked about their symptoms in the trial to minimise the costs of taking part. 
Recruiting staff felt the study was attractive to patients because it was a short study that 
only required a small amount of their time:   
‘…it’s about a 10-minute questionnaire that tries to lighten the burden of 
participating in studies, because, again, with palliative patients, it, fatigue is a major 
issue. So, it’s quite a good study to recruit to, just because it is a small amount of 
time that you are taking.’ (Research nurse two, case one) 
In all three cases, recruiting staff also felt that costs related to the patient’s psychological 
and emotional well-being impacted on their ability to engage in the recruitment process. 
Patients were perceived as not always being ‘in the right frame of mind’ (Chief Investigator, 
case one) to consider taking part in research. This could be due to a number of factors such 
as just being diagnosed with a terminal illness, living with uncertainty or requiring hospice 
care. The eligibility criteria outlined in case two’s protocol allowed patients to be recruited 
up to six weeks after diagnosis so acknowledging the costs of approaching patients around 
the time of diagnosis of advanced disease. Given the sensitive timing, recruiting staff 
wanted to minimise study burden for patients by introducing them to the study at an 
‘appropriate’ (Research nurse five, case two) time.  
Across the three cases, recruiting staff discussed why they felt some patients and carers 
agreed to participate in the trials despite facing many challenges and costs. Understandably, 
the chance they may actually get some benefit from taking part in the trial was a reason 
given by some patients. Some patients felt that it gave them a purpose as they had 
something to do while they were sitting in an inpatient unit. Recruiting staff felt patients 
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and carers took part for altruistic reasons as they believed their participation could help 
others in the future despite facing many personal costs. Altruism was discussed as part of 
the informed consent procedure by the research nurses and is included in all of the three 
cases participant information sheets:  
‘…because it was something that didn’t necessarily make any difference to their 
relative’s care, that’s quite difficult to mention to someone, but then some of them 
were really good because as soon as you said oh it’ll improve care eventually then 
some of them (carers) got on board with that.’ (Research Nurse two, case three) 
Across the three cases, there were costs for clinicians associated with recruiting patients 
and carers to palliative care trials that the ‘Social Marketing Mix Framework’ does not 




The concept of place relates to the location where the participant will receive information 
about, or engage in, the intervention (Nichols et al., 2004). Across the three cases, there 
were a number of categories that were relevant to the classification of ‘Place’. These were 
‘travel to the clinical recruitment centre’, ‘pool of participants’ and ‘understanding the 
patient’s care pathway’. In case two, nurses felt that some patients were discouraged from 
taking part in the trial because they needed to travel to the clinical recruitment centre. The 
patient and carer information sheets explained how travel costs would be covered by the 
study. Some patients were still reluctant to take part because of the distance they needed 
to travel and the difficulties of parking in the hospital: 
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‘…just thinking about having to come and park and do extra follow up appointments 
is a massive thing in our hospital, that’s a huge thing that patients say when they talk 
about trials, how am I going to come in and park?  How am I going to get in there?’ 
(Research nurse three, case two) 
The ‘Place’ where recruitment was taking place influenced the pool of potentially eligible 
participants. In case one, the pace of recruitment was described as slow because they were 
largely recruiting from a single centre organisation. The study coordinating centre needed to 
recruit extra recruitment centres in case two to increase the pool of potentially eligible 
participants. The need to recruit extra clinical recruitment centres to meet the trial’s 
recruitment target had been anticipated by the study coordinating centre in the protocol:   
‘It is anticipated that expansion to further centres will be required to achieve 
adequate recruitment rates and target accrual.’ (Protocol, case two) 
Eligibility rates could fluctuate within individual clinical recruitment centres with some 
months being busier than others. The importance of understanding the patient’s care 
pathway when estimating clinical recruitment centres eligibility rates was highlighted in 
cases two and three. Study coordinating centres needed to understand at what points on 
the care pathway patients may be receptive to receiving information about the trial. The 
Chief Investigator in case two explained how specialist hospitals as organisations may have 
high numbers of eligible patients but this may not always be the most appropriate ‘place’ to 
approach the patient about a palliative care trial: 
‘so even though they said we see lots of (name of diagnosis), actually they only saw 
them for the diagnostic bit, when it came to the care, he was transferred to another 
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local hospital….So what we did was open a centre where they were sending the 
patients out to, so recognising the patient pathway….’ (Chief investigator, case two)  
In case two, the pool of potentially eligible participants was also reduced in one of the 
specialist hospitals because the trial intervention did not cover all of the hospital’s 
catchment area. Patients could also have been recruited to a trial before being seen in a 
specialist hospital. In case three, non-specialist hospital sites were the ‘places’ where 
recruitment took place and they needed to be kept open for longer than anticipated 
because the number of eligible patients was less than predicted: 
‘…and then we had a problem that you know when we first spoke to the site they as 
always oh we’ve got lots of people who meet eligibility, you know we can recruit 
within two months, so we scheduled recruitment to be over three months and it took 
longer than that. So that was then also required renegotiation with the sites that 
they would keep recruitment open...’  (Chief Investigator two, case three)  
 
5.9 Working with partners: barriers to partnering 
 
There were three categories related to the classification of ‘Working with partners: barriers 
to partnering’; ‘health care professional gatekeeping’, ‘lack of clinician engagement in 
research’ and ‘resource issues’. In all three cases, both medical and nursing staff acted as 
gatekeepers. Research nurses accepted the opinion of other clinicians that it was not 
appropriate to approach certain eligible patients about the trial. In case one, the research 
nurses sometimes decided not to accept their opinion and would bypass certain members 
of staff and approach the patient. Their decision was based on how much they trusted the 
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opinion of the individual staff member that it was not appropriate to approach the patient. 
The research nurses would sometimes seek a second opinion from the lead medical clinician 
who was also the Chief Investigator for the trial: 
‘...quite senior medical staff some that just think we shouldn’t be doing research, that 
it’s not ethical that patients don’t want to bothered, they have too much going on 
and you know I’m always happy to hear their opinions but I often get a second 
opinion with other because there are certain members of staff that I know don’t want 
to and I have tried, you know I have really tried to engage and I have done little 
sessions on research and why we do it and you know the importance of progress and 
so on. Umm but yes that’s I say that’s quite high up on what I find most challenging 
about my job really.’ (Research nurse one, case one) 
Lack of clinician engagement in the trial made addressing health care professional 
gatekeeping challenging. This was particularly an issue for the research nurses who were 
recruiting in the inpatient setting. Clinician rotation and turnover in the inpatient setting 
made medical staff engagement particularly challenging for the research nurses:  
‘…a phenomenally high turnover of medical doctors if they’re on rotation, so it would 
mean the research nurses would talk about the study, it would all be fine, and then 
those individuals would rotate onto another ward, and then they’d have to begin 
again in explaining the study, so that made it very difficult to get the medical team’s 
involvement and support for the study.’ (Chief Investigator two, case three) 
Clinicians were often too busy to engage in the recruitment process and some had a limited 
knowledge of research, including randomised controlled trials, and did not see research as 
part of their role or part of routine care. In case three, the research nurses in the control 
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arm were limited in how much education they could provide to clinicians about the trial 
because of the risk of contamination. Identifying and utilising the support of staff who were 
the most engaged in research was viewed as a useful strategy for managing health care 
professional gatekeeping:   
‘I think that you learn to fight your battles. I think that you know who you can 
approach, and who is less open to research, within staff.' (Research nurse two, case 
one) 
The contextual reasons for why health care professionals acted as gatekeepers across the 
three cases and why there was a lack of clinician engagement in research was not fully 
explained by the ‘Social Marketing Mix Framework.’  
Across all of the three cases, resource issues acted as a barrier to partnering. The time that 
Principal Investigators could spend working on the trial was influenced by the demands of 
their clinical workload and could be exacerbated by staff shortages or only working part 
time. In case two, staffing shortages and heavy workloads among those providing the 
intervention could also be detrimental to recruitment. Clinicians who were providing the 
intervention sometimes requested that recruitment to the trial be limited so they could 
cope with the additional demand that the trial was creating. Across the three cases, eligible 
patients were missed because the research nurses were unavailable. Research nurses were 
allocated to work on a number of studies by their organisations and these could also be 
resource intensive studies:  
‘I did miss some of the visits,..I completely missed a couple of patients…., I had 
another study at the time and I had about 25 patients in that and that study was 
so…. intense, it nearly broke me to be honest...’  (Research nurse four, case two) 
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In one of the clinical recruitment centres in case three, the research nurses worked as a 
generic research team to try and manage this issue. A nurse would act as the lead for the 
study while other research nurses would assist when necessary. This would ensure trial 
recruitment could continue if the lead nurse was unavailable. This approach was not 
possible in case one as the research nurse worked part time and often on her own:  
‘…she (research nurse) is not here all the time, I’m not here all time so you do miss 
the odd patient...’ (Chief Investigator, case one) 
Working within a voluntary hospice organisation was seen to make recruitment more 
challenging because of the limited research infrastructure. In contrast to the other cases, 
research nurse time was directly funded by money generated from commercial studies. A 
volunteer was also used to provide administrative support to the research nurse. The ability 
to network with, engage and recruit other hospices to take part in research was also limited 
by the lack of funding.  
 
5.9 Promoting the study 
 
Promoting the study involves identifying the acceptable avenues that reach the target trial 
population (Nichols et al., 2004). Across the three cases, there were a number of categories 
that were relevant when promoting the study to participants. These were; ‘increase trial 
visibility’, ‘flexibility and respectful persistence’, ‘building trust and rapport’ and ‘key and 
careful messaging’. In case two, the Chief Investigator described the strategies they used to 
increase the visibility of the trial among clinicians and potential participants. The study had a 
trial website with a patient and health care professional section to ensure they had visibility 
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on the internet. They were less successful with the use of social media as the trial was 
recruiting an older population ‘that is not very internet savvy’ (Chief Investigator, case two). 
The study had its own acronym and merchandise to help promote the trial brand. The study 
coordinating centre worked with national organisations to publicise the trial which the Chief 
Investigator felt increased awareness among patients and carers as well as potential clinical 
recruitment centres. 
The value of organisations promoting research as part of its ‘core business’ (Chief 
Investigator, case one) and seeing it as a way of improving care was highlighted in both 
cases one and two. Being asked to consider taking part in research could be viewed as 
unusual by patients which organisational buy in could help address:  
‘…there’s quite a lot done here that promotes research at the Trust and a few 
patients have commented on oh yeah I saw that about you know the research that 
was done here, and I think that kind of helps us when approaching patients, is that 
they’re already aware that there’s a good chance they might be approached about 
research and that sort of helps that they kind of know there’s a good chance 
everyone is being asked about something and it’s sort of a bit more normal rather 
than them feeling like they’re being asked to be a guinea-pig or anything like that...’ 
(Research nurse five, case two) 
In all three cases, it was important for recruiting staff to be flexible and demonstrate 
respectful persistence when promoting the trial to patients and carers. Research nurses 
often had to take account of the patient’s physical condition, clinical care, family visiting 
times and their psychological and emotional well-being when promoting the trial. All of 
these factors required a flexible but respectfully persistent approach:  
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‘And, you’re very flexible, because, again, with palliative patients, you may plan to go 
and see somebody at a certain time, and they’re ill, or they’re on the toilet, or their 
family’s come, so you really do need that, sort of, flexibility’. (Research nurse two, 
case one) 
When promoting the trial, recruiting staffs’ roles and responsibilities were determined by 
professional role. In cases one and three, the initial approach was usually made by the 
doctor in charge of the patient’s care. In case two, the specialist nurse took on this role, with 
or without the doctor. They would seek permission from the patient for the research nurses 
to approach them about the study. Research nurses would not go and speak to the patient 
about the trial before seeking medical permission: 
‘...I would never go and umm I would never go and see that patient, what I would do 
is then I would then flag the potential patient up to the medical staff and then what 
would normally happen is they would say you know we’re doing a study, it’s looking 
at (name of intervention) would you be happy to speak to our RN’. (Research nurse 
one, case one) 
The research nurses would discuss the study with the patient and if they were interested, 
give them a copy of the participant information sheet. They would arrange face-to-face 
follow up to answer any further questions and obtain written consent if the patient 
confirmed that they wished to take part in the trial. In case two, the nurses would 
sometimes telephone the patient prior to the consent visit to confirm they were interested 
in taking part in the trial: 
‘...I thank them for speaking with me initially and then I’ll say you know that I know 
you’ve got a lot to take in today, so I don’t want to bamboozle you with so much 
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information, and invite them to take the information home and we’ll agree a time 
and a date for me to ring back. And that is certainly no less than 24 hours but it’s 
generally 24 to 48 hours. I also say to the patients as well you know if you’ve got any 
questions about anything at all you know do use me as I say as a resource. And then I 
will call them at that set time and date that was agreed and I’ll say what are your 
thoughts, do you have any questions, and once they’ve confirmed that they would 
like to take part, then we will make another appointment for them to physically come 
in and see me.’ (Research nurse two, case two) 
Across the three cases, nurses felt building trust and rapport with potential participants was 
important when promoting the trial. Engaging carers in the recruitment process was seen as 
a useful way of building trust and rapport. Carers had the option of taking part in the trial in 
case two and also in case three if the patient lacked capacity. In case one, they were not 
potential participants but the research nurses still felt it was important to engage with 
carers because of the patient’s vulnerability. In all three cases, joint patient-carer 
discussions or advising patients to discuss taking part with their families were suggested 
strategies to engage carers. In cases one and three, it was suggested it was important to 
speak to carers out of courtesy or politeness with one nurse reflecting on how if her parents 
had been approached about a trial, she would like to see information about the study. 
Identifying the key people to engage with was seen as important. Research nurses believed 
carer engagement was a way of reassuring patients and carers that it was voluntary to take 
part in the trial and no coercion had taken place. Unsurprisingly, having had previous clinical 
contact with patients and carers was seen to make engaging carers and building trust and 
rapport more straightforward: 
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‘Well I think the patients that I recruited I already knew, and so it was easy for me to 
go to them ‘cos I’d been involved in some prostate studies and the patients that I 
recruited were those patients that had become end of life, so my approach was very 
much you know we already had a relationship.’ (Research nurse three, case three) 
In all three cases, there was a need for recruiting staff to pay attention to key and careful 
messaging when introducing and explaining the trial to participants. Recruiting staff 
supported their verbal explanation of the study with a participant information sheet. 
Research nurses sometimes used additional written prompts to remind them of what 
needed to be covered in their discussions with patients.  
The need to use key and careful messaging when explaining randomisation as part of the 
informed consent process was a requirement in cases one and two but not in case three as 
it was a cluster trial. As discussed previously, in a cluster trial, randomisation occurs at the 
cluster level rather than the individual level so the informed consent process is tailored to 
the study arm to which the cluster has been allocated (McRae et al., 2011). Nurses felt 
randomisation was a difficult concept for patients to understand in all trials and not just 
those in palliative care. They felt there was a need to ‘spend quite a lot of time’ (Research 
nurse one, case one) explaining it to patients. Some nurses used percentages to explain 
randomisation, some used tossing of a coin as an example, while some explained it was 
decided by a computer. Recruiting staff also explained that they had no control over the 
intervention allocation when discussing randomisation with patients: 
‘It’s quite a hard concept for some people to get their head round I think, and so we 
try and do it as simply as possible, you know we kind of say we have no control over 
we’d obviously explain that the study has two arms and one of them is the standard 
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care for the (name of study) trial and the other would involve the (name of 
intervention)…… And for this trial you obviously need to have something that’s 
always the same to compare it against what you’re changing, so that they can find 
out whether it is better or not better or the same, to see if practice they can suggest 
that practice should change and we have no control over saying whether or not you’ll 
receive the standard care or whether or not you would receive the extra (name of 
intervention).’ (Research nurse one, case two) 
There was a need to keep checking understanding as patients could often struggle to retain 
the information that had been given to them about randomisation.    
In cases two and three, there was a requirement for recruiting staff to discuss palliative and 
end-of-life care with patients and carers as part of the informed consent process. This was 
because of the type of intervention being tested, the wording contained within the 
participant information and the organisational setting where recruitment was taking place. 
In case two, recruiting staff explained how patients could often associate palliative care with 
end-of-life care when they were promoting the trial. The patient information sheet attempts 
to address this viewpoint by explaining it can be provided ‘at any time during the illness’. 
The decision was made by the study coordinating centre to remove the words palliative care 
from the study title and shift the focus to symptom control as ‘we thought that was a better 
sell, to try and get older patients in’ (Chief Investigator, case two).   
Recruiting staff would explain palliative care in terms of symptom control and extra support 
to demystify the terms and to increase patient and carer acceptance of the trial. They would 
also sometimes stress that the trial would not interfere with any of their current treatments:  
197 
 
‘Well we did say that it was after we discussed other clinical studies I must admit, but 
we would say that we have also got a trial which is up and running now which you 
are able to think about and enter into if you like, and this was looking at your quality 
of life and how we could help you with any symptoms as soon as possible, to try and 
keep you as well as possible for as long as possible, and that you know if there were 
any symptoms that hopefully we could pick them up and deal with them as soon as 
we possibly could and for the carer that they would get the support as well.’ 
(Specialist nurse one, case two) 
Recruiting staff could find promoting a palliative trial to patients and carers challenging and 
the reasons why are not fully illuminated by the ‘Social Marketing Mix Framework’.  
 
5.10 Working with partners: partner education  
 
The categories that are relevant to the classification of ‘working with partners: partner 
education’ are ‘engaging recruiting staff’, ‘engaging clinicians’ and ‘preparation for sensitive 
conversations’. The research nurse’s previous clinical experience influenced how much 
preparation and training they needed to work on a palliative care trial. All of the research 
nurses were experienced research nurses but they came from a variety of nursing 
backgrounds. In all three cases, there were research nurses that had gained their experience 
of caring for palliative care patients while working in oncology and/or on oncology trials:  
‘I probably worked with all sorts of different patients with cancer since I qualified and 
I’ve been in respiratory for a long time but I also went and did quite a lot of 
haematology and oncology for a few years, and worked with quite a lot younger 
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people who were also palliative and things so I think it’s never easy, but I think 
maybe a bit of experience as well over the years definitely helps.’ (Research nurse 
five, case two) 
Study coordinating centres felt that it was important to ensure regular contact was 
maintained with recruiting staff in the clinical recruitment centres to promote trial 
engagement and partnering: 
‘One good thing we’ve learnt is a centre will soon have a short term memory and 
loose interest in the trial if you’re not constantly for want of a better terms in their 
face.’ (Chief Investigator, case two) 
In case two, they promptly closed down a couple of clinical recruitment centres during the 
trial because they did not recruit any participants. They used videoconferencing for the site 
initiation process so they could open clinical recruitment centres around the UK with 
minimal cost. Study coordinating centres used various partner education strategies during 
the trial to facilitate trial engagement with recruiting staff which included; a weekly study 
newsletter (case two), site visits (case three), regular teleconferences (case two and three) 
and incentives for clinicians (iPad and per patient recruitment tariffs).  
Research nurses felt it was crucial to personally engage with clinicians in the clinical 
recruitment centres and to maintain their engagement throughout the trial. Personal 
contact was seen as important to facilitate the recruitment process and to attempt to 
address gatekeeping. Research nurses used a variety of formal and informal partner 
education strategies to engage with clinicians. The strategies used included; research 
presentations (case one), attendance at staff meetings (case one), email communication 
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(cases one and two), attendance at multi-disciplinary team meetings (all three cases) and 
one to one contact with clinicians (all three cases). 
Across the three cases, having a ‘research champion’ within the clinical recruitment centre 
was seen as important to promote the trial and to engage with other clinicians. This role 
was largely carried out by the lead medical clinician in the clinical recruitment centres:   
‘The PI for (name of case) is also a senior physician within that MDT as well, and he’s 
very very proactive…it does depend on you know the proactivity of the people 
involved.’ (Research nurse two, case two)  
In case three, the ‘research champion’ role was not always carried out by the lead medical 
clinician. Specialist palliative care professionals who had a consulting role within the clinical 
recruitment centre also took on the role. As discussed in chapter one, specialist palliative 
care doctors and nurses work in the hospital and community setting and their role is to 
provide advice and support to the patient’s usual care team (Bausewein & Higginson, 2012).  
Both study coordinating centre staff and recruiting staff felt this had a detrimental impact 
on trial recruitment, as the ‘research champion’ was often unavailable to engage with other 
clinicians and undertake partner education:  
‘...we had two sites where the PIs were absolutely on board with it, this is important, 
we’re committed to doing this, we’re going to do it, and they were both sort of 
positioned within a functioning clinical team, so that was one control and one 
intervention. And they were basically able to sort of lead their team, we’re doing this 
study, this is important, and then got everybody on board and committed and 
worked with the research nurses...’ (Chief Investigator two, case three) 
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Across the three cases, there were a number of contextual issues that influenced the 
process of partner education that are not explained by the ‘Social Marketing Mix 
Framework’. These included why the professional role of the ‘research champion’ was 
important and why research nurses adopted certain strategies to prepare themselves to 
have sensitive conversations with patients and carers.  
 
5.11 Conclusion  
 
The ‘abbreviated vignettes’ at the beginning of this chapter and the within case analysis in 
appendix 14 highlighted the differences between the three cases in their clinical setting and 
study design. Despite the three cases having different characteristics, similar issues were 
identified in all of the trials in the cross-case analysis. As discussed in chapter four, 
theoretical replication was used in this study because if findings from divergent cases 
corroborate each other, they are seen as more robust. The ‘6 Ps’ of the ‘Social Marketing 
Mix Framework’ provided a useful and practical guide to inform data collection and analysis 
in this study, both within case and across the three cases. They highlighted important issues 
that need consideration when planning and implementing a recruitment strategy in the 
context of a palliative care trial. It was however, as commented on in the previous chapter, 
challenging not to avoid force fitting the study findings into this theoretical framework. This 
required many discussions with my supervisors and hours of reflection to address this 
limitation of using an a priori theoretical framework. The findings indicated that there were 
underlying contextual reasons for the clinician’s recruitment behaviours that could not be 
fully explained by the framework. In the next chapter, study findings are discussed and 
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presented within three overarching but linked classifications; ‘emotional labour’, 
‘paternalism’ and ‘professional hierarchies and power relationships between clinicians’. 
These additional classifications provide a more in-depth understanding of the ‘6 Ps’ within 
















Chapter six: Cross-case analysis findings in relation to ‘emotional 
labour’, ‘paternalism’ and ‘professional hierarchies and power 
relationships between clinicians’. 
6.1 Introduction 
 
In the previous chapter, the ‘6 Ps’ of the ‘Social Marketing Mix Framework’ were used to 
present findings from the cross-case analysis. The cross-case analysis suggested that the ‘6 
Ps’ only partially explained health care professional’s recruitment behaviours and wider 
contextual issues needed to be incorporated into the framework. In this second findings 
chapter, three overarching but linked classifications, derived interpretatively from the data, 
are used to explain the cross-case analysis findings. They highlight important issues that 
need consideration when planning and implementing a recruitment strategy in the context 
of a palliative care trial. 
Firstly, the impact of the ‘emotional labour’ of recruiting patients and carers to palliative 
care trials on clinician’s recruitment practices is described. The categories explored within 
this classification are; ‘costs for research nurses’, ‘choosing the best time to approach 
patients’, ‘explaining palliative care’, ‘preparation for sensitive conversations’ and 
‘managing patient expectations’. Secondly, how ‘paternalism’ influences the recruitment 
process is discussed and the categories explored are; ‘health care professional gatekeeping’ 
and ‘carer gatekeeping’. Finally, how ‘professional hierarchies and power relationships 
between clinicians’ can effect recruitment processes is then outlined and the categories, 
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‘recruiting clinical recruitment centres’, ‘confirming eligibility’ and ‘research champion’ are 
discussed within this classification. 
 
6.2 The ‘emotional labour’ of recruiting patients and carers to palliative care 
randomised controlled trials.  
 
The term ‘emotional labour’ was first introduced by Hochschild (Hochschild, 2012) and 
involves the management and regulation of feelings in the workplace. It is broadly defined 
as ‘the induction or suppression of feeling in order to sustain an outward appearance that 
produces in others a sense of being cared for in a convivial safe place’ (Smith, 2012) (p. 11). 
Recruiting staff in all three cases had to manage the ‘emotional labour’ of approaching 
patients and carers at a difficult time in the patient’s illness trajectory. In case one, this was 
during hospice admission, in case two, at the time of diagnosis of advanced disease and in 
case three, when the patient was at risk of dying. The need for recruiting staff to respond 
rapidly to recruit eligible patients and carers during what appeared to be a short window of 
opportunity was evident in all three cases. This time pressure could be due to the risk of 
patients deteriorating as in cases one and three or commencement of treatment for their 
underlying disease as in case two: 
‘I think because these patients have got a lot going on, they’re poorly people, they 
deteriorate before you have a chance to recruit them or something changes which 





6.2.1 Costs for research nurses 
 
The ‘Social Marketing Mix Framework’ does not acknowledge the ‘Price’ or ‘emotional 
labour’ of recruitment for research nurses and the types of costs they may experience when 
recruiting to a palliative care trial. Balancing the need to respond rapidly while taking 
account of the patient’s unstable and fluctuating condition was an issue for the research 
nurses in cases one and three. Recruiting patients to a palliative care trial could be time 
consuming for the research nurses as multiple visits were often required because of the 
patient’s condition. Recruitment visits could be lengthy because of the level of support 
patients required to go through the participation sheets and consent forms: 
‘….you know they’ve said, you know I can’t actually, I’ve not felt up to reading it or 
you know I can’t read the information, you know so I have sort of read it to them and 
then gone through it with them so things just take a bit longer and you need oodles 
of sort of patience and also not giving up really. Cause it would be very easy to sort of 
say oh no you know, they were sick, that happened, you know I am not going to do 
that but just to go back but always making sure, are you happy to talk about it, is it a 
good time for you you know, I am happy to go away and come back tomorrow.’ 
(Research nurse one, case one) 
The ‘emotional labour’ of recruiting palliative care patients and carers could be exacerbated 
by wider resource issues such as having to work on other trials at the same time, staff 
shortages or working part time. Lengthy and complex consent processes proved particularly 
challenging for the research nurses in case three as they were required to recruit patients 
who lacked capacity as well as those that were at risk of losing capacity. They were required 
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to assess capacity using the processes outlined in the Mental Capacity Act (Department for 
Constitutional Affairs, 2007). The act provides a legal framework, in England and Wales, for 
acting and making decisions on behalf of those who are 16 and over who lack the mental 
capacity to make particular decisions for themselves (Department for Constitutional Affairs, 
2007). The research nurses were required to seek assent from a personal or nominated 
consultee if the patient lacked capacity. The definitions of a personal and nominated 
consultee were contained within the study protocol: 
‘A personal consultee comprises next of kin, immediate carer or attorney with Lasting 
Power of Attorney………..The nominated consultee will have a professional 
relationship with the potential participant, but cannot be connected to study e.g. a 
geriatrician, social worker.’ (protocol, case three)   
If the patient had capacity, advance consent procedures needed to be followed. As 
discussed in chapter one, advance consent involves asking patients if they were to lose 
capacity in the future whether they would wish to continue in the trial. If so they are asked 
to nominate a consultee who the researchers can approach to ask their opinion on the 
patients continued participation in the study (Agar et al., 2013; Department for 
Constitutional Affairs, 2007). Operationalising this aspect of the protocol proved challenging 
and problematic for some of the research nurses. Research nurses could lack confidence 
and skill when assessing capacity and they could also be unclear about who was permitted 
to act as a consultee. For example, the documented next of kin may not have been the carer 
who visited the patient in the hospital so the research nurse could be unsure about who was 
permitted to act as a consultee. Lack of experience and training contributed to this 
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recruitment barrier with the Chief Investigator reflecting on how they should have prepared 
the research nurses better to enact this aspect of the protocol:  
‘So I sort of felt that we should have prepared the research nurses better, they were 
prepared in terms of site initiation visit and but it sort of came to light then that they 
had never used an advance consent before, never used a consultee before, and that 
they were learning. So then we sat and went through all of that, I felt that I could 
have managed that better in anticipating the need for training on that.’ (Chief 
Investigator two, case three)   
Obtaining consultee assent could also be challenging for the research nurses and involved 
‘emotional labour’. Potential consultees could often be too busy to engage in the 
recruitment process. Research nurses had to visit the inpatient unit multiple times to speak 
to carers and some consultees felt they needed to discuss it with other family members 
before making a decision. Allowing carers the time they needed to make a decision about 
whether they would be willing to act as consultee with balancing the pressure to recruit 
patients within a short window of opportunity could lead the research nurses to face a 
difficult dilemma and experience increased emotional burden:  
‘…but I can’t say to somebody I know you want to discuss it with your brother but 
your mum’s only eligible right now and she could change tomorrow, do you know 
what I mean, I can’t say that to them. I just have to go that’s fine, they can discuss it 
with whoever they want, you know they can take as long as they want, and the 
trouble is that they were taking such a long time that they were then passing away or 
coming off (name of intervention) or whatever.’ (Research nurse one, case three) 
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The costs of recruiting to a palliative care trial, such as managing the patient’s unstable and 
fluctuating condition, complex consent procedures and the impact of wider resource issues,       
contributed to the ‘emotional labour’ of recruitment for research nurses.  
 
6.2.2 Choosing the best time to approach patients 
 
Across all three cases, recruiting staff described how they made judgements about when to 
introduce the trial to patients. Their judgements were not only based on their concerns 
about the patient’s physical condition or practical considerations such as visiting times but 
were also related to their concerns about the patient’s psychological and emotional 
wellbeing. Recruiting staff appeared mindful of the major challenges patients and carers 
were facing at the time of recruitment. Staff were concerned that patients were 
‘overwhelmed’ (Research nurse one, case two) with information as they were being 
approached around the time of diagnosis of advanced disease or at the end of their lives. In 
case two, the Chief Investigator expressed that there was never an ideal time for the 
clinician to approach a patient about taking part in a palliative care trial because of the 
patient’s situation. He felt there was a need for those involved in the recruitment process to 
overcome their fears and approach patients about research: 
‘…at the end of it you can’t be too sensitive about it, you’ve got to approach them it’s 
just finding out which is the least worse time out of all of that.’ (Chief Investigator, 
case two) 
Nurses described the strategies they used to support patients during the trial recruitment 
process. In all three cases, they felt allowing patients some time to process or digest what 
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was happening to them before introducing the study was important to increase their 
acceptance of the trial. They also used this approach in trials outside palliative care:  
 ‘I think it’s an issue with all trials, that you have to pick the right time to pitch it to 
the patient otherwise they’re just going to say a straight no because I think 
sometimes at the time of diagnosis they get so much information that to try and add 
another element in, and I manage to get a feel somehow for whether that 
consultation was the right time or whether it needed to wait a week or two ‘til I saw 
them again to raise it, otherwise I found that they were less effective.’  (Specialist 
nurse two, case two) 
This specialist nurse felt comfortable re-introducing the study to patients if she felt she had 
got the initial timing wrong.  
Allowing time for patients to process or digest what was happening to them before 
introducing the trial also appeared to be beneficial for recruiting staff. Across all three cases, 
this appeared to be particularly the case for the research nurses:  
‘People’s understanding of hospices, tends to be that it is a place you go to to die. So, 
when people are referred to the in-patient unit, and they’re admitted, there is that, 
sort of, automatic barrier comes up, so, oh my God, is this it? So, it’s, from my 
perspective, really helpful not to see somebody within the first 48 hours. Because, 
they need to gain a confidence in what we are doing, as an organisation, that the 
place is, you know, a good place to be, and they need to, sort of, feel safe and 
secure.’  (Research nurse two, case one) 
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Choosing when is the best time to approach a patient about a palliative care trial 
contributed to the ‘emotional labour’ of recruitment for recruiting staff, particularly the 
research nurses, because of the patient’s challenging situation.  
When initially introducing the study to patients, research nurses would vary the amount of 
information they gave about the trial to manage the ‘emotional labour’ of ‘promoting’ a 
palliative care trial. Research nurses felt it was important to adopt an individualised 
approach and make a judgement on a case-by-case basis. They adapted the level of 
information they gave about the trial depending on the patient’s response, the patient’s 
level of understanding and their own level of comfort: 
‘...I think it differs very much from patient to patient in terms of how much 
information I think you give them as well, depending on how they sort of take in the 
initial bit of information. Sometimes you have patients who as soon as there’s any 
mention of anything like cancer it’s like you see them shut down immediately, so we 
don’t necessarily give them too much information, so we try and kind of make it so 
it’s most appropriate for that patient sat in front of us.’ (Research nurse five, case 
two) 
Recruiting staff reported that patients responded to being approached about a palliative 
care trial in a variety of ways. Some patients were very accepting and viewed it positively 
while others were less open to the idea of participating in a palliative care study. Recruiting 
staff discussed how some patients were not ready to acknowledge or talk about the 
palliative nature of their illness. In case three, a research nurse described how a minority of 
patients became distressed when the trial was introduced. She felt this was because they 
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were in denial about the seriousness of their condition and she sought reassurance from the 
medical staff that the patient had been informed:   
‘…and then I had a couple of patients who actually got really angry in that leave my 
room, I don’t want to talk to you, I’m going to get better, how dare you start talking 
about such, you know, that I’m not going to get better, that’s negative thoughts, I 
don’t need that, go away, you know sort of real mixed kind of responses, sort of total 
denial so the patient had been told, so I would then go running to the doctors and go 
are you sure you discussed it with the patient ‘cos they don’t seem to either know 
about it or they’re saying that it’s not the case, they’re getting mixed messages,...’ 
(Research nurse one, case three) 
The ’emotional labour’ of introducing the study to patients appeared less demanding for 
those nurses who had had previous clinical contact with the patients. They may have met 
the patient previously because of having a dual clinical role and/or previous contact during 
the diagnosis process or recruited patients to a previous oncology trial. Striking up an 
instant rapport and knowing what the patient understood about their condition were seen 
as the advantages of having previous clinical contact with the patient: 
‘the patients I approach they were known to me and I think the haematology patients 
were known to the haematology team so I think that was easier knowing your 
patients and knowing that they already knew and understood that they were on an 
end of life pathway.’ (Research nurse three, case three) 
As discussed in the previous chapter, nurses believed engaging carers in the recruitment 
process was important when promoting the trial to help build trust and rapport and 
increase patient and carer acceptance of the trial. Involving carers in the recruitment 
211 
 
process and stressing the voluntary nature of taking part also appeared to help nurses cope 
with their anxieties about approaching vulnerable participants: 
‘…a lot of patients are quite vulnerable so I think engaging with the family and 
talking to them and explaining what we’re doing and why we’re doing it that’s really 
helpful...’ (Research nurse one, case one) 
Varying the amount of information given, involving carers and stressing the voluntary nature 
of taking part were strategies used by nurses to manage the ‘emotional labour’ of 
recruitment to a palliative care trial. Previous clinical contact with the patient also helped 
minimise the emotional burden of recruitment for nursing staff. 
 
6.2.3 Explaining palliative care 
 
In cases two and three, recruiting staff could find explaining palliative care as part of the 
recruitment process challenging. One of the medical staff in case two felt it was difficult 
discussing palliative care without acknowledging its association with end-of-life care. 
Research nurses were required to broach issues that they would not routinely have to 
discuss in their day-to-day practice. The need to work outside their usual role caused some 
of the research nurses to feel worried and anxious: 
‘…I actually think I made a mountain out of a molehill ‘cos actually I think the 
patients were quite fine about it, I think it was a lot of it was our worry about how 
they would feel, because we’d kind of never it was quite new to us. Most of our trials 
are very much like this is a therapy that might make you feel better, you know we’re 
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going to do this drainage or something, so this was just completely new so but 
actually I think the patients were quite responsive to it and understood that you 
know it wasn’t that we were saying they were dying, we very much talked about it 
was all about symptom relief...’(Research nurse three, case two) 
In case two, the protocol and carer information sheet required recruiting staff to broach the 
topic of a bereavement questionnaire with patients and carers at the time of consent. Some 
research nurses felt very uncomfortable introducing this aspect of the study around the 
time of diagnosis even though patients had a diagnosis of advanced disease:  
‘The loss of the person you are caring for is always a difficult time for you as their 
carer. We would therefore like to see if the (name of intervention) helps the main 
caregiver cope. With your agreement, this would involve completing a final 
questionnaire over the telephone 24 weeks after bereavement.’ (Carer information 
sheet, case two) 
Research nurses were apprehensive about how participants may react to this part of the 
study. There were concerns that it may lead to patients and carers asking them further 
questions about their prognosis or care that they felt they did not have the skills to answer. 
One of the research nurses stressed the importance of highlighting this sensitive aspect of 
the trial contained within the participant information sheet to potential participants, to limit 
the potential for distress: 
‘...I had that discussion she burst into tears, so it wasn’t ideal, and she said to me 
afterwards she was like I’m really pleased that you highlighted that from the 
information because I wouldn’t have wanted to have been at home and burst into 
tears having read this, but she said that’s really upsetting and she sort of said I can 
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see why you want to do it and it makes sense………….And then there is one of the 
other sort of couples, the patient’s wife was very much like you know yeah this makes 
sense that you want to see how I was doing afterwards as well, and actually they 
were very sort of practical and you know they weren’t so you know quite so shocked I 
don’t think by it. So yeah I think it depended where people were in terms of accepting 
or you know struggling with things.’ (Research nurse five, case two) 
In case three, the protocol and study information did not require recruiting staff to discuss 
the bereavement questionnaire with participants in advance as carers were invited to 
continue in the study post bereavement. This approach did not always appear to reduce 
research nurse discomfort, as one of nurses spoke about telephoning the carers to check 
they were happy to receive the questionnaire even though this procedure was not 
contained within the protocol. Both case two and three’s protocols, contained detailed 
justification for their chosen approach. In case two, the study team had taken advice from 
two palliative care clinician researchers who had experience of carrying out bereavement 
research. One of the researchers had used the same recruitment approach in a previous 
study. In case three, the protocol cited research and guidance that demonstrated the 
importance of including bereaved carers in research and the acceptability of postal 
recruitment methods. They had sought advice from clinicians and experts in ethics, end-of-
life care and bereavement research: 
‘A postal approach to recruitment respects participants' privacy and gives them 
ample freedom to consider taking part in the study. In case they agree, it offers 
opportunity for participants to revisit consent after completing the questionnaire, by 
deciding whether or not to return it. Carers will be contacted NO EARLIER than THREE 
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months following bereavement to minimise any distress and potential harm.’ 
(Protocol, case three) 
The ‘emotional labour’ of explaining palliative care as part of the recruitment process was 
not raised as an issue in case one. This may have been due to the type of intervention or the 
hospice recruitment setting, where the palliative nature of the patient’s condition is openly 
acknowledged.   
 
6.2.4 Preparation for a sensitive conversation 
 
In all three cases, those research nurses who had previous experience of talking to palliative 
care patients and their carers appeared to find having sensitive conversations less 
emotionally demanding than those without similar experience. Research nurse discomfort 
and inexperience manifested itself in nurses declining to work on case three. Clinical 
recruitment centres had to use a core team of research nurses who felt comfortable 
working on the study:  
‘And the nature of the patients, some of our team didn’t like approaching them 
because they weren’t used to that type of patient, that was a problem as well.’ 
(Research nurse two, case three) 
Despite previous palliative care experience, concerns around how to broach conversations 
around death with patients and carers was still raised by some research nurses in cases two 
and three. The assumption that research nurses, by virtue of their role, would have the 
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necessary skills to approach and discuss such sensitive issues with palliative care patients 
and their carers was evident in case three:  
‘The research nurse who is highly trained to talk about sensitive issues will present to 
talk with you.’ If required, she or he will refer you to a colleague who can help you 
more.’  (Patient information sheet, case three) 
In cases two and three, research nurses adopted their own strategies to help prepare for 
and cope with having sensitive discussions with patients and carers. They discussed how 
best to approach these types of conversations within their own research nurse team as well 
as sometimes seeking advice from the palliative care team:  
‘…most of our patients are palliative, so we do have conversations like that with 
them, realistically just when we’re sat chatting to them it comes up obviously, but 
again we have had a chat as a team and I chatted to the palliative care team about 
how it was best for us to talk to patients about it. (Research nurse three, case two)’ 
Clinical shadowing was used as a strategy in case three for a research nurse who had no 
previous palliative care experience. Research nurses across the three cases sought wider 
support from their Principal Investigators and other members of the research team when 
available. The opportunity for ‘more exposure’ (Research nurse three, case three) to 
palliative care studies was seen as a way of increasing confidence when approaching 
patients. Working within a voluntary organisation as a research nurse, where research 
resources are limited, could make coping with the emotional burden of working in palliative 
care research more challenging: 
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‘…working on your own can be quite difficult and I’ve always been part of a research 
team so you know in my last job, we had various different disease sites for cancer, so 
some would cover lung some would cover GI or whatever so you would have your and 
you would do lots of research based on your disease site but you’ve always got those 
colleagues that are working in exactly the same way as you that you can run things 
by or umm you know I’m very, I’m quite isolated really in my job and at times it can 
really upsetting and stressful and challenging and I don’t always feel that I really 
have anyone to share that with.’  (Research nurse one, case one) 
Research nurses adopted a number of strategies to manage the ‘emotional labour’ of 
working on a palliative care trial. Previous palliative care experience helped reduce burden 
but working in the voluntary sector was associated with additional emotional costs.  
 
6.2.5 Managing patient expectations 
 
In cases one and two, nurses explained how they managed patient expectations by 
maintaining clinical equipoise. The majority of recruiting staff reported how patients can 
sometimes be disappointed when they are allocated to the control arm in randomised 
controlled trials and this was especially so in treatment trials or drug symptom control trials. 
Some recruiting staff felt patient disappointment was less of an issue in cases one and two 
because of the nature of the intervention, and in case two, patients would still have access 
to support even in the control arm. Despite the reduced ‘emotional risk’ (Chief Investigator, 
case two), some recruiting staff in case two still felt patients sometimes had preconceived 
ideas about which arm they wanted to be allocated to: 
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‘…sometimes you get patients saying oh but I want that extra care and it’s trying to 
explain to them we can’t guarantee that you will get that, but the only option to 
receive that is through the trial and it’s not something we offer unless you’re in need 
of it clinically and currently.‘ (Research nurse one, case two)  
Nurses spoke about maintaining equipoise by not over promoting the treatment arm and by 
explaining to patients that it is unknown whether the intervention is better or as good as 
standard care. They would sometimes stress to patients that the information they were 
going to provide in the control arm was of equal benefit. This was to cope with the 
‘emotional labour’ of managing patient expectations in a randomised controlled trial: 
’… you’ve just got to tell them, but the information that they’re going to give us, as a 
consequence of this, of doing a standardised arm, is equally of benefit, because it 
gives us a balance. And, so, again, trying to let them know how much of a difference 
their participation will make to us, although, it may not make a lot of difference to 
them, with, in regards to symptom management.’ (Research nurse two, case one).  
In order to deal with the ‘emotional labour’ of operationalising random allocation, nurses 
could have preconceived views about the potential benefits or lack of benefits of the 
intervention. They appeared not always to believe in equipoise even though they spoke 
about trying to maintain it to manage patient expectations:   
‘I think it’s to take that line of equipoise…………. that you know this isn’t black and 
white really, we didn’t know that one arm would be different from the other arm and 
that’s the whole reason for the trial, but letting them see that they wouldn’t be 




Most of the research nurses in case two, spoke about how some patients were interested in 
the study as it provided regular research nurse support even in the control arm. The idea 
that patients would get some direct benefit from being involved in the trial appeared 
important for the research nurses. The nurses seemed to find their support role satisfying 
and appeared to move beyond their recruitment role to become part of the intervention 
team: 
‘...they felt that they had an extra set of eyes on them…..regardless of whether they 
got the (name of intervention) arm or not, they knew that they had a research nurse 
who was essentially keeping an eye on them, and I would have, obviously ‘cos they 
have regular visits with me and telephone calls with me, and they also utilise me as a 
resource as well.’ (Research nurse two, case two) 
One of the research nurses, however, expressed how carrying out this support role could 
become more emotionally demanding as the patient’s disease progressed and their 
condition deteriorated. Operationalising randomisation procedures, including managing 
patient expectations, involves ‘emotional labour’ for recruiting staff with staff not always 
believing in clinical equipoise even though they speak about trying to maintain it.  
 
6.2.6 Summary of emotional labour 
 
In summary, in all three cases recruiting staff had to manage the ‘emotional labour’ of 
approaching palliative care patients and carers at difficult time in the patient’s illness 
trajectory with only a short window of opportunity for recruitment. The patient’s unstable 
and fluctuating condition, alongside managing patient expectations and wider resource 
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issues, contributed to the ‘emotional labour’ of recruitment particularly for research nurses. 
They used various strategies to manage the ‘emotional labour’ of recruitment with previous 
clinical contact and palliative care experience helping to reduce recruitment burden. 
 
6.3 The influence of ‘paternalism’ on recruitment to randomised controlled trials in 
palliative care. 
 
The term paternalism refers to; ‘the intentional overriding of one person’s preferences or 
actions by another person, where the person who overrides justifies this action by appeal to 
the goal of benefitting or of preventing or mitigating harm to the person whose preferences 
or actions are overridden’ (Beauchamp & Childress, 2013) (p.215). In all three cases, there 
was evidence that paternalism could override patient autonomy in the trial recruitment 
process with health care professionals, including recruiting staff, demonstrating paternalistic 
gatekeeping behaviours. This was despite some of the recruiting staff verbally 
acknowledging the importance of involving palliative care patients in research. Carers could 
also demonstrate paternalistic behaviours because of their perception of the ‘Price’ or ‘cost’ 
to the patient of taking part in the trial.  
 
6.3 1 Health care professional gatekeeping  
 
As discussed in the previous chapter, health care professional gatekeeping was a barrier to 
recruitment in all three cases. Paternalistic gatekeeping practices manifested themselves in 
a variety of ways. In all three cases, health care professionals acted in a paternalistic way by 
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applying their own unofficial eligibility criteria during the screening process. In case three, 
one of the Chief Investigators expressed that the reasons why clinicians included or did not 
include patients in the trial could be hidden. The paternalistic criteria applied by health care 
professionals included: staff deciding patients did not want to be bothered or had too much 
going on to take part in the trial (case one), the patient’s suitability for a treatment trial, the 
perception that the patient was struggling with their diagnosis or even a patient’s 
personality (case two): 
‘…and when we look into it they might meet all the eligibility criteria, and none of the 
exclusion criteria but there’s another issue that would mean actually recruitment 
wouldn’t be great for this particular patient…..It could be their how can I put it, their 
personality, could we you know would they be able to comply with the requirements 
of the study.’ (Research nurse two, case two) 
In case two, some recruiting staff acted in a paternalistic way by making a conscious 
decision to withhold information from patients about all the trials they were eligible for. 
They believed they were acting in the patient’s best interest by protecting them from having 
to read multiple patient information sheets and having to make difficult choices about their 
current plan of care:  
‘…we had to edit what we presented to people, if there were three different things, if 
you present a randomised controlled trial of two different drugs against radiotherapy 
or no radiotherapy, against (name of case), when they could only do one of them, 
was just unfair. So we very much, there were a number of people with (name of 
diagnosis) we did not mention this to.’  (Doctor, case two)  
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Treatment trials were seen as having the potential to ‘actually benefit (the patient) clinically’ 
(Research nurse three, case two) so were prioritised by the health care team. Assumptions 
were made that patients would not want to consider a palliative care trial when they had 
been offered chemotherapy or radiotherapy treatment for their underlying disease. This 
was not always the case as the specialist nurses explained how they discussed the palliative 
care trial with patients alongside the treatment trials that were available:  
‘…so I do raise them all and we talk about referral to other centres for second 
opinions and things like that, so I keep it as open as I can.’ (Specialist nurse two, case 
two) 
One of the specialist nurses did acknowledge, however, that treatment trials were discussed 
first with patients so illustrating the priority given to treatment trials in health care. Across 
all three cases, health care professional paternalism was evident with a variety of 
gatekeeping strategies and behaviours used by clinicians during the recruitment process.  
 
6.3.2 Carer gatekeeping 
 
The carer’s perception of the ‘Price’ or ‘cost’ of the patient participating in the trial also led 
them to demonstrate paternalistic gatekeeping behaviours. The extent to which research 
nurses felt carer gatekeeping impacted on recruitment appeared to vary among the three 
cases. Research nurses spoke about approaching patients and carers together. Carers 
preventing access to patients did not appear to be an issue in cases one and two but 
families could sometimes express their concerns about unnecessary burden when the 
research nurses were providing information about the study. In case three, the patients 
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unstable condition meant the research nurses sometimes needed to introduce themselves 
to the carer before or at the same time as speaking to the patient. Families could sometimes 
be aware of the patient’s clinical condition but not the patient themselves. One of the 
research nurses was fearful of approaching patients with the family present in the room, as 
she was worried about how they would react, including concerns they may make a 
complaint. Families could became annoyed and it could be a dilemma for research nurses 
balancing the right to approach a patient with capacity to discuss taking part in research 
with managing the carer’s distress: 
‘I literally couldn’t even tell them who I was and what I was doing or finish the 
sentence before they were like now’s not the time, how dare you? Well it’s just we do 
have to ask at such a difficult time because of the timing of the research, I appreciate 
it’s difficult but the timing is necessary. But it’s not appropriate, they just weren’t 
listening.’ (Research nurse one, case three) 
Carers, like health care professionals, could also demonstrate paternalistic gatekeeping 
behaviours during the recruitment process and this was particularly an issue in case three 
where the patients were at risk of dying.  
 
6.4 The influence of ‘professional hierarchies and power relationships between 
clinicians’ on recruitment practices. 
 
Professional hierarchies and power relationships between clinicians influenced recruitment 
practices in a number of ways. These hierarchies and relationships influenced the 
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recruitment of clinical recruitment centres, trial participants and the research champion 
within the clinical recruitment centres. 
6.4.1 Recruiting clinical recruitment centres 
 
In case two, the Chief Investigator, a senior doctor, used his professional medical contacts to 
identify and recruit potential clinical recruitment centres for the trial: 
‘…then you had centres that were just part of a national network of you know 
investigators knowing each other and doing each other’s trials for them, so that was 
important.’ (Chief Investigator, case two) 
In case one, the Chief Investigator was also a senior doctor who was proactive and 
networked with medical colleagues to promote his organisation as a potential clinical 
recruitment centre. In contrast in case three, the Chief Investigator, who was an academic, 
spoke about needing to build up relationships with clinicians. Access needed to be 
negotiated into potential clinical recruitment centres and this could take a long time: 
‘…in between hearing about whether my expression of interest had been shortlisted, I 
started making contacts with the different studies because I knew that bit would take 
some time, so several months and visiting the different sites and building 
relationships and trust with them in terms of telling them that this was a really 
important salient area of health services research and telling them that we were the 
right crew of people who could do the work on time and safely. So it was really just a 
question of convincing them and just negotiating with them and building levels of 
rapport which I think were really really critical. It’s not just a question of parachuting 
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into a site, there’s so much ground work that needs to take place beforehand.’ (Chief 
Investigator one, case three) 
Chief Investigators who were also senior doctors used their professional medical contacts to 
identify and recruit clinical recruitment centres. The Chief Investigator from an academic 
background needed to negotiate access into the clinical recruitment centres by building up 
relationships with clinicians.  
 
6.4.2 Confirming eligibility    
 
Across the three cases, recruitment roles and responsibilities were determined by 
professional role. Medical staff who had overall clinical responsibility within the trial as well 
as overall clinical responsibility outside the trial had the greatest influence over whether 
patients were or were not recruited to the trial. 
All health care professionals involved in the patient’s care were permitted to identify 
potentially eligible participants. In cases one and three, this included staff who were not 
directly involved in the recruitment process such as inpatient nurses or doctors. In these 
two cases, research nurses disagreed over how helpful inpatient nurses were at giving them 
‘the heads up’ (Research nurse three, case three) that a patient may be eligible. The research 




‘…I don’t think they really got it, if I’m honest, I mean I think a couple of them did 
eventually and sort of got to know what we were looking for, but they certainly never 
really referred patients onto us...’ (Research nurse two, case three) 
Confirmation of trial eligibility was always the responsibility of the lead medical clinician for 
the patient as they held overall ownership of the patient’s care within the clinical 
recruitment centres. Medical confirmation that the patient was a palliative or end-of-life 
care patient was required. Trial recruitment procedures outlined in the study protocols and 
discussed by study coordinating and recruiting staff, reflected this need to seek permission 
from the lead medical clinician before approaching an eligible patient about a trial:  
 ‘So in several of the sites, the PI was there and was very easy to access and could 
answer questions about the study and was there as the source of information that 
the research nurses and other clinicians could call on and would be there to help 
them in negotiating what patients to include or not to include in relation to whether 
somebody could go up and introduce the study to them or not.’ (Chief Investigator 
one, case three) 
Research nurses used formal multi-disciplinary team meetings within their organisations to 
identify eligible patients and to seek medical confirmation of eligibility. Multi-disciplinary 
meetings could be used as a forum for medical staff to decide who the nursing staff could 
and could not approach about a palliative care trial. This appeared to be the case even for 
senior nurses whose role was to provide specialist care to patients:  
 ‘So if they were somebody that was likely to be fit enough for a chemotherapy trial, 
then we would get them to see the medical oncologist and the nurse specialist would 
not talk to them about (name of trial). If they were suitable for the radiotherapy trial, 
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the same applied with the radiotherapy, if we felt that they were not really suitable 
for either then we would then get the nurse specialist to discuss with them and then 
the nurse specialist would then try and see them at the time they got their diagnosis 
from the (name of speciality) consultant and give them the information at that point.’ 
(Doctor, case two)  
Obtaining medical confirmation of eligibility via the multidisciplinary team meeting 
appeared to be more problematic in case three for a number of reasons. Some medical staff 
appeared reticent and fearful of making the decision that the patient may die under their 
hospital care and how it could be difficult for recruiting staff to ‘get past people’s inherent 
optimism’ (Doctor, case three). Dealing with medical staff reticence to admit that the 
patient may be at risk of dying could be difficult for recruiting staff especially when their 
own clinical view was the patient was eligible:  
 ‘…the patients that we thought were eligible, the medics didn’t have the same view 
for a lot of them……they don’t go on the negative side very much, they’re all very 
positive the medics, so it was a little bit against the grain, to say well this could all 
happen but so could this, so it was actually quite difficult to get them on board...’ 
(Research nurse two, case three) 
Confirming the patient was eligible for the trial meant the medical staff had to have a 
difficult conversation with the patient and family about the patient’s clinical condition. This 
could be challenging for medical staff as they may not have met the patient before 
admission and as a result may have had a limited understanding of what the patient 
understood about their illness:  
227 
 
‘In the intervention sites, the ward staff received you know training, they had a 
clinical educator who worked with them for several months, so it’s been much easier 
for them and they’ve got because they had the education they felt much more 
comfortable speaking with the patients and relatives after a while...’ (Researcher, 
case three) 
In order to feel more comfortable about approaching patients, research nurses wanted to 
make sure the medical staff had spoken to the patient about their unstable condition before 
they made their approach, once again reflecting the influence of hierarchy and power 
relationships amongst clinicians: 
‘…we made a conscious decision that we would not approach any patient without the 
consultants talking to them first. So that’s why we had the agreement that the 
consultants would well obviously clinically they’ve got the say on whether the 
patients were eligible but for them to have the conversations first before the research 
team went in.’ (Research nurse three, case three) 
Conversations between medical staff and patients and families could be poorly documented 
which could make it difficult for research nurses to find out what had been discussed. In all 
three cases, research nurses checked the medical notes to confirm trial eligibility but 
obtaining written medical confirmation that a patient was eligible for the trial appeared 
particularly challenging for the research nurses in case three. They needed to find evidence 
that discussions had taken place with the patient and/or family regarding the patient’s 
unstable condition. Seeking out confirmation of eligibility could be a time consuming 
process for research nurses as they often had to ‘play detective’ (Research Nurse one, case 
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three), by finding out information in various ways. In one site, they devised a study criteria 
proforma to place on the patient’s medical notes to try and address this recruitment barrier:  
 ‘And then if we thought we found a patient that was eligible, we would put that on 
the medical notes or give it to the consultant if they were on the ward and get them 
to just fill it in and just sign the bottom, and then we took that that the patient yes 
was eligible and we could approach them. And that worked a little bit better, but it 
improved it but not vastly. But we did try.’ (Research nurse two, case three) 
Research nurses appeared to need to see written confirmation from medical staff that it 
was safe for them to approach the patient about a palliative care trial. This was because of 
the sensitive nature of the information they needed to present and the risk patients and 
families may not have remembered what had been discussed or be in denial about what 
they had been told. Similar concerns were raised by a palliative medicine doctor:    
‘…we couldn’t go to people who didn’t know, weren’t aware obviously that would 
come as a shock, perhaps they had been told but then forgotten, or that we were 
concerned that if they read that they you know they might not have realised, you 
really have to have an in-depth knowledge of how much the patient knew about their 
risk of dying during the admission, which isn’t often, it’s not somewhere you can find 
from the notes, and often something the doctors who are looking after them might 
not know about how much they’ve understood particularly. ‘Cos ideally with this 
study you probably want to get people as soon as they arrive on the ward...’ (Doctor, 
case three) 
Despite medical staff having to confirm trial eligibility, research nurses also had the power 
to influence whether or not a potential participant was recruited to the trial. Research 
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nurses felt they were ‘the patient’s advocate’ (Research nurse three, case two) and their 
role was to act in the patient’s best interest. They would sometimes disagree with a medical 
colleague’s suggestion that a patient was eligible for a trial. Research nurses would also 
have the power to decide on when was the most appropriate time for them to introduce the 
trial to a potential participant: 
‘…one of the consultants used to come out and go oh you can go in now, I’ve just 
literally come out, I’ve just explained it to them, I’ve literally just come out the room 
and I’m like I’m not going to go in now when you’ve just told somebody that they 
might be getting better, they might not be getting better, I’m not going to go in there 
two seconds later. You know I would leave an appropriate amount of time, and also 
relatives would be crying, they’d be very upset and so I had to leave an adequate 
amount of time for that. (Research nurse one, case three) 
Reflecting the influence of professional hierarchies and power relationships amongst 
clinicians, medical staff were required to confirm trial eligibility but research nurses 
ultimately had the power to decide whether or not a patient was recruited to the trial.  
 
6.4.3 Research Champion  
 
As discussed in chapter two, a research champion assists with access to potential 
participants and helps promote the study among patients and other health care 
professionals. The requirement for the lead medical clinician to confirm trial eligibility 
influenced who was the most appropriate professional to act as the ‘research champion’ for 
the trial. In case three, study coordinating centre and recruiting staff felt choosing a 
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Principal Investigator who was a lead clinician rather than a consulting physician or nurse 
was a more useful strategy. The Principal Investigator only being available in the clinical 
recruitment centre intermittently and not having overall responsibility for the patient’s care 
meant the nurses still needed to seek medical confirmation of eligibility from the lead 
clinician. In practice, who took on the role of Principal Investigator was often a practical 
decision and based on their enthusiasm for the topic of the research: 
‘…I mean to some extent it was practical and also to some extent based on the 
enthusiasm of the people I approached, ……in one hospital, the palliative care 
physician that I originally approached said I don’t think it’s a good idea that I am the 
PI on this study because I would like it to be owned by the general medical consultant 
who looks after that ward, you know there’s not a conflict of interest but if it’s owned 
by that consultant, the intervention should we be a site might work better. You know 
they will understand the purpose of the intervention and they will be signed up to it 
and it will have a greater chance of working, whereas it seems that the palliative care 
team are coming in to make that study work, the enthusiasm for it may, well people 
might be less signed up and less enthusiastic.’ (Chief Investigator one, case three) 
In case two, the specialist nurses role in supporting the lead clinician to identify and 
approach eligible patients about the trial was formalised in the trial protocol. One of the 
specialist nurses took on the role of Principal Investigator in a successfully recruiting site. 
Following disclosure of the patient’s diagnosis, medical staff would delegate the 
management of the patient and carer’s emotional fallout to the specialist nurses. Specialist 
nurses would spend time alone with patients and carers away from the medical consulting 
room. They would provide support and information and they had the power and were 
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responsible for making the decision about whether and when to introduce the trial to 
patients: 
‘…the MDT team makes a decision, the news is broken to the patient, and then 
ordinarily there’s like a small break out room where the patients can you know deal 
with…their emotions, and then the specialist nurses had a choice basically between 
either whether the patients were receptive at that stage to learn about the trial...’ 
(Chief Investigator, case two) 
The specialist nurses appeared to accept and value this aspect of their professional role. 
They felt they were experts in the care of patients in their specialist field and viewed 
research as an important part of their nursing role. They accepted that medical staff could 
be busy and had limited time to recruit patients to trials: 
‘…nurses actually have quite a big role in recruiting into clinical trials, it’s very often 
us that are left to fill in the details of trials, consultations with doctors can be quite 
difficult and a bit time pressured if you like, and what we certainly find is that often 
the nurses would take the patient, ‘cos we’ve got more time to sit and talk about 
things and over all the years I have found that it you become quite involved in 
recruitment, or at least in giving information to people about the trials and 
treatments that are available to them, and answering questions to help them decide 
which is the right way for them to go.’ (Specialist nurse two, case two) 
One of the specialist nurses, being a Principal Investigator, was keen for the study to be a 
success. In cases two and three, the research nurses expressed that they valued the support 
of the specialist nurses during the recruitment process. They valued the time the specialist 
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nurses spent talking to patients and carers about their illness as it freed them up to focus on 
the more practical aspects of the recruitment process:   
 ‘…so they do a lot of the work..with the (name of diagnosis) patients.., so that takes 
a lot of the burden off me if that helps, so I’m just there for the nitty gritty, because 
they’re there..to, I’m there to reassure them as well but that’s a big part of their role 
as well.’ (Research nurse four, case two) 
Across the three cases, permission to approach potential participants about the palliative 
care trial was granted by the lead medical clinician in the clinical recruitment centres. This is 
why in case three, the lead medical clinician was best placed to take on the role of Principal 
Investigator rather than a consulting clinician. In case two, the Principal Investigator role 
was also carried out successfully by a specialist nurse. This reflects the role specialist nurses 
have within the medically led multi-disciplinary team. They are responsible for managing the 
patient and carer’s emotional and information needs during and after a diagnosis of 
advanced disease.   
How clinical recruitment centres are recruited, how trial eligibility is confirmed and who 
should take on the ‘research champion’ role in a palliative care trial is influenced by the 
professional hierarchies and power relationships that exist between clinicians. Figure 2 
below illustrates the new palliative care trial recruitment framework proposed that reflects 
the study findings. An adapted ‘Social Marketing Mix Framework’ that incorporates the 
wider overarching contextual issues of ‘emotional labour’, ‘professional hierarchies and 










As in the previous chapter, similar issues were identified across the three cases despite the 
trials having different characteristics. In this chapter, the theory of ‘emotional labour’ was 
used to present the study findings along with the concepts of ‘paternalism’ and 
‘professional hierarchies and power relationships between clinicians’. These three concepts 
are interlinked and they provide a useful theoretical lens to help understand recruitment 
behaviours in the context of a palliative care trial (Collins & Stockton, 2018; Ritchie & Lewis, 
2003). The ‘emotional labour’ of recruiting patients and carers to palliative care trials leads 
health care professionals to demonstrate paternalistic behaviours during the recruitment 
process. Professional hierarchies and power relationships between clinicians facilitate and 
support these paternalistic recruitment practices. They also influence how ‘emotional 
labour’ is experienced by different professional groups. The concept of paternalism can also 
influence how carers respond to the patient taking part in the trial. The overall findings of 
this study suggest that the ‘6 Ps’ of the ‘Social Marketing Mix Framework’ provide a useful 
and practical guide to inform trial recruitment planning and implementation processes but 
the wider contextual issues of ‘emotional labour’, ‘paternalism’ and ‘professional 
hierarchies and power relationships between clinicians’ need to be incorporated into the 
framework. The study findings are now explored and discussed in the context of the wider 





Chapter seven: Discussion  
7.1 Introduction 
 
In this chapter, how the study findings contribute to the knowledge base in palliative care 
are discussed. The revised theoretical propositions that reflect the study findings and the 
wider literature are then outlined. This is followed by the recommendations for clinical 
practice, policy and future research and the strengths and limitations of this case study.  
 
7.2 How the study findings contribute to the knowledge base in palliative care. 
 
The cross-case analysis suggests that the ‘Social Marketing Mix Framework’ concepts of; 
identifying participants; product (including product definition and competition); price 
(including type and minimisation); place; promoting the study; working with partners 
(including barriers to partnering, partner referrals and recruitment and partner education), 
are relevant in the context of palliative care trial recruitment. The findings also indicate, 
however, that wider contextual issues also need to mapped and incorporated into the 
‘Social Marketing Mix Framework’ to make it more relevant for the palliative care setting. In 
this cross-case analysis, health care professionals experienced ‘emotional labour’ when they 
were ‘promoting’ and recruiting to a palliative care trial which lead to paternalistic 
recruitment practices. The study findings highlight how carers can feel the ‘Price’ of the 
patients or their own involvement in a palliative care trial which can also lead to 
paternalism. The ‘professional hierarchies and power relationships’ that existed between 
clinicians influenced how ‘emotional labour’ was experienced by medical and nursing staff in 
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this case study. Professional hierarchies and power relationships between clinicians also 
facilitated and supported paternalistic recruitment practices. 
 
7.2.1 Key study findings discussed in this chapter 
 
An overview of how the theory of ‘emotional labour’ influences the ‘6Ps’ of the ‘Social 
Marketing Mix Framework’ in the context of palliative care trial recruitment is initially 
presented. The key study findings discussed in depth are; the ‘emotional labour’ of 
‘Promoting’ a palliative care trial as a ‘Product’; how ‘emotional labour’ and ‘professional 
hierarchies and power relationships between clinicians’ influence ‘Identifying participants’ 
and ‘Working with Partners’ (partner referrals and recruitment); how the ‘emotional labour’ 
of ‘Promoting’ a palliative care trial as a ‘Product’ can lead to paternalism and finally the 
role of ‘Working with Partners (Partner education) to address ‘emotional labour’ and health 
care professional paternalism in the context of palliative care trial recruitment.  
These key study findings are considered in relation to the existing literature on trial 
recruitment within palliative care (Ritchie & Lewis, 2003). Aspects of this study that 
reinforce what is already known about palliative care trial recruitment are discussed, as well 
as new areas of knowledge that have been identified. The trial recruitment literature 
outside palliative care is also used to explore the study findings, as the majority of what is 
currently known about palliative care trial recruitment is largely anecdotal, as highlighted in 
chapter two. There is a dearth of literature on communication issues in the context of 
palliative care trial recruitment so research that looks at communication issues in the wider 
palliative care literature has been consulted. 
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7.3 An overview of how the theory of ‘emotional labour’ influences the ‘6Ps’ of the 
‘Social Marketing Mix Framework’ in the context of palliative care trial 
recruitment.  
 
The findings of this study, like those of the literature review in chapter two, illustrated the 
importance of considering and minimising the ‘Price’ of taking part in the trial for patients 
and carers by ‘minimising the cost’ of consent and data collection processes. This study also 
found that there is an emotional ‘Price’ for health care professionals when recruiting to a 
palliative care randomised controlled trial that is not fully explained by the ‘Social Marketing 
Mix Framework’ or the palliative care trial literature. The theory of ‘emotional labour’ 
appears to provide a useful explanation for why clinicians adopt certain behaviours during 
the recruitment process. As discussed in chapter six, the term ‘emotional labour’ was first 
introduced by Hochschild (2012) but her work has been extended to focus on the work of 
health care professionals (Huynh et al., 2008; Kerasidou & Horn, 2016), particularly the 
caring role of nurses  (Huynh et al., 2008; James, 1993; Smith, 2012; Theodosius, 2008).  The 
‘emotional labour’ of caring for dying patients and their families has been viewed as 
particularly demanding (James, 1993; Smith, 2012) with death and dying in hospital being 
seen as ‘the ultimate emotional labour’ (Smith, 2012) (p.132).  
Palliative care is carried out in an emotion laden context (Ferrer et al., 2016) with clinicians 
often having to deal with appropriate but powerful emotions from palliative care patients 
and their carers such as denial, anger, frustration and loss. These contextual factors can also 
be an issue in trial recruitment, as illustrated in the study findings. In clinical practice, there 
is an expectation that nurses will manage the emotional fall out from difficult encounters 
(James, 1993). Nurses are seen to be able to manage and cope with extremes of feeling 
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(Smith, 2012) with them often being ‘portrayed as the keepers and carers of emotional 
needs’ (Theodosius, 2008) (p.30-31). In many Western Countries, the idea of a technically 
skilled, rational doctor who remains detached from their own as well as their patient’s 
emotions is favoured (Kerasidou & Horn, 2016) with medical staff learning how they are 
expected to behave from their peers and their medical training (Baker, 1996). Feeling rules, 
a key concept within ‘emotional labour’, refers to the power of social conventions to dictate 
emotion (Hochschild, 2012). Feeling rules can consciously or unconsciously influence what 
emotions we should express in a particular situation even if this is different to how we really 
feel. Feeling rules dictate that nurses are emotionally caring and there is a belief that nurses 
have more time than doctors to sit and talk with patients and carers to address their 
psychosocial needs (Chattoo & Atkin, 2009; Hibbert et al., 2003). Nurses are also seen to be 
able to educate and communicate with families on a more personal, individualised level 
(Anderson et al., 2019; Hibbert et al., 2003).  
Carrying out ‘emotional labour’ can be a positive experience for nurses as they can 
experience a sense of personal and professional accomplishment. It can lead to an increased 
sense of connection between the nurse and the patient and greater job satisfaction (Huynh 
et al., 2008). These positive aspects of ‘emotional labour’ were seen in the study findings 
but some research nurses did not always feel comfortable recruiting patients and carers to a 
palliative care trial. Trial study coordinating centre staff assumed research nurses would 
have the necessary skills to carry out the ‘emotional labour’ of recruiting to a palliative care 
trial because of their professional role. The literature suggests, as in this case study, that 
‘emotional labour’ is influenced by work experiences and is more likely to be performed by 
experienced nurses (Brown et al., 2019; Huynh et al., 2008). Carrying out ‘emotional labour’ 
can also be more challenging when working in a busy clinical environment (Smith, 2012) and 
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the importance of having adequate and sufficient organisational and staffing resources to 
mitigate recruitment burden has been highlighted in the general (Skea et al., 2017) and 
palliative care trial literature (Serfaty et al., 2019). 
The ‘emotional labour’ of trial recruitment for clinicians is not new with a number of issues 
being previously cited in the general and palliative care trial literature. These include, as 
discussed in chapter two, struggling to maintain clinical equipoise (Donovan et al., 2014; 
Fletcher et al., 2012; Holm et al., 2017) and clinician’s applying their own suitability rather 
than eligibility criteria (Brown et al., 2019; Donovan  et al., 2014; Froggatt et al., 2020). 
Clinicians can worry about overburdening and overwhelming participants with information 
at a difficult time (Brown et al., 2019; Valerie et al., 2011). Research nurses can worry about 
bothering patients and struggle with balancing their recruiting role with their perceived role 
as patient advocate (Boxall et al., 2016; Donovan  et al., 2014; Larkin et al., 2019; Tomlin et 
al., 2014). Research nurse decisions can reflect their own views and prejudices and are seen 
to have a detrimental influence on trial recruitment (Tomlin et al., 2014). Research nurses 
can lack confidence when working on trials outside of their specialty (Valerie et al., 2011). 
Research nurses have to work around and build relationships with staff gatekeepers and 
they can feel isolated in their role (Hernon et al., 2020; Spilsbury et al., 2008). They manage 
‘emotional labour’, as in this case study, by accessing support from their research nurse 
colleagues or by developing relationships with specialist nurses (Spilsbury et al., 2008). 
Emotional challenges previously reported in the general trial literature were less 
burdensome issues for clinicians in this study. These include feeling under pressure to meet 
recruitment targets (Hernon et al., 2020; Lawton et al., 2015; Valerie et al., 2011) and 
managing patient disappointment and anger following treatment allocation (Lawton et al., 
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2015). The reasons for these differences are discussed in the previous two chapters. In this 
case study, clinician’s experienced an additional type of ‘emotional labour’ during the 
recruitment process that was related to ‘Promoting’ the palliative care trial to patients and 
carers.  
 
7.4 The ‘emotional labour’ of ‘Promoting’ a palliative care trial as a ‘Product’ to 
patients and carers. 
 
Promoting a trial by using predefined key and careful messaging is recommended under the 
‘Social Marketing Mix Framework’. Patients and carers often associate palliative care with 
death and dying (McIlfatrick et al., 2014; Sarradon-Eck et al., 2019), an issue also reported in 
this study. In the participant information sheets, there was evidence that consideration had 
been given by the study coordinating centres to how the concepts of palliative and end-of- 
life care were to be presented to patients and carers. The ‘emotional labour’ of introducing 
and explaining these terms to patients and carers for health care professionals had been 
given less consideration.  
Outside research, clinicians can find having conversations around deterioration and end-of-
life care challenging and stressful, so it is unsurprising this was also the case in a trial 
recruitment context. Doctors can feel ill prepared for end-of-life communication and they 
can be fearful of destroying a patient’s hope (Buiting et al., 2011; Hancock et al., 2007). 
Concerns about the lack of adequate palliative and end-of-life care training for medical and 
nursing undergraduates continue to be raised (Martins Pereira et al., 2020; Wells et al., 
2020). Clinicians often wait for patients or families to initiate end-of-life conversations 
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rather than actively broaching the topic themselves (Almack et al., 2012; Flierman et al., 
2019), and they can struggle to introduce and explain the concept of palliative care 
(Sarradon-Eck et al., 2019). Patients assume that health care professionals will initiate end-
of-life type conversations (Almack et al., 2012) because they may find it difficult to raise 
themselves (Momen et al., 2012). These contextual issues are problematic in the 
recruitment context as an ‘active’ rather than a ‘passive’ communication stance is required 
when introducing a palliative care trial (Pfeil et al., 2015). This is especially so when under 
pressure to recruit patients and carers within a ‘short window of opportunity’ and similar 
issues have been reported in emergency medicine (Brown et al., 2019) and stroke trials 
(Boxall et al., 2016). 
The ‘emotional labour’ of trying to find out what the patient and carer had been told about 
their condition before approaching them about the trial could be challenging for recruiting 
staff. Similar experiences have been reported in the general palliative care literature with 
patient deterioration not always being communicated to the patient and family and when 
this does occur this can be poorly or inconsistently documented (Bloomer, Botti, et al., 
2018). This issue was illustrated in a recent palliative care trial, where patients and carers 
were not always fully aware of the patient’s condition or the palliative focus of their care 
(Holm et al., 2017). 
Research and specialist nurses attempted to assess the patient’s understanding of their 
condition and their readiness to engage in a palliative care trial conversation. When to 
initiate or continue these discussions, as in clinical practice, was often guided by the nurses 
intuition or clues from the patient (Almack et al., 2012). The need to practice compassionate 
‘conditional candour’ (Abdul-Razzak et al., 2014) appeared important during the 
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recruitment process, which involves evaluating the patient’s readiness, inviting them to take 
part in the conversation and then being attentive to contextual factors such as appropriate 
timing and sensitive language (Zwakman et al., 2020). 
Tailoring information according to the individual patient and carer’s level of understanding 
and readiness is viewed as paramount in end-of-life communication (Etkind et al., 2017; 
Hancock et al., 2007; Parker et al., 2007; Silverman et al., 2017). This can be challenging for 
recruiting staff who need to go through a standardised participant information sheet as part 
of the informed consent procedure. Having the opportunity to build up a rapport with 
patients and carers through previous clinical contact can reduce the ‘emotional labour’ of 
having difficult conversations (Almack et al., 2012). As discussed in chapter one, how trials 
can become part of routine care and best utilise current clinical care pathways was 
identified as the number one question in the PRioRiTy study (Healy et al., 2018). Integrating 
research into routine health care was also a recommendation identified in the MORECare 
palliative care research methods project (Gysels et al., 2013).   
In the palliative care literature, there are differing reports of how open and willing patients 
are to discussing end-of-life care issues. Patients have been reported to be reticent and 
reluctant (Almack et al., 2012; Momen et al., 2012) while other studies have found the 
majority are willing to engage in end-of-life care conversations (Emanuel et al., 2004; Piers 
et al., 2013). Patients can be in denial about the seriousness of their illness or not feel ready 
or able at that particular time to discuss the topic openly (Abdul-Razzak et al., 2014; Almack 
et al., 2012; Zwakman et al., 2020) which can influence the ‘emotional labour’ of promoting 
a trial for clinicians.  
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Glaser and Strauss (1965), in their seminal study of dying in hospital, identified a number of 
awareness contexts that have implications for the process of trial recruitment in palliative 
care. ‘Open awareness’ is where doctors, nurses, patients and family members openly 
acknowledge that the patient’s illness will lead to their death while ‘closed awareness’ is 
when family and clinicians are aware but not the patient  (Glaser & Strauss, 1965; Small & 
Gott, 2012). They also described two intermediate stages; ‘suspected awareness’ and 
‘mutual pretence’. ‘Suspected awareness’ is when a patient suspects they are dying and 
they have attempted to get clinical staff and family to confirm this while ‘mutual pretence’ 
is when everyone knows the patient is dying but it is not openly acknowledged (Field & 
Copp, 1999; Glaser & Strauss, 1965). This suggests that recruiting patients to a palliative 
care trial in a non ‘open awareness’ context can be challenging for recruiting staff and can 
facilitate clinician and carer gatekeeping. 
More recently, ‘open awareness’ has been seen to be a fluid rather than a fixed state (Field 
& Copp, 1999) with even patients who are receiving care in an ‘open awareness context’ 
such as a hospice fluctuating between denial and acceptance as a coping strategy (Copp & 
Field, 2002). The way in which patient and families emotionally cope with a terminal 
diagnosis is believed to define the ‘awareness context’ and is related to their wish to retain 
hope (Timmermans, 1994). Fluctuating levels of patient and carer awareness can make it 
challenging for recruiting staff to ‘promote’ a palliative care trial even in an ‘open 
awareness’ context. Respecting patient and carer ‘awareness’ preferences is important 
(Small & Gott, 2012), including during the trial recruitment process, but this must not be 
used by clinicians as a reason to avoid difficult conversations (Field & Copp, 1999). This 
includes a conversation that involves ‘Promoting’ a palliative care trial.  
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7.5 How ‘Identifying participants’ and ‘Working with Partners (partner referrals and 
recruitment) is influenced by the theory of ‘emotional labour’ and ‘professional 
hierarchies and power relationships between clinicians’.  
 
In health care, there is a ‘division of emotional labour’ with senior doctors being viewed as 
being largely responsible for disclosing ‘life affecting information’ (James, 1993) (p.100). This 
‘division of emotional labour’ is also present in the context of palliative care trial 
recruitment. In the general palliative care literature, doctors are seen to be responsible, by 
other professionals (Anderson et al., 2019; Bloomer, Botti, et al., 2018) and families 
(Anderson et al., 2019), for discussing prognosis and making treatment decisions. The 
importance of using medically led multi-disciplinary team meetings to identify eligible 
patients has also been reported in the general trial literature (Donovan  et al., 2014; Strong 
et al., 2016). James (1993) argues that until the bad news is formally acknowledged by the 
senior doctor responsible for the patient’s care, the ‘emotional labour’ of other 
professionals, patients and carers is ‘carried out in secret or semi-secret’ (p.100). The 
‘emotional labour’ of working in a ‘closed awareness’ context for nurses has been reported 
in the general palliative care literature (Testoni et al., 2020).  
The definition and scope of the specialist nurse role can vary internationally (Begley et al., 
2013) but they have been identified as core members of the multi-disciplinary team in the 
context of cancer and non-cancer care both in the UK (Cox et al., 2017; Wallace et al., 2019) 
and internationally (Fleure & Sara, 2020; Liljeroos & Strömberg, 2019). Specialist nurses can 
take on an advocacy role in the multi-disciplinary team by spending time with patients and 
carers and by taking the lead on communication issues (Wallace et al., 2019). They can 
support medical staff by breaking bad news and by discussing potential treatment options 
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with patients and carers (Fleure & Sara, 2020). There are reports, however, of medical staff 
dominating decision making within multi-disciplinary team meetings (Rowlands & Callen, 
2013). There is the potential to harness the specialist nurse role within the multi-disciplinary 
team to facilitate recruitment to palliative care trials while acknowledging the impact of 
professional hierarchies and power relationships between clinicians on decision-making. 
Country specific factors related to the remit of the specialist nurse’s role and the type of 
training they have received also need to be recognised. 
Palliative care as a field of health care involves high stake decision making (Ferrer et al., 
2016) and the ‘emotional labour’ of predicting a patient’s prognosis has been identified as a 
reason for doctors avoiding prognosis and end-of-life care discussions (Flierman et al., 2019; 
Hancock et al., 2007). Glaser and Strauss (1965) identified four trajectories of dying in the 
hospital setting; certain death/known time; certain death/unknown time; uncertain death 
but a known time when uncertainty will be resolved; uncertain death and uncertain time 
when uncertainty will be resolved (Glaser & Strauss, 1965; Small & Gott, 2012). The first two 
refer to a situation where it has been recognised that there is ‘nothing more to do’ for the 
patient and whether or not the time of death can be predicted (Glaser & Strauss, 1965) (p. 
235). The third category refers to a patient receiving intensive or emergency care and the 
later when someone is seriously ill and the outcome is unclear. Glaser and Strauss (1965) 
describe how patients can vacillate between certainty and uncertainty or be seen to linger. 
Where a predictable dying trajectory is too difficult to identify, this results in the doctor’s 
reluctance to communicate the terminal nature of the illness to the patient so perpetuating 
‘closed awareness’ (Glaser & Strauss, 1965; Small & Gott, 2012). This interrelationship 
between predicting a patient’s prognosis and talking to patient’s about the palliative nature 
of their condition has implications for the trial recruitment process. Lack of certainty 
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regarding the patient’s prognosis can lead to a reluctance to confirm trial eligibility and 
‘promote’ the trial to patients and carers.   
Medical staff can struggle to recognise when a patient is approaching the end of their life 
(Bloomer, Botti, et al., 2018; Butow et al., 2020; Johnson et al., 2020) and this can be the 
case even in specialist palliative care (Pontin & Jordan, 2011; White et al., 2020). Small and 
Gott (2012) argue that changes in the epidemiology of dying with people living longer with 
comorbidities and complex needs means it is challenging for clinicians to predict a patient’s 
illness trajectory. Prognostic uncertainty can be an issue especially in the non-cancer 
population (Chattoo & Atkin, 2009; Flierman et al., 2019). Clinician prediction of survival 
remains the most commonly used approach to formulating a prognosis with doctors tending 
to overestimate survival (White et al., 2016). The role and value of prognostication tools to 
support clinical decision making in advanced disease including in clinical trials requires 
further research (Hui, 2015; Simmons et al., 2017). Nurses can be hesitant to disclose their 
observations of the patient’s deteriorating condition to medical staff but doctors can value 
their opinions (Flierman et al., 2019; Johnson et al., 2020) and nurses may be better at 
predicting survival but further research is required (White et al., 2016; White et al., 2020).  
Palliative care is often seen as a failure by clinicians and providing end-of-life care, 
particularly in the acute hospital setting, is challenging because of the priority given to 
interventions and treatments that aim to prolong life (Gardiner et al., 2011; Hibbert et al., 
2003; Salins et al., 2020; Willard & Luker, 2006). There is also a public expectation that 
patients who go into hospital will get better (Gardiner et al., 2011). There can be tensions 
between the speciality of palliative care that promotes a more holistic and non-
interventionist approach (Hibbert et al., 2003) and other medical specialities that focus on a 
247 
 
more acute model of care (Chattoo & Atkin, 2009; Small & Gott, 2012). Specialist palliative 
care provides advice and support to other medical specialities so professionals who work 
within palliative care, even medical staff, have to negotiate their input into a patient’s care 
(Hibbert et al., 2003; Salins et al., 2020). Specialist palliative care being a consult service was 
identified as a barrier to recruitment in chapter two and the findings of this study help to 
explain why it is important to select a Principal Investigator or ‘research champion’ who has 
overall responsibility for the patient’s care.  
 
7.6 How the ‘emotional labour’ of ‘Promoting’ a palliative care trial as a ‘Product’ 
can lead to ‘paternalism’.  
 
Patients have the right to receive information and make independent judgements about 
their treatment and care (Beauchamp & Childress, 2013). Respect for patient autonomy is a 
key principle of palliative care (Radbruch & Payne, 2009) and was identified as a key 
recommendation from the MORECare research methods project;  
‘Respect is required for autonomous decisions of patients and carers regarding their 
participation in research to avoid limiting their participation through inappropriate 
gatekeeping and paternalistic attitudes’ (Gysels et al., 2013) (p. 913). 
Health care professional paternalism took a number of forms in this study, for example, in 
order to protect the patient, clinicians decided not to inform them of all the research 
studies they were eligible for. These type of decisions were generally not based on an 
assessment that involved the patient (Kars et al., 2016). Clinicians struggle with the dilemma 
and conflict of balancing the ethical principles of respect for autonomy with the demands of 
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beneficence, acting in the patient’s best interest (Beauchamp & Childress, 2013). The act of 
withholding information from a patient, also called gatekeeping in the literature as 
previously discussed, prevents the patient from making an informed and voluntary choice 
about trial participation (Beauchamp & Childress, 2013). Beauchamp and Childress (2013) 
define this type of behaviour as ‘hard paternalism’ and believe it is not ethically justifiable in 
this context. Periera and Hernández-Marrero (2019) argue that this type of paternalistic 
behaviour is misguided and the focus should be on the protection of palliative care patients 
by scrutinising a study’s ethical soundness rather than excluding them from research they 
are eligible for.  
Studies have shown that palliative care patients and their carers can value the opportunity 
to participate in research (Bloomer, Hutchinson, et al., 2018; White & Hardy, 2010), 
including palliative care trials (Aoun et al., 2017; Lovell et al., 2020; Middlemiss et al., 2015). 
For example, a feasibility study that involved collecting urine samples from patients in the 
last weeks of life achieved a recruitment rate of 57% (Coyle et al., 2016). Aoun et al (2017) 
interviewed 316 carers of patients receiving home based palliative care about their 
experiences of trial participation. Carers in both the control and intervention group 
appreciated the opportunity to participate and benefited from their involvement in 
research. A limitation of these studies is that they do not capture the views of those patients 
and carers who decline to take part (Aoun et al., 2017; Lovell et al., 2020; Middlemiss et al., 
2015) or they ask their views of taking part in hypothetical studies (Todd et al., 2009; White 
et al., 2008). In the general palliative care literature, there is some evidence that sensitive 
discussions around prognosis or end-of-life care are not associated with poorer 
psychological patient outcomes (Hancock et al., 2007; Wright et al., 2008) and that the 
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majority of terminally ill patients and their relatives do not find talking about death, dying 
and bereavement stressful (Emanuel et al., 2004). 
Carers can also demonstrate paternalistic attitudes by sometimes overriding the patient’s 
autonomy by acting as the patient’s surrogate decision maker even when the patient has 
capacity. The ‘emotional labour’ for clinicians of balancing the patient’s interests with the 
carer’s interests have been noted in the general palliative care (Hancock et al., 2007) and 
the research literature (Gysels et al., 2013). Carers may not want the clinician to be truthful 
with the patient about their condition in order to maintain hope. The policy imperative to 
be open with patients about their prognosis so they can make autonomous decisions 
regarding their care does not always resonate with lay culture (Noble et al., 2015; Testoni et 
al., 2020). The ‘emotional labour’ of balancing the patient’s interests with the carers 
emotional needs can be stressful and distressing for clinicians (Butow et al., 2020; Noble et 
al., 2015; Testoni et al., 2020). 
Snowden and Young (2017) argue that judging all acts of health care professional 
gatekeeping during a trial as paternalism is an oversimplification of the phenomenon, an 
idea that fits with the findings of this case study. They analysed the gatekeeping literature 
related to nurses and data from two focus groups with hospice community nurses (n=9). The 
nurses were involved in recruitment to a trial of a holistic needs assessment intervention in 
community palliative care. The trial had to be stopped after two years because of poor 
recruitment. They found a continuum of gatekeeping among nurses from unconsciously 
forgetting about the study because of other distractions to more active conscious 
disengagement caused by discomfort and distress.  
250 
 
7.7 The role of ‘Working with partners’ (partner education) to manage ‘emotional 
labour’ and health care professional paternalism.  
 
Training research site staff has been identified as the number one priority for evaluation 
when considering interventions to improve trial recruitment in the general trial literature 
(Bower et al., 2014). Training interventions have tended to be used in the context of cancer 
trials and have taken a workshop format covering generic and trial specific issues over one 
or two days with a mix of health care professionals (Townsend et al., 2015). There has been 
a call for more tailored support for clinicians involved in the recruitment process (Lawton et 
al., 2015).  
Within the nursing literature, it is argued that ‘emotional labour’ needs to be taught so that 
nurses know how to deal with situations that occur in clinical practice and manage their 
feelings more effectively (Smith, 2012). Smith (2012) argues that it is wrong to assume that 
an individual will be able to cope with a difficult and upsetting situation by virtue of their 
role and seniority. Doctors should also accept their own emotional responses. These 
responses should not be a detractor from objective clinical reasoning but rather a source of 
true empathy and an important non-medical factor in the decision making process (Pfeil et 
al., 2015).   
Hochschild (2012) describes how individuals in the workplace use ‘surface acting’ and ‘deep 
acting’ to ensure emotions are expressed according to social and cultural norms. The use of 
the term ‘acting’ has been seen as controversial in some of the nursing literature as it 
suggests nurses are displaying their emotions in an unauthentic way (Huynh et al., 2008). 
When ‘surface acting’ we ‘deceive others about how we are feeling without deceiving 
ourselves’ (Hochschild, 2012)(p.33). It involves changing our outer expression to make our 
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inner feelings correspond to how we appear (Smith, 2012). An example of this would be, 
presenting a ‘professional face’ to patients, while privately feeling uncomfortable about 
approaching them about a trial (Theodosius, 2008). 
In contrast, when ‘deep acting’ the individual works on and learns to believe in the emotions 
they are expressing. They do this by using their imagination, such as transferring positive 
memories of talking to patient to a current situation, or by exhorting emotion, such as 
‘psyche’ themselves up to do something they are not looking forward to (Hochschild, 2012; 
Theodosius, 2008). This learning process can eventually lead to the person being unaware 
that they have worked on and created the required emotional response such as feeling 
comfortable approaching the patient (Hochschild, 2012; Theodosius, 2008) . In Hochschild’s 
(2012) study of flight attendants, more mature and experienced staff members were found 
to be better at ‘deep acting’. This meant they were better able to distinguish between their 
private and work selves (Smith, 2012). This may explain why specialist nurses and research 
nurses who had experience of talking to palliative care patients and carers felt more 
comfortable recruiting to a palliative care trial in this case study.  
The ‘emotional labour’ of caring for palliative care patients and carers can be overlooked 
and as Hochschild (2012) questions ‘what is it that ‘’peoples jobs’’ actually require of 
workers.’’ (p.10) There is a risk that if emotions are not addressed they may accumulate 
(Brighton et al., 2019) and may lead to job related stress and burnout (Hochschild, 2012; 
Huynh et al., 2008). In a study of generalist palliative care professionals, a range of emotions 
were present during difficult conversations with patients and carers. Across disciplines and 
experience levels; anxiety, sadness, empathy, frustration and insecurity influenced care 
252 
 
delivery with anxiety and empathy being the most common emotions experienced (Luff et 
al., 2016; Martin et al., 2015). 
Brighton et al (2019) identified two types of emotions experienced by non-medical 
generalist professionals during difficult patient and carer conversations that support the 
findings of this study. These were ‘skill focused’ emotions and ‘situation focused’ emotions. 
Skill focused emotions relate to a health care professionals lack of confidence in their ability.  
Situation focused emotions are the clinician’s emotional response to the situation based on 
their assessment of the situation and what others may be feeling. The use of pro-active 
strategies such as palliative care skills training to address skill focused emotions and more 
reactive strategies such as reflective practice, to address situation based emotions were 
seen as potentially useful strategies to reduce avoidance in non-medical generalist 
professionals (Brighton et al., 2019).  
Training is needed to help clinicians to translate communication guidelines into practice 
while considering their own emotional needs (Anderson et al., 2019). The literature on end- 
of-life communication can be contradictory and difficult to follow (Brighton & Bristowe, 
2016). Studies have found that communication style is as important if not more important 
than the content of end-of-life care discussions for patients and carers (Parker et al., 2007). 
Patients and carers value many core non-specialist communication skills (Brighton & 
Bristowe, 2016) that include empathy, care, compassion, and honesty, balanced with 
sensitivity and hope, encourage questions and check understanding (Parker et al., 2007). 
There is some evidence from paediatric trials that even in the most difficult situations, 
parents can understand and accept the timing and reasons for a clinician approaching them 
about a trial as long as it is carried out in a considerate way (Valerie et al., 2011).  
253 
 
The type of strategies used by recruiting staff in this study to prepare for ‘Promoting’ a 
palliative care trial are reflected in the communication literature. In order to manage the 
‘emotional labour’ of having a difficult conversation, generalist palliative care clinicians have 
reported using a variety of strategies. These include; self-care such as self-reflection, 
preparatory work such as rehearsing a conversation beforehand, using a team approach as a 
source of support and forum for processing challenging situations and using professional 
identity to enable separation of professional self from personal self (Luff et al., 2016). The 
way in which recruiting staff support each other when working on a palliative care trial 
suggests the presence of ‘emotional intelligence’. There are disagreements over the term 
(Nightingale et al., 2018) but ‘emotional intelligence’ is generally seen as the ability to 
recognise and regulate emotion in oneself and others while ‘emotional labour’ involves 
emotional self-regulation (Huynh et al., 2008; Raghubir, 2018). Understanding and being 
aware of others emotions, as well as your own, and managing relationships are key 
attributes of ‘emotional intelligence’. It is argued that those professionals who work in an 
emotionally intelligent way work more collaboratively, make better decisions and care for 
their patients more effectively (Raghubir, 2018). Strategies that develop and support 
emotionally intelligent practices such as self-reflection, are important in the context of trial 
recruitment, as in end-of-life-care (Bailey et al., 2011; Johnson et al., 2020) and health care 
generally (Nightingale et al., 2018), to help manage the ‘emotional labour’ of recruitment 
and address health care professional paternalism.  
The requirement to assess and manage the patient’s fluctuating mental capacity, follow 
advance consent procedures and involve proxies, as appropriate, in the recruitment process 
contributes to the ‘emotional labour’ of ‘promoting’ a palliative care trial. As discussed in 
chapter one, end-of-life care research is likely to involve patients who are at risk of losing 
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capacity or lack capacity (White et al., 2019) and this is something researchers need to 
anticipate (Gysels et al., 2013). This issue is not unique to palliative care research (Brown et 
al., 2019; Hamilton et al., 2017; Ries et al., 2020) and it has been estimated that 26 % of 
patients in general medical inpatients lack capacity (Sessums et al., 2011). Establishing 
capacity, particularly in those with mild cognitive impairment can be challenging (Agar et al., 
2013; Jayes et al., 2019). Clinicians can lack confidence and awareness of how to assess 
capacity (Jayes et al., 2019). They can also have a lack of understanding of legal 
requirements such as who can act as a proxy decision maker (Shepherd, 2020b). Trials that 
involve patients who lack capacity are resource intensive. This is because of the skills and 
time required to conduct sensitive capacity assessments, identify and contact suitable 
proxies and seek their assent (Shepherd, 2020b). Carers may experience emotional and 
decisional burdens when acting as a proxy in the context of research and may need support 
to enact this role (Shepherd et al., 2019). Nominated consultees may also lack confidence 
and understanding of their role (Evans et al., 2020). In the context of stroke trials, those 
research nurses with more experience of caring for stroke patients felt more comfortable 
assessing capacity in patients with severe stroke symptoms (Boxall et al., 2016). 
In this study, recruiting staff were used to explaining randomisation to patients as part of 
the informed consent procedure. This is a generic recruitment skill and all clinicians in this 
study were experienced in recruiting to trials. Specialist palliative care professionals may 
feel less confident and require training as highlighted in a recent palliative care trial (Holm 
et al., 2017). The general trial literature and the study findings suggest that even the most 
experienced recruiting staff can experience ‘emotional labour’ when operationalising 
randomisation procedures. The need for health care professional training and support to 
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enact randomisation procedures has been identified in the general trial literature (Donovan 
et al., 2014; Donovan  et al., 2014; Rooshenas et al., 2016).   
 
7.8 The final theoretical propositions for this study 
 
The study’s theoretical propositions have been iteratively developed to reflect the study 
findings and the wider literature discussed above. The final theoretical propositions are: 
 The use of subjective criteria to predict a patient’s prognosis as part of a palliative 
care trial’s eligibility criteria acts as a barrier to recruitment.  
 Involving recruiting staff who have previous experience of caring for palliative care 
patients and their carers will be a facilitator to recruitment. 
 The provision of training for recruiting staff on how to introduce a palliative care trial 
to patients and carers will help address health care professional gatekeeping. 
 The provision of ongoing support for those involved in recruiting to a palliative care 
trial will help address health care professional gatekeeping. 
 Choosing a Principal Investigator who has overall responsibility for the patient’s care 
influences how well the trial meets its recruitment target. 
 
7.9 Recommendations for clinical practice and policy 
 
The new palliative care trial recruitment framework proposed that reflects the study 
findings is an adapted ‘Social Marketing Mix Framework’ that incorporates the wider 
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overarching contextual issues of ‘emotional labour’, ‘professional hierarchies and power 
relationships between clinicians’ and ‘paternalism’ (see figure 2 in chapter six). The 
requirement to take account of trial specific and local circumstances when applying the 
updated framework still needs to be recognised.    
It is recommended when choosing a ‘research champion’ to consider the influence of 
‘professional hierarchies and power relationships between clinicians’ on the recruitment 
process. The study findings illuminate why the lead medical clinician may be the best person 
to take on the role of Principal Investigator to facilitate the recruitment process but they 
also suggest that specialist nurses can take on this role because of their position in the 
multi-disciplinary team. There has been a growing recognition that non-medical 
professionals should be encouraged and supported to take on key research roles including 
that of Principal Investigator (National Institute for Health Research, 2021). There is a need 
to expand palliative and end-of-life care research activity so the assumption that the lead 
medical clinician is best placed to take on the role of ‘research champion’ needs to be 
challenged. This should also be the case for the role of Chief Investigator as the study 
findings suggest that an investigator with a medical background can make engaging and 
recruiting research sites more straightforward and less time consuming. Palliative care 
promotes a multi-disciplinary approach to care and this needs to be reflected in the trial 
context. Who is the best person to take on the role of Principal Investigator and Chief 





The findings of this study have highlighted that those health care professionals who are 
involved in recruiting patients and carers to a palliative care trial, should have access to 
‘partner education’ to manage their emotional labour. It has been previously recognised 
that researchers and clinicians need training to address the practical and ethical challenges 
associated with conducting end-of-life care research (Gysels et al., 2013). This ‘partner 
education’ is in addition to the generic training that is recommended in the general trial 
literature that aims to address the challenges, for clinicians, of exploring patient preferences 
and discussing key trial concepts such as equipoise, randomisation and uncertainty (Fletcher 
et al., 2012; Townsend et al., 2015).  
Study coordinating centres need to incorporate recruitment training into trial planning and 
set up processes to address emotional labour. Those running a trial should not assume 
health care professionals will have the necessary skills and confidence, by virtue of their 
professional role, to recruit to a palliative care trial. As discussed previously, the recruitment 
process is an interactional activity between a patient and a recruiter so focusing purely on 
how information is presented in a participant information sheet will not address this 
recruitment barrier. There is evidence from the general trial literature that even when the 
trial’s target population informs the content, format and appearance of the participant 
information, this makes little or no difference to recruitment rates (Treweek et al., 2018). 
Outside palliative care, there is evidence that the communication style of the recruiter is a 
key factor influencing the patient’s willingness to take part in the trial (Albrecht et al., 2008; 
Jenkins & Fallowfield, 2000). The need to provide training on how to discuss a palliative care 
trial to address emotional labour echoes one of the recent recommendations from the 
updated MORECare project;  
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‘19. Clinicians should be supported and provided with training to ensure they are 
confident in their skills to discuss research studies with patients (and/or family 
members) during routine clinical contact.’ (Evans et al., 2020)(p. 480) 
Any training should reflect the characteristics of the trial and the health care professional’s 
experience. The training may need to cover a number of issues which are outlined in table 
17.  
Table 17: Recommendations for palliative care trial training to address emotional labour 
 
 
 How to explain palliative and end-of-life care to patients and carers and dispel the 
myths surrounding the terms (Reigada et al., 2020).  
 The use of general verbal and non-verbal communication skills to assess the 
potential participant’s understanding of their condition and willingness to engage 
in a trial conversation (Moore et al., 2018).  
 How to manage the patient’s fluctuating physical condition and the psychological 
needs of patients and carers (Oechsle, 2019; Wang et al., 2018). 
 How to assess capacity and enact proxy and advance consent procedures (Evans et 
al., 2020; Gysels et al., 2013).  
 Stressing the importance of approaching patients to maintain patient autonomy 
(Evans et al., 2020; Gysels et al., 2013). 
 Ideally, there would be opportunities for clinicians to role-play potential clinical 
recruitment scenarios in a supportive environment (Luff et al., 2016; Townsend et 
al., 2015). 
 




There is currently little evidence of the positive impact of trial recruitment training on 
recruitment rates, patient understanding, satisfaction or levels of informed consent. A 
review of trial recruiter training programmes showed that training was well received by 
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clinicians, including role play, and some programmes were shown to increase recruiter 
confidence in communicating key trial concepts (Townsend et al., 2015). The challenge in 
palliative care trials is ensuring ‘partner education’ does not contaminate the study by 
corresponding too closely to the intervention being tested (Koffman et al., 2019). Involving 
patient and public involvement representatives in training programmes or directly in the 
recruitment process may help address gatekeeping (Froggatt et al., 2020) but evidence 
supporting the impact of such involvement in palliative care research is limited (Chambers 
et al., 2019). The importance of training for health care professionals responsible for 
recruiting adults who lack or are at risk of losing capacity has been identified but more 
research is needed to explore their experiences and support needs (Shepherd, 2020b). 
Outside of research, how professionals communicate decision options to patients and test 
their decision-making abilities is unclear (Jayes et al., 2019). In relation to prognostication in 
palliative care, there is currently no clear guidance on how clinicians can be taught to 
perform this aspect of their role better (White et al., 2016).  
Clinical supervision models of support have been recommended for research nurses in the 
general trial literature to address the ‘emotional labour’ associated with their role (Boxall et 
al., 2016; Hernon et al., 2020). Smith (2012) argues that nurses need an arena where they 
can work on their feelings and emotions and learn from them but this requires 
organisational support. The opportunity to reflect on the impact, both positive and negative, 
of working on a palliative care trial should be available to clinicians throughout the trial as 
recruitment interactions may go smoothly or there may be difficulties. It maybe that the 
‘emotional labour’ of recruiting to a palliative care trial is something that not all clinicians 
are able or want to undertake but this needs to be openly acknowledged. In their seminal 
study of dying in hospital, Glaser and Strauss (1965) identified that nurses who did not want 
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to talk about end-of-life care would hand the patient over to a nurse who was comfortable 
discussing such issues, a nurse they termed a ‘death talker’. They described how a division 
of labour could develop among nurses to protect those who are unable to take on this role.  
This study has illustrated the resource intensive nature of palliative care trial recruitment 
and the impact it can have on recruiting staff. As highlighted in chapter one, palliative care 
research is underfunded and more funding is required to ensure those who are recruiting to 
a palliative care trial have the necessary resources, training and support to carry out their 
role. As discussed in chapter five, accrual-based metrics are used in the UK to determine the 
level of recruiting staff support a trial may receive. This may unfairly discriminate against 
palliative care studies because of the time and resources required to recruit patients. Similar 
concerns have been raised in trials aimed at those with complex cognitive and 
communication needs (Shepherd, 2020b).  
 
7.10 Recommendations for future research 
 
Full scale trials that struggle or do not meet recruitment targets are costly and wasteful and 
the importance of reducing research waste in health care (Chalmers & Glasziou, 2009), 
including in palliative care (Sleeman & Murtagh, 2014), has been raised in the literature. 
Feasibility and pilot studies have a role in reducing research waste by identifying successful 
recruitment strategies and/or designing out any issues that may negatively impact on a 
trial’s recruitment success (Blatch-Jones et al., 2018). They may also identify that a study is 
in fact not feasible (Morgan et al., 2018), as illustrated in a recent study of peer support to 
maintain psychological wellbeing in people with advanced cancer (Walshe et al., 2020). The 
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use of embedded randomised controlled trials within a study to test a recruitment strategy, 
such as changes to a patient information sheet (Cockayne et al., 2017), is also an approach 
that is being developed in the field of trial methodology (Rick et al., 2014) and has the 
potential to be used within palliative care research.  
The role and value of qualitative research in addressing recruitment related issues and 
identifying key areas for ‘partner education’ has been identified in trials outside palliative 
care. The QuinteT Recruitment Intervention (qualitative research integrated into trials) has 
been used in a number of non-palliative care randomised controlled trials over the last two 
decades. The intervention is seen as particularly useful in trials that are predicted to be 
challenging and difficult to recruit to and its impact on recruitment rates has recently been 
evaluated (Rooshenas et al., 2019). The QuinteT Recruitment Intervention’s purpose is to 
understand why a trial may be experiencing recruitment difficulties so that tailored support 
can be provided to recruiting staff.  It is recommended that the intervention is integrated 
into the feasibility or main phase of a study or used when a trial is struggling to reach its 
recruitment target (Donovan et al., 2016; Rooshenas et al., 2019). Applying approaches used 
in the QuinteT intervention may lead to a greater understanding of the ‘clear obstacles’ and 
‘hidden challenges’ that prevent a palliative care trial reaching its recruitment target 
(Donovan  et al., 2014).  
As used in this study, the intervention involves carrying out semi-structured interviews with 
study coordinating centre and recruiting staff and reviewing trial documentation. A more 
challenging aspect of the intervention for the palliative care setting, but not impossible 
(Noble  et al., 2015), is inviting those patients who have declined to take part in the trial to 
take part in an interview. This may be challenging because of potential concerns raised by 
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health care professionals, carers and research ethics committees and the patient’s unstable 
condition. Patients and carers can provide valuable insights into how the trial or ‘product’ 
has been ‘promoted’ to them and the reasons why they declined to take part (Houghton et 
al., 2020; Hughes-Morley et al., 2016; Stevens & Ahmedzai, 2004). A recent Cochrane review 
of potential participants’ views and experiences of the trial recruitment process, including 
those who agreed to take part and those who declined, has called for more research 
exploring underrepresented groups including adults who lack capacity to consent (Houghton 
et al., 2020).  
An important part of the process is the audio recording of the appointment where recruiting 
staff introduce and explain the trial to potential participants. This process would provide 
valuable insights into how a palliative care trial is ‘promoted’ to patients and carers during a 
recruitment consultation. This is in addition to how well randomisation procedures have 
been explained and clinical equipoise maintained. This process would allow an assessment 
of how well patients and health care professionals have grasped the key concepts to 
support informed consent. It would also lead to a better understanding of how willing and 
accepting patients and carers are to being approached about a palliative care trial. Tailored 
strategies can then be put in place to address recruitment challenges such as individual and 
group recruiter feedback, research nurse training, ‘tips’ and ‘guidance’ documentation, 
changes to participant information, review and discussion of screening logs and scrutiny of 
patient pathways (Rooshenas et al., 2019).  
The fact multiple recruitment visits are often required in palliative care trials, recruitment 
activity does not always occur in the out-patient setting and the cost implications of carrying 
out this type of research means this approach may not always be possible but should be 
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considered, where appropriate, as a means of capturing the recruitment process in ‘real 
time’. Patients, carers and health care professionals also need to feel comfortable being 
recorded. Recording and analysis of end-of-life conversations between patients and 
clinicians has taken place in the trial context, as illustrated in a trial of early palliative care, 
where patients consented to palliative care clinic visits being audio recorded (Lim et al., 
2017) and in palliative care research generally (Parry et al., 2014). 
 
7.11 Strengths of the study 
 
To the author’s knowledge, this is the first qualitative multiple case study focusing on 
recruitment issues in palliative care randomised controlled trials. As discussed in chapter 
two, the evidence underpinning how clinicians recruit palliative care patients and carers to 
palliative care randomised controlled trials is largely anecdotal. In-depth semi structured 
qualitative interviews with study coordinating centre and recruiting staff from three diverse 
UK trials, as well as trial documentation, produced new insights into the recruitment process 
in palliative care trials.   
Outside the trial recruitment context, health care professionals struggle with the ‘emotional 
labour’ of prognostication and discussing palliative and end-of-life care with patients and 
carers. Professional hierarchies and power relationships between clinicians support 
paternalistic practices and influence how ‘emotional labour’ is experienced by health care 
professionals in clinical practice. The study findings contribute to the knowledge base in 
palliative care as they have identified how these wider contextual factors also influence the 
trial recruitment process. They help to explain why paternalism is a particularly challenging 
264 
 
issue in palliative care randomised controlled trials. The study findings have identified the 
importance of ‘partner education’ to help address the ‘emotional labour’ of palliative care 
trial recruitment in addition to generic randomised controlled trial training. The findings are 
relevant and applicable to palliative care research generally and not just randomised 
controlled trials. They build upon the findings of the literature review in chapter two and 
Kars et al’s (2015) review of reasons for gatekeeping in palliative care research. 
The study findings also help meet the priorities set by the Prioritising Recruitment in 
Randomised Trials study (Healy et al., 2018), specifically questions 5 and 7;  
5 ‘What are the barriers and enablers for clinicians/healthcare professionals in 
helping conduct randomised trials?’ 
7 ‘What are the best approaches to ensure inclusion and participation of under-
represented or vulnerable groups in randomised trials?’ 
One of the concerns raised about case study research is how the study findings can be 
generalised beyond a single or small number of cases. Unlike experimental research, 
generalisation occurs through analytical rather than statistical generalisation. As previously 
discussed, theoretical propositions were used to guide data collection and analysis in this 
study. The ‘Social Marketing Mix Framework’ and the findings of the literature review in 
chapter two informed the initial theoretical propositions. The theoretical propositions were 
updated during the study and at the end of the study to reflect the emerging findings and 
the wider theoretical, palliative care and trial recruitment literature. The concept of 
analytical generalisation means the findings can be used to understand trial recruitment 
processes beyond the three cases used in this study (Ritchie & Lewis, 2003; Yin, 2018).  
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Additionally, theory building was strengthened by using multiple diverse cases rather than a 
single case (Yin, 2018).  
There is a limited choice of theories for researchers to draw upon to help them understand 
the trial recruitment process. Recently, the ‘Social Marketing Mix framework’ has also been 
used as an analytical framework to understand trial recruitment processes in a non-
palliative care trial (Tompkins et al., 2019). The ‘6 Ps’ of the ‘Social Marketing Mix 
Framework’ provided a useful and practical guide to inform data collection and analysis in 
this study, both within case and across the three cases. At a descriptive level, the theory 
highlighted important issues that need consideration when planning and implementing a 
recruitment strategy in the context of a palliative care trial so was a useful theory to use. 
Despite this, it was challenging to see beyond the theory to fully understand the contextual 
reasons for why similar patterns were being seen across the cases. Whether collecting, 
analysing and interpreting the data without the use of an a priori framework would have 
been more straightforward is difficult to say. The concepts of ‘emotional labour’, 
‘paternalism’ and ‘professional hierarchies and power relationships between clinicians’ were 
required as an additional theoretical lens to fully interpret the findings in this study to 
reflect the palliative care context. This case study is the first study, to the author’s 
knowledge, to adapt the ‘Social Marketing Mix Framework’ to reflect the wider contextual 
issues of ‘emotional labour’, ‘paternalism’ and ‘professional hierarchies and power 





7.12 Study limitations 
 
In the systematic review in chapter two, the literature was searched until October 2016. 
This reflects the state of knowledge in this area at the time that the empirical data collection 
was planned, and the results of the synthesis of this literature review informed the design 
and conduct of the empirical study. Rather, then, than updating this and potentially causing 
confusion about what literature was available to inform the empirical study, studies 
published since this date were captured through citation tracking and other literature 
notifications and was incorporated into the discussion to contextualise the findings of the 
empirical study. This approach may have meant key papers exploring recruitment issues in 
palliative care randomised controlled trials may have may have been missed. These papers 
may have supported or challenged the findings of this study.   
When choosing a research design, the researcher needs to be aware of its limitations. Case 
studies require multiple skills (Walshe et al., 2004) and can be very time consuming and 
resource intensive (Baxter & Jack, 2008; Creswell & Poth, 2016). They have been described 
as being ‘simple in theory yet complex in nature’ (Harrison et al., 2017) (p.3) with data 
analysis being particularly challenging because of the need to bring together large amounts 
of data (Crowe et al., 2011). Managing the issue of anonymity can also be challenging in 
case study research as an in depth description of the case may lead to individual participants 
and organisations being identified. This was a particular issue in this study as there are only 
a small number of palliative care trials active in the UK at any one time. Details of how 
anonymity was managed and why this approach was taken in this study is discussed in detail 
in chapter four. The decision to anonymise the case, clinical recruitment centres and 
individual participants may have meant Chief Investigators, study coordinating centre and 
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recruiting staff were more willing to take part in this study and be more open and honest in 
their responses. A limitation of this approach is that the reader does not have access to a 
detailed description of the case when reviewing and interpreting the study findings. 
Practical as well as methodological considerations influenced case selection in this study as 
well as resource issues. Yin (2018) recommends that the number of cases included in a study 
should be no more than 4 or 5 because of their complexity. A further case would have been 
selected in this study if additional resources had been available. This is because the findings 
suggested that recruiting to a pharmaceutical symptom control trial may raise particular 
issues for recruiting staff. Resource issues impacting on how many cases are included in a 
study is acknowledged in the case study literature (Creswell & Poth, 2016; Yin, 2018).  
The aim was to sample and recruit clinical recruitment centres and recruiting staff with 
different characteristics such as those centres who had and had not recruited to target and 
staff with different roles and clinical backgrounds. In practice, clinical recruitment centres 
and recruiting staff were included in the study as they agreed to take part. Recruiting 
clinicians to take part in a qualitative research study, including research nurses (Elliott et al., 
2018), can be a challenging and time consuming process (Barclay et al., 2019; Broyles et al., 
2011; Signorelli et al., 2018). Those who were interested usually responded quickly to the 
invitation and the reasons for staff declining included not having the time or that the study 
was not on the National Institute for Health Research portfolio. Lack of time and workload 
demands have been previously reported as barriers to recruiting clinicians to participate in 
qualitative research (Barclay et al., 2019; Broyles et al., 2011; Signorelli et al., 2018). Using 
snowball sampling within the Health Research Authority approval system added additional 
complexity to the recruitment process. Having previous experience of the Health Research 
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Authority approval system and liaising with NHS Research and Development departments 
was useful in this study.  
Those who were willing to discuss their views and experiences of trial recruitment self-
selected themselves to take part in the study and those with no time declined to take part. 
Participant views may not be representative of other professionals who are involved in the 
palliative care trial recruitment process. Recall bias may also have been an issue as health 
care professionals needed to remember their experiences of recruiting patients and carers 
to a palliative care trial (Forero et al., 2018). Social desirability bias can also be an issue in 
qualitative research studies, the idea that participants present themselves, and their social 
context, in a way that is perceived to be socially acceptable such as denying the presence of 
health care professional gatekeeping. Gentle probing during the telephone interviews was 
used as a strategy in this study to help minimise social desirability bias (Bergen & Labonté, 
2020). This study does not capture the patient and carer’s perspective of being recruited to 
a palliative care trial. Their views and experiences may be different to those expressed by 
health care professionals, an issue found in the general trial literature (Valerie et al., 2011).   
The inability to be on site to collect data due to resource issues meant collecting 
observational data and/or recording of recruitment consultations was not an option in this 
study. Observing and/or listening to how health care professionals recruit patients and 
carers to trials and comparing this to their interview responses would have strengthened 
the findings of this study. As discussed in chapter four, being on site may have made 
documentary evidence collection easier as staff needed to feel comfortable and be fully 
bought into the idea of sharing documentation. The ability to fully understand the 
organisational factors that influenced the recruitment process are also limited by the 
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primary source of data being semi structured interviews with health care professionals 
involved in the recruitment process.  
This study took place in a UK context and it is important to acknowledge that palliative care 
provision and resources, both clinical and research, may differ internationally which may 
affect the trial recruitment process. In 2017, only 14% of the global population had access to 
palliative care that was integrated into main stream health care services and this access was 
concentrated in European countries that included the UK (Clark et al., 2020). The cultural 
context can also influence communication issues in palliative and end-of-life care, such as 
patient and carer preferences for prognosis disclosure and willingness to engage in end-of-
care discussions (Moore et al., 2018; Shah et al., 2020; Shen et al., 2018; Zafar et al., 2016). 
Health care professionals can also be a culturally diverse group. Cultural issues have the 
potential, therefore, to influence the palliative care trial recruitment process. Research 
ethics and governance requirements may also differ between nations, such as the type of 
information that needs to be included in the participant information sheet or mode of 
consent, which will also affect the trial recruitment process (Gardiner et al., 2010; Preston et 
al., 2020).  
The benefits of having palliative care clinical and research experience and supervisors with a 
similar background meant that study design, data collection, interpretation and data 
presentation decisions could be developed, discussed and reviewed by a research team with 
relevant experience ‘in the field’. A limitation of this approach is that other specialist and 
generalist palliative care clinical and research professional’s interpretations of recruitment 
issues in palliative care trials may not reflect those presented in this thesis.  
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As discussed in chapter one, relevant stakeholders for the research question were health 
care professionals with experience of palliative care trials. Additional stakeholders were not 
involved in this study as both myself and my supervisors are experienced palliative care 
clinicians and have relevant trial experience. The advantages of this were; the small pool of 
eligible health care professionals with relevant trial experience was not limited further, 
there were no study delays due to trying to engage busy health care professionals and there 
was no additional costs. Involving additional stakeholders in the study design process could 
have influenced; the choice of theoretical framework; the research question; the definition 
of the case and the development of recruitment materials and data collection procedures. 
Presenting and discussing study findings and recommendations with stakeholders may have 
facilitated and strengthened the outputs from this study. How best to disseminate the study 
findings could also have been discussed with stakeholders. Some would argue that it is 
unethical to carry out a study without formal stakeholder engagement. Ideally, this would 
have occurred, despite my own and my supervisor’s relevant experience, but practical issues 
influenced the decision not to engage additional health care professional stakeholders. The 
study findings have subsequently been presented at conferences attended by national and 








7.13 Key messages and dissemination 
 
Table 18: Key study messages 
 
 An adapted ‘Social Marketing Mix Framework’ that incorporates the wider 
overarching contextual issues of ‘emotional labour’, ‘professional hierarchies and 
power relationships between clinicians’ and ‘paternalism’ is a useful framework 
for planning and monitoring recruitment activity in a palliative care trial (see figure 
2).  
 Trial specific and local circumstances still need to be recognised when applying the 
updated framework.  
 Study coordinating centres need to incorporate recruitment training and support 
when planning, setting up and running a palliative care trial to address emotional 
labour. They should not assume clinicians will have the necessary skills and 
confidence, by virtue of their professional role, to recruit to a palliative care trial. 
 There is a need to expand palliative and end-of-life care research activity so the 
assumption that the lead medical clinician is best placed to take on the role of 
‘research champion’ needs to be challenged. 
 This should also be the case for the role of Chief Investigator as the study findings 
suggest that an investigator with a medical background can make engaging and 
recruiting research sites more straightforward and less time consuming. Palliative 
care promotes a multi-disciplinary approach to care and this needs to be reflected 
in the trial context. 
 Further research is required to explore who is the best person to take on the role 
of Chief Investigator and Principal Investigator in a palliative care trial and the type 
of training required to address the ‘emotional labour’ of recruitment.   
 
It is important that these key messages are disseminated to a wide audience both nationally 
and internationally. This audience includes; research nurses, palliative care researchers, trial 
methodologists, clinicians involved in the care of palliative care patients, health care 
organisations responsible for providing palliative care. Specifically in the UK, the National 
Institute for Health Research Clinical Research Network who as discussed previously provide 
funding and support for research carried out within the NHS. A number of strategies will be 
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used to disseminate the study findings. This will include; an overall findings paper, a paper 
focusing on the nursing aspects of the study findings, with both of these articles being 
submitted to a peer review journal. Other forms of communication will be used to 
disseminate the study findings into practice such as newsletters, blogs and twitter. As 
discussed previously, the literature review and study findings have already been presented 
at international conferences (see page 13 for details). 
 
7.13: The Covid-19 Pandemic 
 
This thesis was written during the COVID-19 pandemic where the importance of health care 
research, particularly the role of adequately powered randomised controlled trials to treat 
or vaccinate against COVID 19, was highlighted in the media (Wilkinson, 2020). The impact 
of the COVID-19 pandemic on palliative care research, including trials, is more difficult to 
assess. As discussed in chapter one, the pandemic and the associated social distancing 
requirements has led to more flexible approaches to consent being accepted by research 
ethics committees. This may continue post pandemic which may have the potential to 
reduce patient, carer and clinician burden. The impact of the economic fallout of COVID-19 
on palliative care research is a concern. As discussed in chapter one, palliative care research 
is historically underfunded and has a limited infrastructure. Concerns have already been 
raised about the impact of the pandemic on future research funding and infrastructure 
outside the speciality of palliative care (Griffiths et al., 2020). This lack of funding could also 
have a detrimental impact on palliative care research, including randomised controlled 
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trials, over the next few years. This is a notable concern as the societal need for palliative 
care is predicted to increase substantially globally by 2060 (Sleeman et al., 2019). 
 
7.14 Conclusion  
 
The findings of this qualitative multiple case study suggest that the ‘Social Marketing Mix 
Framework’ provides useful practical guidance for those planning and implementing a trial 
recruitment strategy in the palliative care setting. This study has highlighted that many of 
the health care professional related issues that influence the trial recruitment process can 
be hidden and reflect wider contextual issues. Paternalism is present in palliative care 
research but why it occurs is complex. Professional hierarchies and power relationships 
between clinicians support paternalistic practices and influence how ‘emotional labour’ is 
experienced. The ‘emotional labour’ of recruiting to a palliative care trial for health care 
professionals needs to be recognised in order to address paternalistic practices. It needs to 
be addressed and managed by those responsible for designing and running palliative care 
trials as well as those organisations that employ clinicians involved in the recruitment 
process. It also needs to be recognised by health care professionals themselves. The 
requirement to take account of trial specific and local circumstances when applying the 
updated framework needs to be recognised. The findings of this study may also be useful for 
researchers and clinicians involved in palliative care research outside the context of 
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Appendix 1: Search strategy for the literature review in chapter two 
 




- palliat* or 
- hospice* or 
- terminal care or 
- terminal care/(not exploded) or 
- palliative care/or 
- palliative medicine/and 
- randomi*ed controlled trial* or 
- randomised controlled trial/ (publication and topic)  







- palliat* or 
- hospice* or 
- terminal care or 
- palliative care/or  
- terminally ill patients/or 
- terminal cancer/and 
- clinical trials/or 
- randomi*ed controlled trial* 






- hospice* or 
- terminal care or 
- palliative care/or 
- terminal care/(not exploded), and 
- Randomi*ed Controlled Trial*, or 
- Clinical Trials/(exploded), or 
- randomised controlled trial/ 
- limits:  human, 01/01/1990 to 08/10/2016, exclude Medline 
Embase via 
Ovid 
- palliat* or 
- hospice* or 
- terminal care or 
- exp palliative therapy/or 
- terminal care/and 
- randomi*ed controlled*  or 
- randomized controlled trial/ 




Appendix 2: A hierarchy of evidence tool, adapted for the purposes of this review 
(Eagar et al 2007). 
 
 
7 Very well supported evidence: barriers/facilitators/strategies evaluated with a 
systematic review, meta-analysis (this section has been added for the purposes of this 
review). 
 
6 Well supported evidence: barriers/facilitators/strategies evaluated with a prospective 
randomised controlled trial. 
 
5 Supported evidence: barriers/facilitators/strategies evaluated with a control group and 
reported in a peer-reviewed publication. 
 
4 Promising evidence: barriers/facilitators/strategies evaluated with a comparison group. 
 
3 Acceptable evidence: barriers/facilitators/strategies evaluated with an independent 
assessment of outcomes, but no comparison group (e.g. pre and post testing, post testing 
only or qualitative methods) or historical comparison group (e.g. normative data).  
 
2 Emerging evidence: (this section has been divided into two for the purposes of this 
review) 
 2 a Barriers/facilitators/strategies evaluated without an independent assessment 
of outcomes (e.g. formative evaluation, service evaluation conducted by host 
organisation).  
 2 b Suggested as a possible barrier/facilitator/strategy by a group of expert health 
care professionals e.g. through a consensus exercise (stronger evidence than 
single author/research team opinion).  
1 Expert opinion: (this section has been divided into three for the purposes of this review)  
 1a Expert opinion unsupported by evidence (Professional opinion):suggested as a 
possible barrier/facilitator/strategy by health care professionals 
 1b Expert opinion unsupported by evidence (Researcher opinion): suggested as a 
possible barrier/facilitator/strategy by researchers 
 1c Expert opinion unsupported by evidence (Participant’s opinion): suggested as a 









Applicant: Lesley Dunleavy  
Supervisor: Catherine Walshe/Nancy Preston  
Department: Health Research  
FHMREC Reference: FHMREC15042  
22 February 2016  
 
Dear Lesley  
 
Re: Recruitment of patients or family carers to palliative care randomised controlled trials via 
health care professionals: a qualitative case study  
 
Thank you for submitting your research ethics application for the above project for review by 
the Faculty of Health and Medicine Research Ethics Committee (FHMREC). The application was 
recommended for approval by FHMREC, and on behalf of the Chair of the University Research 
Ethics Committee (UREC), I can confirm that approval has been granted for this research project.  
 
As principal investigator your responsibilities include:  
 
- ensuring that (where applicable) all the necessary legal and regulatory requirements in order 
to conduct the research are met, and the necessary licenses and approvals have been obtained;  
- reporting any ethics-related issues that occur during the course of the research or arising from 
the research to the Research Ethics Officer (e.g. unforeseen ethical issues, complaints about the 
conduct of the research, adverse reactions such as extreme distress);  
- submitting details of proposed substantive amendments to the protocol to the Research Ethics 
Officer for approval.  
 
Please contact the Diane Hopkins (01542 592838 fhmresearchsupport@lancaster.ac.uk) if you 
have any queries or require further information.  




Dr Diane Hopkins  
Research Development Officer  





Appendix 4: Invitation email/letter to the trial’s Chief Investigator   
 
Dear Dr/Professor, 
I am currently undertaking a PhD in Health Research at Lancaster University and my area of 
interest is recruitment issues in palliative care RCTs. Recruitment is a real challenge in 
clinical practice with less than 50% of trials meeting their recruitment targets (Treweek et al 
2013). I obtained your contact details from the……………. database/website and I believe you 
are the Chief Investigator for the…………………..trial.    
 
I am contacting you to see if you would be interested in supporting my PhD research.   
I wish to explore how those involved in the recruitment process carry out the recruitment of 
patients or family carers to palliative care RCTs and to look at why they implement certain 
recruitment strategies and the factors that influence their choices. Having a better 
understanding of this process has the potential to help address this complex but key issue in 
clinical practice. 
 
I am using a qualitative case study approach and I would like to interview those staff 
members involved in recruitment both from the study coordinating centre and clinical 
recruitment centres as well as collect and analyse ,with the appropriate permissions, 
recruitment related trial documentation (not documentation containing identifiable 
patient/carer data).  
 
This study has been reviewed by the Faculty of Health and Medicine Research Ethics 
Committee, and approved by the University Research Ethics Committee at Lancaster 
University (approval letter attached with REC approved supporting documentation). 
 
 
What does taking part involve?   
 
 I would need you to forward the relevant study information to those within your 
study coordinating centre who have knowledge of the recruitment process for your 
trial. I would need you to confirm whether any management approval was required 
before you approached them about the study.  
 
I would need you to forward the relevant study information to the PIs at your clinical 
recruitment centres. If the PIs details are also in the public domain or you have their 
permission to pass their details on to me, I will also contact them directly, to see if their 
organisations are interested in taking part but would only do this once you have agreed to 
take part in the study. 
 
 If the PIs agree to support the study they will be asked to forward the study 
information to the recruiting staff in their centre. The PIs will be asked what 
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management approval will be required by their organisation to carry out the study 
before staff are approached.  
 
 The study information can be provided in electronic or paper format.  
Thank you for taking the time to read this email/letter. Please do not hesitate to contact me 
if you have any queries or questions about the study. If I have not heard from you within 2 






International Observatory on End of Life Care 
Faculty of Health and Medicine 





01524 592183 (office) 
 
Treweek, S., Lockhart, P., Pitkethly, M., Cook, J.A., Kjeldstrøm, M., Johansen, M., Taskila, 
T.K., Sullivan, F.M., Wilson, S., Jackson, C. and Jones, R., 2013. Methods to improve 
recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. 










Appendix 5: Example invitation letter/email to study participants 
 
Email/letter to the staff involved in the recruitment of patients or carers in each clinical 
recruitment centre                                     
Dear Dr, Sir or Madam, 
I am currently undertaking a PhD in Health Research at Lancaster University and my area of 
interest is recruitment issues in palliative care RCTs. Recruitment is a real challenge in 
clinical practice with less than 50% of trials meeting their recruitment targets (Treweek et al 
2013).  The Chief Investigator for the …………………..trial  and your Principal Investigator have 
kindly agreed to support my research. I am contacting you to see if you would be interested 
in taking part in my study.   
I wish to explore how those involved in the recruitment process carry out the recruitment of 
patients or carers to palliative care RCTs and to look at why they implement certain 
recruitment strategies and the factors that influence their choices. Having a greater 
understanding of this process has the potential to help address this complex but key issue in 
clinical practice. 
 
I have attached a participant information sheet which explains more about what is involved 
in taking part in the study. If you are interested in taking part in the study or have any 
queries or questions please do not hesitate to contact me on the contact details below. 
Thank you for taking the time to read this letter/email.   





International Observatory on End of Life Care 
Faculty of Health and Medicine 





Treweek, S., Lockhart, P., Pitkethly, M., Cook, J.A., Kjeldstrøm, M., Johansen, M., Taskila, 
T.K., Sullivan, F.M., Wilson, S., Jackson, C. and Jones, R., 2013. Methods to improve 
recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. 
BMJ open, 3(2). 
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Appendix 6: Study Participant Information Sheet 
 
Recruitment of patients or family carers to palliative care randomised controlled trials via 
health care professionals: A qualitative case study  
 
My name is Lesley Dunleavy and I am conducting this research for my PhD in Health 
Research at Lancaster University.  
 
What is the study about?  
 
Randomised controlled trials (RCTs) are accepted as the ‘gold standard’ for evaluating the 
effectiveness of interventions in health care. Recruiting the required number of participants 
to RCTs remains a major challenge and this is especially so in palliative care. The purpose of 
this study is to explore how those involved in the recruitment process undertake the 
recruitment of patients and/or family carers to palliative care RCTs and to look at the 
strategies they use and why they make the choices they do. Having a greater understanding 
of this process has the potential to help address this complex but key issue in clinical 
practice.   
 
Why have I been approached? 
 
You have been approached because the study requires information from people who have 
experience of recruiting patients and/or family carers to palliative care RCTs. We 
understand you are or have been recently involved in a palliative care RCT. The Chief 
Investigator of the trial has agreed to support the study but you are under no obligation to 
take part. We are approaching people to be interviewed with different roles and 
experiences of the trial recruitment process from the study coordinating centre or from 
clinical recruitment centres.  
   
Do I have to take part? 
 
No. It is completely up to you to decide whether or not you want to take part. If you do 
decide to take part, you will be given this information sheet to keep and be asked to confirm 
that you consent to take part in the study at the start of the recorded interview. If you do 
decide to take part, you are still free to withdraw without giving any reason. However, once 
your data has been anonymised and incorporated into themes it might not be possible for it 
to be withdrawn, though every attempt will be made to extract your data, up to the point of 
publication.  
 
What will I be asked to do if I take part? 
 
If you decide you would like to take part, you would be asked to:  
 
 Confirm on the audio recording that you agree with the non-optional statements on 




 Take part in a recorded telephone, WebEx/Skype or face to face interview with the 
researcher about your experiences of recruiting patients and/or family carers to a 
palliative care RCT. Participants who wish to use Skype should be aware that the 
internet cannot be guaranteed to be a completely secure means of communication. 
The interview will not involve discussion of individual patients and we must ensure 
that there is no disclosure of information about individual patients during the 
interview. The interview is expected to last around 30-60 minutes. 
 
The part of the study that is optional:  
 
 Confirm on the audio recording that you agree with the optional statement on the 
consent form.   
 
 Provide the researcher with any non-patient identifiable documentation related to 
trial recruitment such as participant information sheets, posters, staff training 
presentations.   
 
   
Will my data be identifiable? 
 
The information you provide will be anonymised. The typed version of your interview will be 
made anonymous by removing any identifying information including your name, the trials 
name and the name of the site where recruitment is taking place or has taken place. 
Anonymised direct quotations from your interview may be used in the reports or 
publications from the study, so your name will not be attached to them. Trial 
documentation collected and analysed as part of this case study will also be anonymised 
prior to being reported or published.  
 
However, given the small number of palliative care trials carried out in the UK, it is possible 
that you and the trial maybe identified because of information that is available about the 
trial in the public domain. We will take every step we can to anonymise the data and to use 
the data sensitively in this study. 
 
How will my data be stored? 
 
The data collected for this study will be stored securely and only the researcher and her 
supervisors will have access to this data. If a transcriber is used they will be asked to sign a 
Lancaster University confidentiality agreement and the audio files sent to the transcriber 
will be encrypted.   
 
Audio recordings will be deleted once the project has been examined. 
 Hard copies of written transcripts and study documentation will be kept in a locked 
cabinet. 
 





 At the end of the study, hard copies of written transcripts and study documentation 
will be kept securely in a locked cabinet for ten years. At the end of this period, they 
will be destroyed.  
 
 All your personal data will be confidential and will be kept separately from your 
interview responses. 
 
There are some limits to confidentiality: if what is said in the interview makes me think that 
you, or someone else, is at significant risk of harm, I will have to break confidentiality and 
speak to a member of staff about this.  If possible, I will tell you if I have to do this. 
 
What will happen to the results? 
 
The results will be summarised and reported in a thesis and may be submitted for 
publication in an academic or professional journal and presented at national and 
international conferences. You will not be personally identified in any report or publication. 
 
Are there any risks? 
 
There are no risks anticipated with participating in this study. However, if you have any 
queries or concerns following participation you are encouraged to inform the researcher on 
the contact details listed below.  
  
Are there any benefits to taking part? 
 
Although you may find participating interesting, there are no direct benefits in taking part. 
 
Who has reviewed the project? 
 
This study has been reviewed by the Faculty of Health and Medicine Research Ethics 
Committee, and approved by the University Research Ethics Committee at Lancaster 
University. 
 
Where can I obtain further information about the study if I need it? 
 
If you have any questions about the study, please contact the main researcher: 
 
Lesley Dunleavy 
International Observatory on End of Life Care, Faculty of Health and Medicine, Division of 







Dr Catherine Walshe 
International Observatory on End of Life Care, Division of Health Research, C52 Furness 
Building, Lancaster University, Lancaster, LA1 4YG, 01524 510124, 
c.walshe@lancaster.ac.uk   
Dr Nancy Preston 
International Observatory of End of Life Care, Faculty of Health and Medicine, Furness 




If you wish to make a complaint or raise concerns about any aspect of this study and do not 
want to speak to the researcher, you can contact:  
 
Professor Bruce Hollingsworth 
Head of Division       
Division of Health Research 
Faculty of Health and Medicine 
Lancaster University  




If you wish to speak to someone outside of the Division of Health Research, you may also 
contact:  
 
Professor Roger Pickup     
Associate Dean for Research      
Faculty of Health and Medicine  
(Division of Biomedical and Life Sciences)  
Lancaster University  















Appendix 7: Consent form 
 
Recruitment of patients or family carers to palliative care randomised controlled trials: A 
qualitative case study 
 
We are asking if you would like to take part in a research study that aims to explore how 
those involved in the recruitment process undertake the recruitment of patients and/or 
family carers to palliative care RCTs. Before you consent to participating in the study, we ask 
that you read the participant information sheet and confirm for the audio recording that 
you agree with each of the statements below. If you have any questions or queries before 
confirming your agreement to take part, please discuss the study with the main researcher, 
Lesley Dunleavy. 
 
Date of consent: Please confirm for the audio recording  
 
Name of participant: Please confirm for the audio recording 
 
Name of researcher: Please confirm for the audio recording 
 
1. I confirm that I have read the information sheet (version 2.1, dated 14/06/2017) and 
fully understand what is expected of me within this study  
2. I confirm that I have had the opportunity to ask any questions and to have them 
answered.  
 
3. I understand that my interview will be audio recorded and then made into an 
anonymised written transcript. 
4. I understand that audio recordings will be kept until the research project has been 
examined. 
5. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my legal rights being affected.  
 
6. I understand that once my data have been anonymised and incorporated into 
themes it might not be possible for it to be withdrawn, though every attempt will be 
made to extract my data, up to the point of publication. 
 
7. I understand that the information from my interview will be pooled with other 
participants’ responses, anonymised and may be published.  
 
8. I consent to information and quotations from my interview being used in reports, 
conferences and training events. 
 
9. I understand that given the small number of palliative care trials carried out in the 
UK, it is possible that myself and the trial maybe identified because of information 
that is available about the trial in the public domain. I understand that every step will 
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be taken by the researcher to anonymise the data and to use the data sensitively in 
this study. 
 
10. I understand that any information I give will remain strictly confidential and 
anonymous unless it is thought that there is a risk of harm to myself or others, in 
which case the researcher may need to share this information with her research 
supervisor. 
 
11. I consent to Lancaster University keeping written transcriptions of the interview for 
10 years after the study has finished. 
 
12. I consent to take part in the above study.  
 
The optional part of the study  
 
13. I agree to provide non-patient identifiable documentation related to trial 
recruitment such as participant information sheets, posters, staff training 
presentations. I understand that any trial documentation collected and analysed as 














Appendix 8: Interview Topic Guide  
This is a semi structured interview topic guide for those professionals/staff members 
involved in recruitment for the palliative care randomised controlled trials selected as 
‘cases’ for this study. The interview topic guide will be iterative and flexible and the topics 
listed below may not necessarily be covered in order. It will be adapted as appropriate to 
reflect the individual characteristics of the trial and whether staff from the study 
coordinating centre is being interviewed or those from a clinical recruitment centre. The 
interview schedule may be modified and developed further as a result of the interview 
responses. How the topic guide relates to the ‘6 Ps’ has been highlighted. 
 
 The participant’s professional and work experience related to research and 
palliative care.  
 
 Roles and responsibilities, team composition (Working with partners: partner 
referrals and recruitment) and the characteristics of the setting/s where 
recruitment activity takes place (Place). 
  
 Characteristics of the trial such as inclusion/exclusion criteria guided by the 
documentation obtained about the trial prior to the interview. (Product: defining 
the product/Identifying Participants: defining the target audience). 
 
 Recruitment procedures for trial participants (How identified, approached and 
consented) (Working with partners: partners referrals and recruitment, Promoting 
the study, Price) 
 
 Exploration of phraseology used to discuss the trial with participants (Promoting 
the study). 
 
 How well the trial is recruiting or has recruited.  
 
 What factors have helped or hindered recruitment to the trial. (Dependent on the 
responses of the participant) 
 
 Recruitment strategies (Dependent on the responses of the participant) 
 
 Lessons learnt about recruitment (Dependent on the responses of the participant) 
 





























Hospice Cancer Single Medical clinician Charity 
3 Feasibility 
trial 








Hospital Cancer Multiple Medical clinician Charity 
5 Parallel 
trial 
Psychological intervention Hospital/ 
hospice 























Artificial hydration  Hospital/ 
hospice  
Cancer Multiple Academic/medical 
clinician 
Public 
9 Phase 2 
placebo 
trial 






















Unknown Cancer Unknown Academic Public 
13 Feasibility 
trial 
Music therapy Hospice Cancer Single Academic Charity 
14 Feasibility 
trial 




control intervention for 
carers 












Hospital Cancer and 
non-cancer 





Hospital Cancer and 
non-cancer 
















Appendix 11: An example section of charting (original data summarised with short summary in bold) from case two for the 









Multi-disciplinary team meeting Screen clinical notes/clinic lists 
Chief 
Investigator, 
case two  
 All potentially eligible patients discussed at MDT. They 
were lucky in that everybody with a diagnosis of (name of 
diagnosis) comes through a cancer multi-disciplinary team. 
 
Specialist nurse 
one, case two 
  Research nurses screened referral and patient lists.  
Research nurses looked at the referral and patients 
lists so they would all be aware of who was coming 
to clinic and who was suitable. 
Specialist nurse 
two, case two 
 
   
Doctor, case two  All patients with (name of diagnosis) come through their 
(name of speciality) MDT so identified there and decision 
made regarding what trial to discuss. All of the patients with 
(name of diagnosis) come through their (name of speciality) 
MDT so they were identified there. Decision made at that 
point which way we thought they were going to go. If fit 
enough for chemotherapy/radiotherapy trial, they would see 
the oncologist. The nurse specialist would not talk to them 
about (name of trial). If not really suitable for treatment the 




they got their diagnosis from the (name of speciality) 
consultant and give them the information at that point. 
Research nurse 
one, case two 
 Patients would normally be identified at the MDT. Patients 
would normally be identified and discussed at the MDT. That 
is where they would get their initial diagnosis so they would 
be picked up then if we did not know about them previously. 
Check clinic lists for eligible patients. Checks clinic 
lists for the (name of speciality) clinics. 
Research nurse 
two, case two 
 Identify patients through the (name of speciality) MDT, PI a 
senior physician within the MDT, he is very proactive, 
process works well in practice. Identify patients through the 
(name of speciality) MDT. RN would forward all the details of 
the study comprehensively to everybody who attends the 
MDT and also have printed sheets of inclusion/exclusion 
available. PI for (name of trial) is a senior physician within 
that MDT and he is very very proactive. Feels process works 
well in practice. 
 
Research nurse 




Cancer MDTs where they pick up a lot of their patients, 
thinks it is quite good, also have a regional MDT that runs 
at her site. RNs would attend the cancer MDT for the newly 
diagnosed patients. That is where they pick up a lot of their 
patients and get the results and she thinks it is quite good.  
Also have a regional MDT that runs at her site so all of the 
regional patients come through them, so feels they are quite 
lucky in that respect. 
Screen from notes, clinic letters, pathology, scans. 
Recheck the details in the notes, screen all the 
clinics. Screen for eligible patients from the notes, 
clinic letters, pathology, scans and things. Even if 
already aware of patients, they recheck the details in 
the notes. Before clinic, RNs screen all the clinics and 
pick eligible patients up from there.   
Research nurse 




Screens notes, letters, pathology reports and clinics 
lists, doctors do not look at the nitty gritty of the 
inclusion criteria. She would read the notes, clinic 
letters/lists and pathology reports to identify 
patients and to make sure they actually fit the 
criteria. Expressed that doctors do not look at the 
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nitty gritty of the inclusion criteria. Feels RNs should 
have the time to scrutinise the criteria and look 
through the notes properly. She likes doing things 
properly, thinks she is a control freak. 
Research nurse 
five, case two  
Made aware of patients through MDT, gets an email about 
the outcomes of the meeting, other team members attend.  
Made aware of patients diagnosis through the MDT meeting. 
Does not attend that meeting so much these days because of 
time, gets an email about the outcomes of that meeting. 




Patients screened for eligibility in the MDT. All new patients 





sheet, case two 
Patients screened for eligibility in the MDT. Discussion of 
your case with a number of different cancer specialists we 





Appendix 12: An example section of descriptive mapping charting for the classification ‘Working with partners: Partner 











Easier in the intervention wards as facilitator who provided 
training on how to support patients and carers at the end-
of-life. Much easier in the intervention wards, facilitator who 
worked with clinicians to help them understand what 
(inclusion criteria) was, not to be frightened of it, she 
provided training for them in supporting patients and their 
family members. Some RNs had not worked in end-of-life 









Preparation for sensitive conversations 
(category) 
 
Training/formal training (sub-categories) 
 
 






Palliative care clinical shadowing for RNs   
RN with no palliative care clinical experience did some 
shadowing in clinical practice to increase her understanding 
of palliative care. 
Takes time and skill to assess and consent patients with 
cognitive impairment. RNs were unfamiliar with procedures 
in non-drug trials. Preparation and training needed. A lot of 
patients in one site were assessed as lacking capacity, when 
researchers met patients they felt they probably had capacity 
but were unwell. The consent process required a lot of 
facilitation and enablement. She felt it takes time and skill to 
explain a study to someone who might have a degree of 














Preparation for sensitive conversation 
(category) 













lack of capacity regulation in drug trials but they had never 
used an advance consent or consultee before and they were 
learning. Felt that should have prepared the RNs better and 








Clinical educator made staff feel more comfortable talking 
to patients and carers. Staff in the intervention arm felt much 
more comfortable speaking with the patients and relatives 
after a while as they had a clinical educator who worked with 
them for several months. 
 
 
Clinical educator  
 
 
Preparation for sensitive conversation 
(category) 
Training/formal training (sub categories) 
Research 
nurse one,  
case three 
No experience of patient denial, new situations. Accessed 
support from colleagues, RN colleagues did not want to 
work on study as felt uncomfortable and no palliative care 
experience. Never dealt with patients in denial before, a real 
shock for her, really interesting situations that had never 
come across before and did not know what to do. Accessed 
valuable support from the ward team, lead palliative care 
nurse and the Principal Investigator. Other research nurses in 
the team did not want to be involved in the study due to lack 
of experience and feeling uncomfortable. Details of clinical 









Using a ‘core team’ 
 
Preparation for sensitive conversation 
(category) 
 
Previous relevant clinical 
experience/previous experience of 
talking to palliative care patients and 
carers (sub-categories) 
Discussions with colleagues/research 
team discussions/discussions with the 




Some RNs lacked experience and felt uncomfortable 
approaching palliative care patients, used a core team of 
nurses, needs to be considered. Some of her team did not 
like approaching eligible patients as they were not used to 
this type of patient. They managed this as a team by only 
involving core people who were comfortable and this did 
improve the situation a little. Felt important to think about 
who approaching patients to make sure comfortable and 







using a ‘core team’ 
 
 
Preparation for sensitive conversation 
(category) 
 
Previous relevant clinical 
experience/previous experience of 
talking to palliative care patients and 
carers (sub-categories) 
Discussions with colleagues/research 
team discussions (sub-categories) 
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recruiting a couple of patients as you get used to what you 








More experience of palliative care studies would give you 
more confidence. Previous clinical contact helps. Did not 
think she was adequately prepared to approach patients 
about this study, having more ‘exposure’ to end-of-life care 
studies would give you a little bit more confidence. Patients 
she approached were already known to her, easier as you 
knew what they understood about their condition.   









Preparation for sensitive conversation 
(category) 
Training/informal training (sub- 
categories) 
Previous relevant clinical 
experience/previous experience of 




RNs fearful of having conversations, surprised at patient 
response, supported them through the process. New area of 
practice for RNs, those with palliative care experience 
supported those with less experience. Thought the RNs were 
fearful, they thought it was going to be worse than it actually 
was, patients were much more open about having those sorts 
of conversations, were quite surprised at how much the 
patients felt the benefits. He nurtured them through that 
process of understanding what it is like in palliative care and 
it is not as scary as it seems.  
Experienced team of RNs, some found it was a new area, 
more used to intervention trials. Patient conversations more 
challenging as talking about new issues, some had more 
experience of those sorts of conversations because of nurse 
training, providing support to the nurses who were a bit less 
















Preparation for sensitive conversation 
(category) 
 
Discussions with colleagues/research 
team discussions/discussions with the 





Previous relevant clinical 
experience/previous experience of 
talking to palliative care patients and 
carers (sub-categories) 
Discussions with colleagues/research 
team discussions (sub-categories) 
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Preparation for sensitive conversation 







Research nurse is highly trained to talk about sensitive issues 
but can refer to a colleague if required.  
Nursing 
background 
Preparation for sensitive conversation 
(category) Previous relevant clinical 
experience/previous experience of 











Appendix 13: Final analytical framework 
Classification  
 































National Institute for Health 
Research (NIHR) Clinical 
Research Network 
funding/support 
Expression of interest clinical area of interest 
Clinical professional 
networking 




Reputation as a good clinical 
recruitment centre 
clinical recruitment centre screening log, previous 
similar trial experience, previous recruitment record 
Clinical recruitment centre 






Who identifies potential 
participants 
 doctors, principal investigators, research nurses, 
specialist nurses, inpatient nurses 
Initial screening   Multi-disciplinary team 
meetings 
screening by memory, screen for multiple studies, 
research nurse has a ‘presence' in handover, team 
'recce'/discussions, email referrals 
Screening tools telephone reminder for principal investigator,  
screening crib list for research nurse, nurse led 
telephone line, screening logs, patient lists 
Clinicians apply own 
eligibility criteria 
personality, patients do not want to be bothered, 
patients have too much going on, patient advocate 
Confirming eligibility Active questioning symptom assessment 















Type of eligibility 
criteria 





objective measure, subjective criteria, 
performance status scale, clinical judgement, risk of 




Level of patient 
and carer interest 
in the trial 
Patient/carer interested  not a drug trial, pilot study, regular research nurse 
contact and support even in control arm, popular 
study/also includes carer, access to intervention after 





no treatment, extra hospital visits, not interested in 
any trial, intervention not needed, not ready to talk 






 implementing the blinding process, do not know if 
better or as good as standard care, maintaining a 
balance between the two arms, not over promoting  
the intervention arm, patients disappointed when 
allocated to the control, information they provide of 
equal benefit, not disadvantaged by being in the 
control arm, patients have preconceived ideas about 
which arm they want to be in 
Maintaining equipoise 
among clinical staff 
maintaining clinical staff blinding, clinical staff have 






  competing trial discussions, order of priority for 

















 not in right frame of mind, overwhelmed with 
information, dealing with uncertainty, level of 
acceptance of diagnosis 
Unstable/fluctuating 
condition 
deterioration, fatigue/tiredness,  too poorly, 
complex symptoms, symptom burden, frail 
disease group, cognitive impairment 
Participants  
motivations for 
taking part in the 
research 
Altruism  give something back to help others  
Purpose  do something valuable, gives them purpose  
Potential benefit for 
themselves 
benefit to themselves, nothing else working, nothing 
to lose,  participate in something together, somebody 
interested in them 
Costs for carers Carer gatekeeping 
 
 not an issue, family raise concerns, ‘heavy’ 
gatekeeping, family annoyed 
Proxy consent time commitment 
Costs for research 
nurses 
  limited support, working in isolation, time pressured, 






Reduce data collection 
burden 
 pilot study, study length, short questionnaires, 
questionnaires too long 
Consent process research nurse support required to go through 
participant information sheet, simpler consent 
process, vary amount of information given 
Choosing the best time 
to approach patients 
visiting time, not at time of admission, short window 
between diagnosis and randomisation, before 
treatment, time of diagnosis, post diagnosis follow up 
appointment, re-approach, assessed on a patient by 










Good support network  principal investigator support, specialist nurse 
support, clinical supervision, reflective practice,  
administrative support, ward team support 
Place  Pool of potential 
participants 
Recruiting from a single 
centre 
 low incidence of symptom burden,  
size of recruitment centre (hospice inpatients)   
Recruiting from multiple 
centres 
 
high incidence of disease burden,  
fluctuating rates of eligible patients, ’patients are like 
buses’ 
Understanding 
the patient’s care 
pathway 
 
Recruiting from a 
specialist hospital 
 diagnostic centre, recruitment centre catchment area 
(hospice catchment area), competing recruitment 
centres 
Recruiting from a non-
specialist centre 
hospital inpatients overestimating eligibility rates 




Distance to travel  travel to specialist centre, travel costs covered 
 











Resource issues Availability of staff to 
support the research 
Clinician rotation-turnover medical staff rotation  
Research nurse availability small part-time research team 
Principal Investigator 
availability 
small part-time research team, propping up clinical 
services 





Limited research funding  
 
funding from commercial studies, no funding for 








Category Sub-category Sub-category Elements 
Research governance issues 
 
 
research naïve clinical units, research governance 






Medical staff  
 
not ethical to be doing research with this population, 
overprotectiveness, reluctance to diagnose dying 
 





adapt the protocol, overt/covert 
Research nurses 
strategies for managing 
gatekeeping 
 
Accept clinical staff’s opinion 
 
not always appropriate to approach, accept certain 
clinical staff’s opinion 
 
Bypass clinical staff 
 
bypass medical staff, bypass nursing staff, all patients 
should be offered research, seek second opinion 
Lack of clinician 
engagement in 
research 
Lack of medical staff 
engagement 
 
 limited knowledge of randomised controlled 
trials/research, research not seen as important,  
some more engaged than others, staff too busy 




 staff too busy 






promotion of research 
 centre of excellence, want to improve care,  
research is core business 
Visibility on the internet social media, trial website 
Trial branding acronym, merchandise 
Working with national 
organisations 





Category Sub-category Sub-category Elements 




Symptom control looking at quality of life, amended study title to focus 
on symptom control, fewer symptoms, not just end of 
life care, not interfere with treatments  
Extra support extra support for patients, extra support for families, 
something slightly different 
Talking about death associate with end of life, bereaved carer 
questionnaire, hospice care, ask questions about 
prognosis, advance care planning, loss of a loved one 
Explaining 
randomisation 
 clinical team unaware of allocation, clinical staff no 
control over allocation, patient no control over 
allocation, tossing a coin, use percentages, decided by 
computer, difficult to understand, patients struggle to 




Using the participant 
information sheet 





Patient and public involvement input 
 Building trust and 
rapport 
Engaging family carers  Joint patient/carer discussions, joint decision, carer 
participant, carer non participant, courtesy to involve 
Previous clinical contact dual clinical roles, explain differences in roles to 
patients 
Stress voluntary nature 
of taking part 
being honest about what is involved, not affect care if 










Initial approach First approach by doctor principal investigator approaches first, lead clinician 
approaches first, doctor seeks patient permission for 
research nurse to approach 
First approach by specialist 
nurse 
specialist nurse seeks patient permission for research 
nurse to approach 
First approach by specialist 
nurse and doctor 
 
Follow up contact Face to face follow up medical permission for research nurse to approach 
patients, research nurse/doctor/specialist 
nurse/principal investigator follow up/multiple follow 
up visits/proxy consent 






















Previous experience of 
discussing randomised 
controlled trials with patients 
and carers  
nursing background 
 
Previous experience of 
talking to palliative care 





Research team discussions using a ‘core team’ 
Discussions with the 
palliative care team 





Formal training clinical educator, clinical shadowing, assessing 
capacity, advance consent/involving consultees 
Informal training knowing the study inside out, learning from other 
















Research champion Dedicated specialist nurse nurse principal investigator 
Support of lead clinician medical principal investigator, consult service, 
principal investigator on site, selection of principal 
investigator pragmatic choice 
Personal repeated 
contact with clinicians 
Formal strategies 
 
presentations, attend staff meetings, email 
communication, dissemination of research findings, 
attend handover/multi-disciplinary team meeting 
Informal strategies 
 
one to one contact, being approachable, networking, 
provide research advice and support, being 
accessible, out of hours support 
Engaging 






contact with clinical  
recruitment centres 
Site initiation process 
 
provide study materials, opening sites remotely 
Ongoing trial management 
support and advice 
 
site visits, email communication, trial teleconference  
newsletters, incentives (recruitment tariff, IPad), close 





Appendix 14: Within case analysis 
 
In this appendices, a summary of the within case analysis findings for the three cases is 
presented in relation to the ‘6 Ps’ of the ‘Social Marketing Mix Framework’, as this was the a 
priori framework used in this study. An ‘abbreviated vignette’ of each of the three cases is 
presented in chapter five to provide contextual information for the detailed cross-case 
analysis in chapters five and six. The summaries below highlight the differences in clinical 
setting and study design between the three cases. The cases were purposively selected 
because of these differences to reflect the concept of theoretical replication as discussed 
previously (Yin, 2018). 
As discussed in chapter five, data collection for the three selected cases was carried out 
sequentially and occurred between March 2017 and June 2018. Nineteen participants took 
part in a telephone interview and the mean interview length was 39 minutes (range 25–60 
minutes). The data collection details for each of the individual cases is included in the 




Case one largely took place in a single voluntary organisation. Another specialist palliative 
care unit also recruited a small number of participants to this study but they were unable to 
take part in an interview due to staffing shortages. All of the recruiting staff involved in the 
trial at the primary voluntary organisation agreed to take part in a telephone interview. The 
main research nurse for this study worked part time and often on her own. The Chief 
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Investigator also worked in another organisation so was not always available to recruit to 
the trial. As the study was taking place in a charitable organisation and outside the National 
Health Service, a volunteer was used for research administrative support. The organisation 
funded research nurse time by working on studies that had financial incentives including 
commercial studies. One of the research nurses also had a clinical role within the 
organisation.  
 
Case one ‘vignette’ 
 
 
Characteristics of the case 
Trial design A double blind non-pharmaceutical placebo controlled trial 
Intervention Non-pharmaceutical intervention  
Control Non-pharmaceutical placebo 
Participants Patients with advanced cancer 
Primary Outcome Symptom control 
Study duration  ≤ one week 
Single or multi 
centre 
Largely single centre 
Setting Hospice inpatients 
Recruitment 
target 
The recruitment rate was described as slow and at the time of data 
collection, approximately 83 % of the recruitment target had been 








In summary in case one, medical staff, usually the Chief Investigator, 
would initially approach the patient about the trial in the inpatient 
unit:  
‘I think largely it’s for me to identify people on our ward 
rounds or when we go and see them. This is a study that is 
looking at hospice inpatients and then I’ll flag them up, I’ll 
mention the study to the patient and then flag them up to the 
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research nurse to go and have a further chat with them.’ 
(Chief Investigator, case one) 
 
The research nurses would then discuss the study with the patient, 
provide written information and if the patient wished to enter the 
trial, they would then obtain written informed consent.  
Participant characteristics, data collected and analysed  








38 minutes (range 25-55)  
Type of 
participant 
Principal Investigator/Palliative Medicine consultant (also the Chief 
Investigator for the trial)=1 
Research nurse=2 
Prior experience 
in palliative care 
trial recruitment 
All of the participants were experienced in recruiting to palliative care 






Study protocol, patient information sheet, patient consent form, GP 
letter, UK Clinical Trials Gateway website, results paper. 
 
 
Summary of the within case analysis for case one 
 
 
Identifying participants: defining the target audience 
 An estimation of the patient’s prognosis was required when determining eligibility. 
 Patients could not take part in the study if they were sharing a room with 
somebody already in the trial to avoid contamination. 
Product: Defining the product 
 A pilot study assessed the trial’s acceptability to patients. 
 Patients could continue on their symptom control medication and access extra as 
needed. They could access the intervention after the trial if they found it helpful.  
 Managing patient disappointment when allocated to the control arm was less of 
an issue in this trial as it was not a pharmaceutical symptom control trial. 
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Product: The product’s competition 
 Patients were ineligible if they or a close relative had used the intervention before. 
The intervention was routinely available so this excluded quite a few participants 
Price: ‘Type of Costs’ and Price: ‘Minimising the costs’ 
 Symptom burden and fatigue had an impact on the patient’s ability to engage in 
the recruitment process. 
 To minimise study burden, research nurses would read and go through the 
participation information sheet and consent form with patients. 
 Recruiting staff felt that the trial was attractive to patients, as it only required a 
small amount of their time.  
 Carer gatekeeping did not appear to be an issue in this trial. 
 Research nurses allowed patients time to process or digest what was happening to 
them before introducing the trial (generally not within 48 hours of admission). 
 Working within the hospice as a research nurse could feel isolating and not like 
working as part of a hospital team.  
Place 
 The recruitment rate was described as slow as they were largely recruiting from a 
single centre voluntary organisation with a small number of beds.  
Promoting the study 
 The hospice promoted research as part of its ‘core business’ (Chief Investigator, 
case one).   
 The research nurses used a flexible and respectfully persistent approach when 
recruiting patients because of their physical, psychological and emotional well-
being and the need to work around clinical care and family visiting times. 
 Research nurses would seek medical permission before approaching patients 
about the trial. 
 Research nurses felt it was important to engage carers in the recruitment process 
to build trust and rapport because of the patient’s vulnerability.  
 There was a need for key and careful messaging when explaining the concept of 
randomisation as it was a difficult concept for patients to understand.  
Working with partners: barriers to partnering 
 Health care professional gatekeeping was an issue but research nurses did not 
always accept the clinician’s view that the patient was not eligible. This was 
dependent on how much they trusted the opinion of the staff member. They 
would sometimes seek a second opinion from the lead medical clinician who was 
the Chief Investigator. 
 A useful strategy for managing gatekeeping was identifying and using the support 
of staff who were the most engaged in research. 
 Clinician rotation and turnover in the hospice made medical staff engagement 
particularly challenging for the research nurses. 
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Working with partners: partner education  
 The ‘research champion’ was the lead medical clinician in the hospice.  
 Research nurses used a number of strategies to engage with clinicians including 
one to one contact, email communication, research presentations and attending 
staff and multi-disciplinary team meetings.  
Working with partners: partner referrals and recruitment  
 Research nurses attended the inpatient unit ‘handover' to screen for potential 
participants. 
 Confirmation of trial eligibility required checking with the patient that they were 
still symptomatic. 
 The Chief Investigator was proactive and networked with medical colleagues to 
promote his organisation as a potential clinical recruitment centre. 
 
In summary, case one was a double blind non pharmaceutical placebo controlled trial for 
symptom control, largely recruiting patients with advanced cancer from inpatients within a 
single voluntary organisation. The recruitment rate was described as slow with ≤ 60 patients 
recruited over a 7.5 year period. The Chief Investigator was a doctor and all of the 
interviewees were experienced in recruiting to palliative care studies, including trials. 
Clinician prognostication was required when ‘identifying participants’. Managing patient 
disappointment when they were randomised to the control arm was less of an issue in this 
trial as the ‘product’ was not a pharmaceutical symptom control intervention. Research 
nurses supported symptomatic and fatigued patients through the recruitment process to 
‘minimise the costs’ of taking part. They would seek medical permission to ‘promote’ the 
trial to patients and used key and careful messaging when explaining randomisation. Health 
care professional gatekeeping and clinician rotation and turnover was a ‘barrier to 
partnering’. Research nurses used a number of ‘partner education’ strategies to engage 
clinicians in the recruitment process and the lead medical clinician was the ‘research 
champion’ within the organisation. The inpatient unit ‘handover’ was used to screen for 
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eligible ‘partner referrals’ and the Chief Investigator used their medical contacts to promote 




In this case study, five clinical recruitment centres out of the 18 that were approached via 
the study coordinating centre agreed to take part and this included three specialist tertiary 
centres. All but one of the clinical recruitment centres that agreed to take part, a specialist 
tertiary hospital, had met their recruitment targets. Two of the sites that agreed to 
participate had recruited the highest number of participants in the trial. These sites were 
the study coordinating centre and a specialist tertiary hospital. Nine out of the 15 recruiting 
staff approached across the five cases agreed to participate in an interview. The main 
reason, when given, for staff declining to take part in the study was lack of time. 
 
Case two ‘vignette’ 
 
 
Characteristics of the case 
Trial design Two arm parallel trial, no blinding 
Intervention Complex service intervention  
Control  Usual care 
Participants Patients (and their family carers) newly diagnosed with advanced 
cancer (within six weeks of diagnosis and not on chemotherapy at 
time of enrolment) 
Primary Outcome Quality of life 
Study duration  24 weeks 
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Single or multi 
centre 
Multi centre 
Setting Secondary or specialist tertiary hospital outpatient departments 
Recruitment 
target 
≤ 200 patients in 2 years over 10 sites 
Recruitment 
achieved 
≤ 200 patients in 30 months over 20 sites  
Recruitment 
procedures 
In summary in case two, the lead medical clinician and/or specialist 
nurse would initially approach the patient and carer about the trial in 
the outpatient department. Depending on the clinical recruitment 
centre, the research nurse, specialist nurse or doctor would then 
follow the patient up and obtain written informed consent from 
those participants who wished to take part in the trial. 
Participant characteristics and data collected and analysed 
Period of data 
collection 






36 minutes (range 25-52)  
Type of 
participant 
Principal Investigator/Hospital consultant (also the Chief Investigator 
for the trial)=1 
Principal Investigator/Hospital consultant=1 




in palliative care 
trial recruitment 
The Chief Investigator, also the Principal Investigator in the study 
coordinating centre, was an experienced hospital consultant and 
clinical researcher in (name of speciality) medicine. They were a 
generalist palliative care professional rather than a specialist 
palliative care professional. In the other participating centres, the 
Principal Investigators were hospital consultants apart from one site, 
a specialist tertiary centre, where the role was carried out by a cancer 
specialist nurse. This was not the first time the specialist nurse had 
taken on the role of Principal Investigator in a (name of speciality) 
trial. All of the interviewees were experienced in recruiting to trials 
but case two was the first specific or ‘overtly’ (Specialist nurse two, 
case two) palliative care trial they had recruited to. All of the clinical 
recruitment centres had research nurse support and in one of the 
sites, the research nurses had both clinical and research roles. The 
research nurses that were interviewed came from a variety of nursing 
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backgrounds but currently worked on oncology studies. Both of the 
cancer specialist nurses that took part in this study had worked in this 





Study protocol, patient information sheet, patient consent form, 
carer Information sheet, carer consent form, carer GP letter, patient 
study recruitment poster, trial recruitment figures for each hospital 
site, monthly recruitment figures for site four, an invitation to 
participate in the trial for clinical recruitment centres, ‘Frequently 
asked questions’ document for health care professionals, published 




Summary of the within case analysis for case two 
 
 
Identifying participants: defining the target audience 
 The inclusion criteria included a performance status scale to aid prognostication. 
 The eligibility criteria were broad which facilitated recruitment to the trial.  
Product: Defining the product 
 Research nurses felt patients were interested in the trial as it involved both 
patients and carers, and ensured regular research nurse support, even in the 
control arm. 
 Research nurses described how some patients and carers were not interested in 
the trial. This could be because; it was not a treatment trial; they felt they did not 
need the intervention; they did not want to commit to the extra hospital visits or 
they were not interested in taking part in any trials.  
 Patients and health care professionals were not always in clinical equipoise. 
 Managing patient disappointment when they were allocated to the control arm 
was less of an issue for recruiting staff in this trial as it was not a treatment trial. 
Patients could still access support in the control arm.  
Product: The product’s competition 
 Competing treatment trials recruiting from the same patient population was a key 
barrier to recruitment especially in the specialist centres. Treatment trials were 
prioritised by health care professionals. 
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 There was only a short window of opportunity for recruiting staff to enrol patients 
into the trial (within six weeks of diagnosis and before was chemotherapy 
commenced).  
Price: ‘Type of Costs’ and Price: ‘Minimising the costs’ 
  Recruiting staff were concerned about the patient’s psychological and emotional 
well-being as they had just been diagnosed with advanced cancer. 
 Nurses felt it was important to adopt an individualised approach when introducing 
the trial to patients and carers.  
 Research nurses felt carer gatekeeping was not a notable issue in this trial. 
Place 
 Having to travel to the hospital sites and the difficulties of parking deterred some 
patients from taking part in the trial.    
 There was a need for the study coordinating centre to understand the patient’s 
care pathway to identify when patients may be receptive to receiving information 
about the trial. 
Promoting the study 
 The study coordinating centre had a presence on the internet and used trial 
branding to promote the trial.  
 There was a need for key and careful messaging when explaining the concept of 
randomisation as it was a difficult concept for patients to understand.  
 Patients and carers could often associate palliative care with end-of-life care. 
Explaining palliative care could be challenging for recruiting staff and they 
explained it in terms of symptom control and extra support. 
 There was a requirement to discuss a bereavement questionnaire at the time of 
consent which could make research nurses feel uncomfortable. 
 Previous clinical contact with the patient made promoting the trial less demanding 
for research nurses.  
Working with partners: barriers to partnering 
 Research nurses and medical staff aced as gatekeepers in this trial. 
 Some eligible patients were missed as research nurses were unavailable as they 
were working on other studies. 
Working with partners: partner education  
 The study coordinating centre kept in regular contact with clinical recruitment 
centres to promote engagement.  
 Research nurses gained their experience of caring for palliative care patients while 
working in oncology and/or on oncology trials. 
 Research nurses prepared themselves for sensitive discussions by discussing as a 
team and sometimes seeking advice from the palliative care team. 
 Specialist nurses acted as research champions in this trial. They played a key role 
in the recruitment process and the research nurses valued their input. 
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Working with partners: partner referrals and recruitment  
 The cancer multi-disciplinary team meeting was a key strategy for identifying 
eligible patients in this trial.  
 Clinical recruitment centres were recruited via the National Institute for Health 
Research Clinical Research Network and the professional medical contacts of the 
Chief Investigator. 
 Organisations needed to demonstrate their reputation as a good clinical 
recruitment centre to be involved in the trial.  




In summary, case two was a multi-centre parallel trial of a complex service intervention for 
patients (and their family carers) newly diagnosed with advanced cancer. The trial recruited 
from secondary or specialist tertiary centre outpatients and ≤ 200 patients were recruited in 
30 months over 20 sites. The Chief Investigator was a doctor and the Principal Investigators 
were doctors apart from one site where the role was carried out by a specialist nurse. All of 
those interviewed were experienced in recruiting to trials but this was the first palliative 
care trial they had recruited to. The trial’s eligibility criteria were broad which facilitated 
‘identifying participants’ but patients and health care professionals were not always in 
clinical equipoise. The ‘products competition’ were treatment trials recruiting from the 
same patient population. Patients were newly diagnosed with advanced cancer so recruiting 
staff were concerned about their emotional well-being, and so they adopted an 
individualised approach when introducing the trial to ‘minimise costs’. Travel to and limited 
parking at the ‘place’ of recruitment deterred some patients from taking part in the trial. 
Explaining palliative care could be challenging for recruiting staff but having had previous 
clinical contact with the patient made ‘promoting’ the trial less demanding. Research nurses 
working on other studies was a ‘barrier to partnering’ in this trial. Specialist nurses acted as 
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‘research champions’ in case two and research nurses used their colleagues and the 
palliative care team to prepare for sensitive discussions with patients and carers. Cancer 
multi-disciplinary team meetings were used to identify potential participants and clinical 
recruitment centres were recruited via the National Institute for Health Research and the 




In case three, all of the study coordinating centre staff agreed to take part in a telephone 
interview and four out of the 11 recruiting staff approached agreed to participate in the 
study. The main reason, when given, for staff declining to take part in the study was lack of 
time. All of the staff interviewed were from two of the clinical recruitment centres that had 
not reached their recruitment targets. One of these centres had been delayed opening due 
to staffing issues but once opened reached nearly half of its target within three months. 
 
Case three ‘vignette’ 
 
Characteristics of the trial 
Trial design Feasibility, parallel cluster trial  
Intervention Complex organisational level intervention 
Control  Usual care 
Participants Advanced cancer and non-cancer patients at the end of life (or proxy 
if required) 
Primary Outcome Symptom control and quality of life 
Study duration  2 weeks 





Setting Hospital inpatients (general medical wards) 
Recruitment 
target 
 40-45 patients in each arm over three months. 
Recruitment 
achieved 
Only half of the sites reached their recruitment target with 
recruitment taking longer than the anticipated three months. One of 
the sites (intervention) took six months to reach its recruitment 
target while the other (control) took four and a half months. 
Recruitment 
procedures 
In summary in case three, usually the trial would be initially 
introduced to the patient by the lead medical clinician. In the 
intervention arm, a specialist nurse was employed to coordinate the 
implementation of the intervention and they would sometimes 
introduce the trial to the patient. The research nurses would then 
approach the patient to discuss the study further and obtain written 
informed consent from those who wished to take part in the trial. If 
the patient lacked capacity, a consultee would be approached to 
provide proxy assent: 
‘…so you know if she’d been in (specialist nurse) she would say 
to me when I got on the ward right this patient’s done, fully 
discussed, documented, they’re aware of the study, you just 
need to go in and talk to them.’ (Research nurse one, case 
three) 
Some research nurses declined to work on the trial and the reasons 
why are explored in chapter six.  
Participant characteristics and data collected and analysed 









43 minutes (range 32-60) 
Type of 
participant 
Chief Investigator/senior academic (non-medical professionals)=2  
Researcher based in the study coordinating centre=1 
Principal Investigator (control arm)/Palliative medicine consultant=1 
Research nurse (intervention arm)=1 
Research nurse (control arm)=2 
Prior experience 
in palliative care 
trial recruitment 
The Chief Investigators were experienced palliative care researchers 
but one of them had not worked on a trial before. The Principal 
Investigator that was interviewed had been involved in palliative care 
randomised controlled trials previously but this was their first cluster 
trial. All of the nurses were experienced research nurses and had 
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experience of recruiting to trials. Two of the nurses had worked on 





Study protocol, patient information sheet (intervention and control), 
patient consent form, carer Information sheet (intervention and 
control), carer consent form, consultee information sheet (control 
and intervention), consultee approval form for continued 
participation if capacity is lost, recruitment letter to bereaved 
relative, trial recruitment figures for each site,  
clinical scenarios and materials to support recruitment for health care 
professionals, published study conference posters, published results 




 Summary of the within case analysis for case three 
 
Identifying participants: defining the target audience 
 Medical staff were required to estimate the patient’s risk of dying during the 
hospital admission. This eligibility criteria could be challenging to implement 
especially in the control arm.  
 There was a risk of contamination if medical staff were supported and trained in 
how to apply this eligibility criteria. The risk of dying criteria was removed from 
the control arm during the trial for pragmatic reasons.  
Product: Defining the product 
 Randomisation occurred at the organisational level rather than the individual level 
as it was a cluster trial. The intervention was aimed at the organisation rather than 
directly at the patient or carer but they were asked to complete questionnaires. 
Product: The product’s competition 
 There we no trials competing for the same patient population within the hospital    
inpatient units at the time of recruitment.  
Price: ‘Type of Costs’ and Price: ‘Minimising the costs’ 
 The patient’s unstable and fluctuating condition influenced their ability to engage 
in the recruitment process.  
 Research nurses were concerned about the length of the study information. They 
read and went through the documentation with patients to try and minimise study 
burden.  




 The costs of taking on the role of consultee could be too burdensome for some 
carers.  
 Research nurses were not always clear about who was able to act as a consultee 
and could lack confidence and skill when assessing capacity.  
 Carer gatekeeping was an issue in this case. Research nurses were worried in some 
instances that families may make a complaint.  
Place 
 The clinical recruitment centres were non-specialist hospitals and they had less 
eligible patients than predicted. Sites needed to be kept open to recruitment 
longer than anticipated.   
Promoting the study 
 There was no need for recruiting staff to explain randomisation as part of the 
informed consent procedure as it was a cluster trial.   
 The research nurses used a flexible and respectfully persistent approach when 
recruiting patients because of their physical, psychological and emotional well-
being and the need to work around clinical care and family visiting times. 
 A minority of patients became distressed when they were introduced to the trial. 
 Carers were invited to complete a questionnaire post bereavement rather than at 
the time of consent. This could still make research nurses feel uncomfortable. 
Working with partners: barriers to partnering 
 It was challenging for research nurses to engage medical staff in the inpatient 
setting because of clinician rotation and turnover.  
 In one of the sites, research nurses worked as a generic research team to ensure 
recruitment could continue if the nurse was unavailable. A nurse would act as the 
lead for the study while other research nurses would assist when necessary.  
Working with partners: partner education  
  Specialist palliative care professionals who had a consulting role within the clinical 
recruitment centre also took on the role of ‘research champion’ but they were 
often unavailable and did not have overall responsibility for the patient’s care.  
 Research nurses who had previous experience of talking to palliative care patients 
and their carers and/or previous clinical contact appeared to find having sensitive 
conversations less emotionally demanding than those without similar experience.  
 Clinical recruitment centres had to use a core team of research nurses who felt 
comfortable working on the study.  
Working with partners: partner referrals and recruitment  
 The Chief Investigator, a non-medical academic, needed to build up relationships 
with clinicians in clinical recruitment centres to negotiate access and this could 
take a long time. 
 To be eligible to take part in the trial, organisations needed access to staff who 
were able to deliver the intervention. 
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 Research nurses used routine multi-disciplinary team meetings on the inpatient 
units to screen for potentially eligible participants. 
 The lead medical clinician was responsible for confirming trial eligibility but some 
medical staff appeared reticent and fearful of making the decision that the patient 
may die under their care. This decision required them to have a difficult 
conversation with the patient. 
 
 
In summary, case three was a multi-centre feasibility cluster trial of a complex 
organisational level intervention for patients (or proxy if required) with advanced cancer or 
non-cancer at the end of life. The trial recruited from non-specialist hospital inpatients and 
only half of the four sites reached their recruitment target. The Chief Investigators were 
non-medical senior academics and experienced palliative care researchers. All of the 
research nurses who took part in the interview had general trial recruitment experience. 
Medical staff were required to predict the patient’s risk of dying when ‘identifying 
participants’ which was challenging to operationalise especially in the control arm. Research 
nurses were concerned about the ‘costs’ of consent procedures for patients because of their 
condition. Carer gatekeeping was an issue in this trial and research nurses could be 
concerned that families may make a complaint. When ‘promoting’ the trial research nurses 
used a flexible and respectfully persistent approach because of the patient’s condition. A 
minority of patients became distressed when they were introduced to the trial. Clinician 
rotation and turnover in the inpatient setting was a ‘barrier to recruitment’ in this trial. 
Those research nurses with previous palliative care experience and/or who had previous 
clinical contact with the patient found having sensitive conversations less emotionally 
demanding. Some research nurses declined to work on the trial. Confirmation of trial 
eligibility was the responsibility of the lead medical clinician but they could be reticent and 
fearful of making the decision that the patient may die under their care because it required 
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them to have a difficult conversation with the patient. Negotiating access into clinical 
recruitment centres required the Chief Investigator, a non-medical academic, to build up 
relationships with clinicians which could take a long time.   
 
To conclude, a summary of the within case analysis findings for the three cases is presented 
in relation to the ‘6 Ps’ of the ‘Social Marketing Mix Framework’, as this was the a priori 
framework used in this study. The summaries highlight the differences in clinical setting and 
study design between the three cases. An ‘abbreviated vignette’ of each of the three cases 
is also presented in chapter five. This is to provide contextual information for the detailed 
cross-case analysis that is outlined in chapters five and six. 
 
 
 
